LASERSIGHT INC /DE
8-K, 1998-01-14
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Previous: HEALTH PROFESSIONALS INC /DE, 10-K, 1998-01-14
Next: BET HOLDINGS INC, 10-K/A, 1998-01-14



                                             

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


                                    FORM 8-K


                                 CURRENT REPORT


                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934


Date of Report (date of earliest event reported):  January 14, 1998
                                                   (December 30, 1997)


                             LASERSIGHT INCORPORATED
                             -----------------------
              Exact name of registrant as specified in its charter


                                    Delaware
                                    --------
                  State or other jurisdiction of incorporation



          0-19671                                                65-0273162
          -------                                                ----------
Commission File Number                                         I.R.S. Employer
                                                              Identification No.


                 12161 Lackland Road, St. Louis, Missouri 63146
                 ----------------------------------------------
                     Address of Principal Executive Offices


Registrant's telephone number, including area code:  (314) 469-3220




<PAGE>

Item 2.   Acquisition or Disposition of Assets.

     Sale of MEC and LSIA.  On December  30,  1997,  the Company sold all of the
outstanding  stock of MEC Health Care, Inc.  ("MEC") and LSI  Acquisition,  Inc.
("LSIA"),  two wholly owned  subsidiaries of the Company,  to Vision Twenty-One,
Inc.  ("Vision 21") in a transaction which was effective as of December 1, 1997.
The  total  consideration  paid by Vision 21 to the  Company  consisted  of $6.5
million in cash paid at closing  and  820,085  unregistered  shares of Vision 21
common stock,  subject to certain  post-closing  adjustments  (such shares,  the
"Vision 21 Shares").  The Vision 21 Shares are to be liquidated  pursuant to the
following schedule (or sooner at Vision 21's option):

                             Month                    Approximate
                             (1998)                    Percentage
                             ------                    ----------

                 February . . . . . . . . . . .            21%

                 March . . . . . . . . . . . .             21%

                 April . . . . . . . . . . . .             28%

                 May  . . . . . . . . . . . . .            30%
                                                          ----

                          Total                           100%

Under its agreements  with the Company,  Vision 21 is to liquidate the Vision 21
Shares by a sale  through a market maker  designated  by Vision 21 pursuant to a
shelf  registration  statement  or a private  placement,  or  through  Vision 21
repurchasing the Vision 21 Shares.  The Company is entitled to receive a minimum
of $6.5  million and a maximum of $7.475  million  from the  liquidation  of the
Vision 21 Shares. If the Company has not received at least $6.5 million (subject
to  certain  post-closing  adjustments)  from the  liquidation  of the Vision 21
Shares by May 29,  1998,  then on such date Vision 21 is to pay the Company such
shortfall in cash. If more than $6.5 million is raised  through the  liquidation
of the Vision 21 Shares,  then such excess shall be used first to pay  customary
broker,  underwriter and placement agent fees, commissions and discounts related
to the  liquidation of the Vision 21 Shares, and the balance of the  liquidation
proceeds, if any, shall be paid to the Company,  provided that the Company shall
not receive liquidation proceeds in excess of $7.475 million. If Vision 21 fails
to make the payments  contemplated by the plan of distribution,  the Company can
either  require  Vision 21 to have a  registration  statement  covering  all the
Vision 21 Shares not yet liquidated  declared  effective by the SEC, or sell the
Vision  21  Shares  in a  private  placement  subject  only to  compliance  with
applicable securities laws.

     The  parties  agreed to  indemnify  each  other  for  certain  breaches  of
representations,  warranties  and  covenants  contained  in the  Stock  Purchase
Agreement  for unlawful  sale or transfer of the Vision 21 Shares.  In addition,
Vision 21 agreed to  indemnify  the Company  for Vision 21's  failure to satisfy
obligations and liabilities of MEC and LSIA, and the Company agreed to indemnify
Vision 21 from certain claims of fraudulent  inducement related to the execution

<PAGE>

of the services  agreement  between LSIA and Northern New Jersey Eye  Institute,
P.A. ("NNJEI"),  breaches of such services agreement by the Company, MEC or LSIA
prior to closing,  and the  unenforceability  of such services  agreement due to
actions or  inactions of the Company,  MEC or LSIA which  occurred  prior to the
closing.

     Post-Closing  Adjustments.  The final  number of the Vision 21 Shares to be
received  by the  Company is subject to certain  post-closing  adjustments.  The
Company is required to reimburse  Vision 21 for operating  profits for the month
of December  1997  generated  by MEC and LSIA,  negative  working  capital as of
November  30,  1997 of MEC and LSIA less than  negative  $180,000,  if any,  and
negative  net  worth as of  November  30,  1997  for MEC and  LSIA,  if any.  In
addition,  if prior to December  31, 1998 Vision 21 does not enter into  certain
practice management agreements with NNJEI and an affiliated physician, or absent
such  agreements,  if the  benefits  Vision 21 derives  from  existing  practice
management  agreements  for the period  ending  December  31,  1998 is less than
$133,000, then the Company is required to reimburse Vision 21 for such shortfall
on a dollar-for-dollar basis up to a maximum reimbursement of $500,000.

     Reduction in Foothill Borrowing.  The Company used $2.0 million of its cash
proceeds  from the sale of MEC and LSIA to reduce the  principal  balance of the
Company's term loan with Foothill  Capital  Corporation  ("Foothill")  from $4.0
million  to $2.0  million.  The  Company  used  approximately  $1.5  million  of
additional cash proceeds from the sale to repay in full the outstanding  balance
under its revolving loan with Foothill.

     Restructuring of Foothill Loan Facility.  Effective  December 30, 1997, the
Company  restructured  the terms of its agreements with Foothill.  The revolving
loan will remain in place in accordance  with its previous terms but the maximum
amount available thereunder is reduced to $2.0 million. In addition, the Company
pledged the Vision 21 Shares to Foothill as collateral  under the loan facility.
Moreover,  after the Company has received $2.5 million from the  liquidation  of
the Vision 21 Shares,  any additional  proceeds must first be applied to pay off
the Company's  term loan with Foothill,  and any further  proceeds to retire any
then-outstanding  advances under its revolving loan with Foothill. In any event,
the  Company's  term loan is to be paid in full on June 15, 1998 (rather than in
monthly  installments  of  $1.33  million  beginning  on May 1,  1998)  and  all
availability  under the  Company's  revolving  loan  terminates on June 15, 1998
(rather than declining by $1.33 million per month  beginning on August 1, 1998).
Until June 16,  1998,  Foothill  has waived the  Company's  compliance  with the
financial  covenants which were contained in the agreements  between the Company
and Foothill.



<PAGE>


Item 7.  Financial Statements, Pro Forma Financial Information and Exhibits.

      (a) Financial Statements

          Not applicable.

      (b) Pro Forma Financial Information.

          The following   unaudited  pro  forma  condensed   combined  financial
          statements are filed with this report, beginning on page 6:

          1)  LaserSight Incorporated Unaudited Pro Forma Condensed Consolidated
              Balance Sheet as of September 30, 1997.

          2)  LaserSight Incorporated Unaudited Pro Forma Condensed Consolidated
              Statement of Operations for the nine month period ended  September
              30, 1997.

          3)  LaserSight Incorporated Unaudited Pro Forma Condensed Consolidated
              Statement of Operations for the year ended December 31, 1996.

          4)  LaserSight  Incorporated  Notes to Unaudited  Pro Forma  Condensed
              Consolidated Financial Statements.

      (c) Exhibits


          Exhibit 2.(i)   Stock Purchase  Agreement effective  December 1, 1997,
                          between  Vision  Twenty-One,  Inc.,  MEC  Health Care,
                          Inc.,    LSI   Acquisition,   Inc.   and    LaserSight
                          Incorporated.

          Exhibit 2.(ii)  Stock Distribution Agreement dated as  of December 30,
                          1997,  between  Vision Twenty-One, Inc. and LaserSight
                          Incorporated.

          Exhibit 2.(iii) Consent  and   Amendment   Number  Four  to  Loan  and
                          Security  Agreement  dated December 30, 1997,  between
                          LaserSight    Incorporated    and   Foothill   Capital
                          Corporation.


<PAGE>



                                   SIGNATURES
                                   ----------


Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.


                                               LaserSight Incorporated



Date:   January 14, 1998                       By:  /s/ Gregory L. Wilson
                                                   -----------------------
                                                   Gregory L. Wilson
                                                   Chief Financial Officer


<PAGE>

<TABLE>

                         PRO FORMA FINANCIAL INFORMATION

                    LASERSIGHT INCORPORATED AND SUBSIDIARIES
                 PRO FORMA CONDENSED CONSOLIDATED BALANCE SHEET
                               SEPTEMBER 30, 1997
                                   (UNAUDITED)
<CAPTION>

                                                                                       Pro Forma
                                                                                      Adjustments
                                                                ----------------------------------------------------
                                                Historical           MEC               LSIA              Other           Pro Forma
                                              ----------------  ---------------   ---------------    ---------------   -------------
ASSETS
Current Assets
<S>                                            <C>              <C>               <C>                <C>                <C>      
   Cash and cash equivalents                   $  1,164,158     $  (497,319) (1)  $   (33,756) (1)    $ 3,000,000 (3)    $ 3,633,083
   Marketable equity securities                           -               -                 -           6,200,000 (4)      6,200,000
   Accounts receivable - trade, net               3,840,332            (360) (1)     (577,592) (1)              -          3,262,380
   Notes receivable - current portion, net        3,711,675               -                 -                   -          3,711,675
   Inventories                                    3,991,541               -                 -                   -          3,991,541
   Other current assets                           1,169,719          (4,843) (1)     (234,974) (1)              -            929,902
                                               -------------    ----------------  ---------------    ----------------    -----------
     Total Current Assets                        13,877,425        (502,522)         (846,322)          9,200,000         21,728,581

Restricted cash                                   3,200,000               -                 -                   -          3,200,000
Notes receivable, less current portion, net       3,538,268               -                 -                   -          3,538,268
Property and equipment, net                       2,214,293        (155,857) (1)     (689,906) (1)              -          1,368,530
Goodwill, net                                    14,783,566      (6,004,459) (1)   (1,570,459) (1)              -          7,208,648
Patents, net                                     11,462,339               -                 -                   -         11,462,339
Other assets, net                                 5,719,558        (137,500) (1)            -                   -          5,582,058
                                               -------------    ----------------  ----------------   ----------------    -----------
Total Assets                                   $ 54,795,449     $(6,800,338)      $(3,106,687)        $ 9,200,000        $54,088,424
                                               =============    ================  ================   ================    ===========

LIABILITIES AND STOCKHOLDERS' EQUITY
Current Liabilities
   Accounts payable                            $  2,525,677     $  (775,822) (1)  $   (44,664) (1)    $         -        $ 1,705,191
   Note payable, less discount                    3,677,778               -                 -          (3,500,000) (3)       177,778
   Current portion of capital lease obligation      224,549               -          (224,549) (1)              -                  -
   Accrued expenses                               1,748,266         (78,478) (1)       (7,188) (1)         400,000 (5)     2,062,600
   Accrued commissions                            1,110,529               -                 -                   -          1,110,529
   Income taxes payable                                   -               -                 -            1,558,648 (6)     1,558,648
   Other current liabilities                         63,998         (18,663) (1)      (22,500) (1)              -             22,835
                                               -------------    ----------------  ----------------   ----------------   ------------
     Total Current Liabilities                    9,350,797        (872,963)         (298,901)         (1,541,352)         6,637,581

Refundable deposits                                 203,000               -                 -                   -            203,000
Accrued expenses, less current portion              590,369               -                 -                   -            590,369
Deferred income taxes                               570,296               -                 -                   -            570,296
Long-term obligations                               971,018               -          (471,018) (1)              -            500,000

Redeemable convertible preferred stock           14,374,027               -                 -                   -         14,374,027

Stockholders' Equity                             28,735,942      (5,927,375) (7)   (2,336,768) (7)      10,741,352 (7)    31,213,151
                                               -------------    ----------------  ----------------   ----------------  -------------
Total Liabilities and Stockholders' Equity     $ 54,795,449     $(6,800,338)      $(3,106,687)        $  9,200,000     $  54,088,424
                                               =============    ================  ================   ================  =============
</TABLE>

<PAGE>

<TABLE>


                         PRO FORMA FINANCIAL INFORMATION

                    LASERSIGHT INCORPORATED AND SUBSIDIARIES
            PRO FORMA CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS
               FOR THE NINE MONTH PERIOD ENDED SEPTEMBER 30, 1997
                                   (UNAUDITED)
<CAPTION>

                                                                                     Pro Forma
                                                                                    Adjustments
                                                                        ------------------------------------
                                                     Historical               MEC                 LSIA              Pro Forma
                                                   ----------------    ----------------     ----------------     ----------------


<S>                                                 <C>                <C>                  <C>                    <C>         
REVENUES, Net                                       $  18,083,073      $ (6,268,133) (2)    $ (2,442,268) (2)      $  9,372,672

COST OF SALES                                           2,934,001                 -                    -              2,934,001
PROVIDER PAYMENTS                                       4,450,855        (4,450,855) (2)               -                     -
                                                   ----------------    ----------------     ----------------     ----------------

GROSS PROFIT                                           10,698,217        (1,817,278)          (2,442,268)             6,438,671

RESEARCH, DEVELOPMENT AND
   REGULATORY EXPENSES                                  1,729,153                 -                    -              1,729,153

SELLING, GENERAL AND ADMINISTRATIVE
   EXPENSES                                            13,568,380        (1,533,202) (2)      (2,244,422) (2)         9,790,756
                                                   ----------------    ----------------     ----------------     ----------------

LOSS FROM OPERATIONS                                  (4,599,316)          (284,076)            (197,846)           (5,081,238)

OTHER INCOME AND EXPENSES:
   Interest and dividend income                           292,272           (33,496) (2)         (24,106) (2)           234,670
   Interest expense                                     (911,966)                 -                71,675 (2)         (840,291)
   Gain on sale of subsidiaries                                -                  -                    -                     -
   Other                                                (280,400)                 -                    -              (280,400)
                                                   ----------------    ----------------     ----------------      ----------------

NET LOSS BEFORE INCOME TAXES                          (5,499,410)          (317,572)            (150,277)           (5,967,259)

INCOME TAX EXPENSE                                             -                  -                    -                     -
                                                   ----------------    ----------------     ----------------      ----------------

NET LOSS                                              (5,499,410)          (317,572)            (150,277)           (5,967,259)

CONVERSION DISCOUNT ON PREFERRED
   STOCK                                                 (41,573)                 -                    -               (41,573)

PREFERRED STOCK DIVIDEND
  REQUIREMENTS                                           (13,350)                 -                    -               (13,350)
                                                   ----------------    ----------------     ----------------      ----------------

LOSS ATTRIBUTABLE TO COMMON
  STOCKHOLDERS                                      $ (5,554,333)     $    (317,572)        $   (150,277)          $(6,022,182)
                                                   ================    ================     ================      ================

LOSS PER COMMON SHARE
   Primary:                                         $      (0.59)                                                  $     (0.64)
   Assuming full dilution:                          $      (0.59)                                                  $     (0.64)

WEIGHTED AVERAGE NUMBER
   OF SHARES OUTSTANDING
   Primary:                                             9,342,000                                                     9,342,000
   Assuming full dilution:                              9,390,000                                                     9,390,000

</TABLE>


<PAGE>

<TABLE>


                         PRO FORMA FINANCIAL INFORMATION

                    LASERSIGHT INCORPORATED AND SUBSIDIARIES
            PRO FORMA CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS
                      FOR THE YEAR ENDED DECEMBER 31, 1996
                                   (UNAUDITED)
<CAPTION>

                                                                                 Pro Forma
                                                                                Adjustments
                                                                    ----------------------------------
                                                 Historical              MEC                    LSIA              Pro Forma
                                               ---------------    -----------------      -----------------     -----------------


<S>                                            <C>                <C>                    <C>                     <C>          
REVENUES, Net                                  $  21,503,990      $  (6,179,419) (2)     $  (1,703,524) (2)      $  13,621,047
                                                                            

COST OF SALES                                      3,415,276                  -                      -               3,415,276
PROVIDER PAYMENTS                                  4,221,599         (4,221,599) (2)                 -                      -
                                               ---------------    -----------------      -----------------     -----------------

GROSS PROFIT                                      13,867,115         (1,957,820)            (1,703,524)             10,205,771
                                                         
RESEARCH, DEVELOPMENT AND
   REGULATORY EXPENSES                             1,720,246                  -                      -               1,720,246

SELLING, GENERAL AND ADMINISTRATIVE
   EXPENSES                                       17,107,218         (1,725,096) (2)        (1,562,288) (2)         13,819,834
                                               ---------------    -----------------      -----------------     -----------------

LOSS FROM OPERATIONS                             (4,960,349)           (232,724)              (141,236)            (5,334,309)

OTHER INCOME AND EXPENSES:
   Interest and dividend income                      314,287            (35,978) (2)           (15,454) (2)            262,855
   Interest expense                                (151,634)                  -                  55,075 (2)           (96,559)
   Gain on sale of subsidiaries                           -                   -                      -                      -
   Other                                           (415,681)               8,299 (2)                 -               (407,382)
                                               ---------------    -----------------      -----------------     -----------------

NET LOSS BEFORE INCOME TAXES                     (5,213,377)           (260,403)              (101,615)            (5,575,395)
                                                        

INCOME TAX BENEFIT                               (1,139,008)                  -                      -             (1,139,008)
                                                                 
                                               ---------------    -----------------      -----------------     -----------------

NET LOSS                                         (4,074,369)           (260,403)              (101,615)            (4,436,387)
                                                 
CONVERSION DISCOUNT ON PREFERRED
   STOCK                                         (1,010,557)                  -                      -             (1,010,557)
                                                                  

PREFERRED STOCK DIVIDEND
  REQUIREMENTS                                     (358,618)                  -                      -               (358,618)
                                               ---------------    -----------------      -----------------     -----------------

LOSS ATTRIBUTABLE TO COMMON
  STOCKHOLDERS                                 $ (5,443,544)      $    (260,403)         $    (101,615)          $  (5,805,562)
                                               ===============    =================      =================     =================

LOSS PER COMMON SHARE
   Primary:                                    $      (0.69)                                                     $       (0.74)
   Assuming full dilution:                     $      (0.61)                                                     $       (0.65)

WEIGHTED AVERAGE NUMBER
   OF SHARES OUTSTANDING
   Primary:                                        7,893,000                                                          7,893,000
   Assuming full dilution:                         8,423,000                                                          8,423,000

</TABLE>

<PAGE>

                    
                    LASERSIGHT INCORPORATED AND SUBSIDIARIES

    NOTES TO UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL STATEMENTS


The  unaudited  pro forma  condensed  balance sheet as of September 30, 1997 has
been prepared  assuming that the  disposition  had occurred as of that date. Pro
forma  unaudited  condensed  consolidated  statements of operations for the year
ended  December 31, 1996 and the nine months ended  September 30, 1997 have been
prepared  assuming that the  disposition had occurred as of the beginning of the
year ended  December 31, 1996.  The unaudited pro forma  condensed  consolidated
statements of operations  are not  necessarily  indicative of results that would
have occurred had the  disposition  been  consummated as of the beginning of the
year ended December 31, 1996 or that which might be attained in the future.

Pro forma adjustments are as follows:

1.   To eliminate  the assets and  liabilities  included in the balance sheet of
     MEC and LSIA as of September 30, 1997.

2.   To eliminate  revenue and  expenses  related to MEC and LSIA for the entire
     period.

3.   To reflect cash proceeds  from the transaction  of $6.5 million  after note
     payable  pay down of $2.0  million  and  payoff of $1.5  million in line of
     credit   borrowings  made  subsequent  to  September  30,  1997  that  were
     outstanding at December 30, 1997.

4.   To  reflect  receipt of $6.5  million in Vision 21 shares net of  estimated
     purchase price adjustments.

5.   To reflect the accrual of estimated transaction costs.

6.   To  reflect  income  tax  liabilities  resulting  from the  transaction  at
     statutory rates, which may differ from actual effective tax rates.

7.   The pro  forma  gain on the sale of MEC and LSIA  assumes  the  transaction
     occurred on September  30, 1997.  Such gain reflects the $13.0 million sale
     price  less  $0.7  million  in  estimated   post-closing   adjustments  and
     transaction costs, for a net selling price of $12.3 million.  Deducted from
     such net selling  price are the net book value at September 30, 1997 of MEC
     (approximately $5.9 million) and LSIA (approximately $2.3 million), and the
     pro forma income tax liabilities at statutory rates of  approximately  $1.5
     million,  resulting  in a pro  forma  gain on the  sale of MEC and  LSIA of
     approximately  $2.5 million.  Such pro forma gain will vary from the actual
     gain based on the actual effective income tax rates, the change in net book
     value of MEC and LSIA from  September 30, 1997 to November 30, 1997 and the
     actual   post-closing   adjustments  and  transaction  costs.  The  Company
     estimates its gain will approximate $1.5 million.




                            STOCK PURCHASE AGREEMENT



                          DATED: As of December 1, 1997



<PAGE>


                            STOCK PURCHASE AGREEMENT
                            ------------------------


     This Stock Purchase  Agreement (this  "Agreement"),  effective  December 1,
1997,  is by and among  VISION  TWENTY-ONE,  INC.,  a Florida  corporation  (the
"Purchaser"),  MEC  Health  Care,  Inc.  ("MEC"),  a Maryland  corporation,  LSI
Acquisition,  Inc. ("LSI"), a New Jersey corporation (collectively the "Acquired
Companies")   and  LaserSight   Incorporated,   a  Delaware   corporation   (the
"Stockholder").

                                 R E C I T A L S
                                 ---------------

     A.  Stockholder  owns all of the issued and  outstanding  shares of capital
stock of the Acquired Companies.

     B. Purchaser desires to purchase from the Stockholder,  and the Stockholder
desires to sell to Purchaser, all of the issued and outstanding capital stock of
the Acquired Companies, pursuant to and in accordance with this Agreement.

     NOW, THEREFORE, in consideration of the mutual representations,  warranties
and covenants  contained herein,  and on the terms and subject to the conditions
herein set forth, the parties hereto hereby agree as follows:

     1. DEFINITIONS.  As used in this Agreement,  the following terms shall have
the meanings set forth below:

         1.1.   AAA.  The  term  "AAA"  shall  mean  the  American   Arbitration
Association.

         1.2. Accounts Receivable. The term "Accounts Receivable" shall have the
meaning set forth in Section 3.35.

         1.3.  Affiliate.  The term  "Affiliate"  with  respect to any person or
entity shall mean a person or entity that directly or indirectly  through one or
more  intermediaries,  controls,  or is controlled by or is under common control
with, such person or entity.

         1.4.  Assets.  The term  "Assets"  shall  mean all of the assets of the
Acquired Companies, except as otherwise provided in this Agreement.

         1.5. Business.  The term "Business" shall have the meaning set forth in
Section 16.1(b)(i).

         1.6. Cash  Compensation.  The term "Cash  Compensation"  shall have the
meaning set forth in Section 3.11(a).
<PAGE>

         1.7.  Claim Notice.  The term "Claim Notice" shall have the meaning set
forth in Section 14.3(a).

         1.8.  Closing.  The term "Closing"  shall mean the  consummation of the
transactions contemplated by this Agreement.

         1.9.  Closing  Date.  The term  "Closing  Date" shall mean December 30,
1997, or such other date as mutually agreed upon by the parties.

         1.10.  Code.  The term "Code" shall mean the  Internal  Revenue Code of
1986, as amended.

         1.11.  Commitments.  The term "Commitments"  shall have the meaning set
forth in Section 3.16(a).

         1.12.  Common  Stock.  The term  "Common  Stock"  shall mean the common
stock, par value $.01 per share, of Purchaser.

         1.13.  Company.  The term  "Company"  shall  also  mean  the  "Acquired
Companies."

         1.14. Company Balance Sheet Date. The term "Company Balance Sheet Date"
shall have the meaning set forth in Section 3.9.

         1.15.  Company Common Stock. The term "Company Common Stock" shall mean
the common stock of the Acquired Companies.

         1.16.  Compensation Plans. The term "Compensation Plans" shall have the
meaning set forth in Section 3.11(b).

         1.17. Competing Business.  The term "Competing Business" shall have the
meaning set forth in Section 16.1(b)(ii).

         1.18. Competitor. The term "Competitor" shall mean any person or entity
which,  individually or jointly with others,  whether for its own account or for
that of any  other  person or  entity,  owns or holds  any  ownership  or voting
interest in any person or entity engaged in the business of providing management
services to eye care  professionals  and of providing  managed care  services to
health maintenance  organizations,  preferred  provider  organizations and other
third party payor entities.

         1.19.  Controlled  Group.  The term  "Controlled  Group" shall have the
meaning set forth in Section 3.12(g).

         1.20.  Damages.  The term "Damages" shall have the meaning set forth in
Section 14.1.
<PAGE>

         1.21.  Effective Date. The term "Effective  Date" shall mean 12:01 a.m.
on December 1, 1997.

         1.22.  Election  Period.  The term  "Election  Period"  shall  have the
meaning set forth in Section 14.3(a).

         1.23.  Employee Benefit Plans. The term "Employee  Benefit Plans" shall
have the meaning set forth in Section 3.12(a).

         1.24. Employee Policies and Procedures. The term "Employee Policies and
Procedures" shall have the meaning set forth in Section 3.11(d).

         1.25.  Employment  Agreements.  The term "Employment  Agreements" shall
have the meaning set forth in Section 3.11(c).

         1.26.  Environmental  Damages.  The term "Environmental  Damages" shall
mean all claims,  judgments,  damages,  losses,  penalties,  fines,  liabilities
(including  strict  liability),  encumbrances,  liens,  costs  and  expenses  of
investigation and defense of any claim,  whether or not such claim is ultimately
defeated,  and of any good faith  settlement  of judgment,  of whatever  kind or
nature,   contingent  or  otherwise,   matured  or  unmatured,   foreseeable  or
unforeseeable,  including  without  limitation  reasonable  attorneys'  fees and
disbursements and consultants'  fees, any of which are incurred at any time as a
result of:

              (i) the existence prior to the Closing Date of Hazardous  Material
upon,  about,  beneath the Property or migrating or threatening to migrate to or
from the Property, or the existence of a violation of Environmental Requirements
pertaining to the Property; or

              (ii) the release or threatened release of Hazardous Material upon,
about,   beneath  Off-Site   Locations  or  the  existence  of  a  violation  of
Environmental  Requirements  pertaining  to the Off-Site  Location for which the
Seller or the Seller is a potentially  responsible  party  regardless of whether
the  existence of such  Hazardous  Material or the  violation  of  Environmental
Requirements arose prior to the present ownership or operation of the Property.

         1.27. Environmental Requirements. The term "Environmental Requirements"
shall mean all  applicable  statutes,  regulations,  rules,  ordinances,  codes,
licenses,  permits,  orders,  approvals,  plans,  authorizations,   concessions,
franchises  and  similar  items  of  all  governmental  agencies,   departments,
commissions,  boards,  bureaus or instrumentalities of the United States, states
and political  subdivisions thereof and all applicable judicial,  administrative
and regulatory decrees, judgments and orders relating to the protection of human
health or the environment.
<PAGE>

         1.28. ERISA. The term "ERISA" shall mean the Employee Retirement Income
Security Act of 1974, as amended.

         1.29. Escrow Agent. The term "Escrow Agent" shall mean Shumaker, Loop &
Kendrick, LLP, an Ohio professional limited liability partnership.

         1.30.  Escrow  Agreement.  The term "Escrow  Agreement"  shall mean any
Escrow Agreement  entered into among the  Stockholder,  Purchaser and the Escrow
Agent at the Closing.

         1.31.  Exchange Act. The term  "Exchange Act" shall mean the Securities
Exchange Act of 1934, as amended.

         1.32. Financial Statements.  The term "Financial Statements" shall have
the meaning set forth in Section 3.9.

         1.33.  GAAP. The term "GAAP" shall mean generally  accepted  accounting
principles,  applied on a consistent  basis with prior periods,  as set forth in
the  opinions  and  pronouncements  of the  Accounting  Principles  Board of the
American   Institute  of  Certified   Public   Accountants  and  statements  and
pronouncements  of the  Financial  Accounting  Standards  Board or in such other
statements  by such other entity or other  practices  and  procedures  as may be
approved  by a  significant  segment  of the  accounting  profession,  which are
applicable to the circumstances as of the date of the determination.

         1.34. Governmental Authority.  The term "Governmental  Authority" shall
mean any national, state, provincial,  local or tribunal governmental,  judicial
or administrative authority or agency.

         1.35. Hazardous Material.  The term "Hazardous Material" shall mean any
substance:

              (i) the presence of which  requires  investigation  or remediation
under any Environmental Requirement; or

              (ii)  which is  defined  as a "solid  waste,"  "hazardous  waste,"
"hazardous substance,"  "pollutant" or "contaminant" under any federal, state or
local statute,  regulation,  rule or ordinance or amendments  thereto including,
without limitation, the Comprehensive  Environmental Response,  Compensation and
Liability Act (42 U.S.C.  ss.9601 et seq.) and/or the Resource  Conservation and
Recovery Act (42 U.S.C. ss. 6901 et seq.); or
<PAGE>

              (iii) the presence of which,  under any Environmental  Requirement
poses a hazard to the health or safety of persons on or about the Property; or

              (iv) which contains petroleum, including crude oil or any fraction
thereof.

         1.36.  Indemnified  Party. The term "Indemnified  Party" shall have the
meaning set forth in Section 14.3(a).

         1.37.  Indemnifying Party. The term "Indemnifying Party" shall have the
meaning set forth in Section 14.3(a).

         1.38.  Indemnity  Notice.  The term  "Indemnity  Notice" shall have the
meaning set forth in Section 14.3(d).

         1.39. Insurance Policies.  The term "Insurance Policies" shall have the
meaning set forth in Section 3.17.

         1.40. IRS. The term "IRS" shall mean the Internal Revenue Service.

         1.41. Material Adverse Effect. The term "Material Adverse Effect" shall
mean a  material  adverse  effect  on the  Assets  and the  Acquired  Companies'
business,   operations,   condition  (financial  or  otherwise)  or  results  of
operations, taken as a whole, considering all relevant facts and circumstances.

         1.42.  Off-Site Location.  The term "Off-Site  Location" shall mean any
site or facility to which Hazardous  Material generated on the Property prior to
the Closing Date was transported  for recycling,  reuse,  treatment,  storage or
disposal.

         1.43. Permitted Encumbrances.  The term "Permitted  Encumbrances" shall
have the meaning set forth in Section 3.14(b).

         1.44. Property. The term "Property" shall mean all real property owned,
leased or used by the Acquired Companies.

         1.45.  Proposed  Stock  Purchase  Consideration  Adjustment.  The  term
"Proposed Stock Purchase  Consideration  Adjustment"  shall have the meaning set
forth in Section 2.5.

         1.46.  Proprietary Rights. The term "Proprietary Rights" shall have the
meaning set forth in Section 3.18.
<PAGE>

         1.47.  SEC.  The term "SEC"  shall  mean the  Securities  and  Exchange
Commission.

         1.48. Securities. The term "Securities" shall mean the shares of Common
Stock of Purchaser to be  delivered to the  Stockholder  and the Escrow Agent at
the Closing.

         1.49.  Securities  Act.  The  term  "Securities  Act"  shall  mean  the
Securities Act of 1933, as amended.

         1.50.  Stock.  The term  "Stock"  shall have the  meaning  set forth in
Section 2.1.

         1.51.  Stock  Distribution  Agreement.  The  term  "Stock  Distribution
Agreement" shall mean the Stock Distribution  Agreement entered into between the
Stockholder and the Purchaser.

         1.52.   Stock  Purchase   Consideration.   The  term  "Stock   Purchase
Consideration"  shall mean the  consideration  set forth in Section  2.3 of this
Agreement.

         1.53. Stock Purchase  Consideration  Adjustment Amount. The term "Stock
Purchase  Consideration  Adjustment  Amount" shall have the meaning set forth in
Section 2.5(a).

         1.54.   Subsidiaries.   The   term   "Subsidiaries"   shall   mean  the
subsidiaries, if any, of the Acquired Companies identified on Schedule 3.2.

         1.55.  Tax Returns.  The term "Tax Returns"  shall have the meaning set
forth in Section 3.19.

         1.56.  Third Party  Claim.  The term "Third Party Claim" shall have the
meaning set forth in Section 14.3(a).

     2. PURCHASE AND SALE OF STOCK.

         2.1. Purchase of Stock. Upon and subject to the terms and conditions of
this  Agreement,  Purchaser  agrees to  purchase  and accept  delivery  from the
Stockholder of, and the Stockholder agrees to sell, assign, transfer and deliver
to Purchaser, at the Closing, all of the issued and outstanding shares of common
stock of the Acquired Companies  (collectively,  the "Stock"), free and clear of
all liens, pledges, security interests, claims, charges, restrictions,  equities
or encumbrances of any kind whatsoever.
<PAGE>

         2.2. The Closing.  The Closing  shall take place on the Closing Date at
the offices of Shumaker, Loop & Kendrick,  LLP, 101 E. Kennedy Boulevard,  Suite
2800,  Tampa,  Florida  33602 or at such other  location  as the  parties  shall
mutually agree.

         2.3.  Stock Purchase  Consideration.  As  consideration  for the Stock,
Purchaser,  at the Closing,  shall pay to the Stockholder,  the aggregate sum of
Thirteen  Million Dollars  ($13,000,000)  (the "Stock Purchase  Consideration"),
subject to adjustment as set forth in Section 2.5, in the following manner:

              a. Cash.  The sum of Six Million  Five  Hundred  Thousand  Dollars
($6,500,000)  shall  be  delivered  to  the  Stockholder  by  wire  transfer  of
immediately  available  funds to such account or accounts as shall be designated
by the Stockholder prior to Closing.

              b. Common  Stock.  Eight  Hundred  Twelve  Thousand  Five  Hundred
(812,500)  shares of Common  Stock which shares shall be subject to the terms of
the Stock Distribution Agreement and the Escrow Agreement.

              c.  Additional  Shares.  Within five  business days of the Closing
Date, the Purchaser  shall deliver to the Stockholder  such additional  positive
number  of  shares  of  Common  Stock  (the  "Additional  Shares")  equal to the
difference  between (i) that number of shares  equal to Six Million Five Hundred
Thousand Dollars ($6,500,000) divided by the average closing price, as quoted on
the NASDAQ  National  Market  System,  for the five  business  days  immediately
preceding  the Closing  Date (the  "Valuation  Price")  less (ii)  812,500.  The
Additional  Shares  shall be  subject  to the  terms of the  Stock  Distribution
Agreement.

         2.4. Fractional Shares.  Notwithstanding any other provision herein, no
fractional  shares of Common  Stock will be issued.  Fractional  shares shall be
rounded down to the nearest whole number of shares.

         2.5. Stock Purchase Consideration Adjustments.

              A. A portion  of the  Common  Stock  component  of Stock  Purchase
Consideration consisting of One Hundred Twenty-Five Thousand (125,000) shares of
Common Stock,  plus such  additional  positive  number of shares of Common Stock
equal to the  difference  between (i) that number of shares equal to One Million
Dollars   ($1,000,000)   divided  by  the  Valuation  Price  less  (ii)  125,000
(collectively, the "Adjustment Shares") shall be subject to the Escrow Agreement
and to adjustment on a dollar for dollar basis as follows (such adjustment to be
referred to as the "Stock Purchase Consideration Adjustment Amount"):

                   (i)  Shareholder  shall  return to  Purchaser  that number of
Adjustment  Shares equal to the December  Operating  Results (as defined herein)

<PAGE>

divided  by the  Valuation  Price.  For  purposes  hereof,  "December  Operating
Results" shall mean the sum of the operating  profits of the Acquired  Companies
for the month of December 1997 (which shall be  calculated  in  accordance  with
GAAP,  consistently  applied  and in  accordance  with  the  Stockholder's  past
practices,  excluding  amortization  of  goodwill),  the total of which shall be
reduced by cash receipts from the month of December 1997 which were not utilized
to reduce the  Stockholder's  revolving loan with Foothill Capital  Corporation,
provided  that in no event  will the  adjustment  contemplated  by this  Section
2.5(a)(i) result in the Purchaser  having to issue any additional  Common Stock;
and

                   (ii) if the aggregate Net Working Capital (as defined herein)
of the  Acquired  Companies  reflected  on the  Financial  Statements  as of the
Company  Balance  Sheet Date (as defined in Section 3.9) is more  negative  than
negative $180,000, then the Stockholder shall return to Purchaser that number of
Adjustment  Shares  equal to the  negative  dollar  amount in excess of $180,000
divided by the Valuation Price.  For purposes hereof,  Net Working Capital shall
be  calculated  on an  aggregate  basis  including  LSI and MEC and is the total
current  assets of LSI and MEC reflected on the  Financial  Statements as of the
Company  Balance  Sheet Date less the total current  liabilities  of LSI and MEC
reflected on the Financial Statements as of the Company Balance Sheet Date;

                   (iii) if the aggregate  Net Worth (as defined  herein) of the
Acquired  Companies  reflected  on the  Financial  Statements  as of the Company
Balance  Sheet  Date is less then zero,  then the  Stockholder  shall  return to
Purchaser  that number of  Adjustment  Shares equal to the amount less than zero
divided  by the  Valuation  Price.  For  purposes  hereof,  Net  Worth  shall be
calculated on an aggregate basis including LSI and MEC and shall be as reflected
on the Financial Statements as of the Company Balance Sheet Date; and

                   (iv)  such  other  adjustments  as the  Stockholder  and  the
Purchaser shall mutually agree to in writing.

              B.  Within  ninety  (90) days  following  the  Closing  Date,  the
Stockholder   shall  present  to  the  Purchaser  its  proposed  Stock  Purchase
Consideration  Adjustment  Amount (the "Proposed  Stock  Purchase  Consideration
Adjustment")  calculated in accordance with Section 2.5(a) hereof and consistent
with historical  practices and operations.  The Purchaser  shall,  within thirty
(30) days after the  delivery by  Stockholder  of the  Proposed  Stock  Purchase
Consideration  Adjustment,  complete their review thereof. In the event that the
Purchaser believes that the Proposed Stock Purchase Consideration Adjustment has
not been  prepared on the basis set forth above or  otherwise  contests any item
set forth therein, the Purchaser shall, on or before the last day of such 30 day
period,  so object to Stockholder  and Escrow Agent in writing,  setting forth a
specific  description  of the  nature  of the  objection  and the  corresponding
adjustments  the Purchaser  believes should be made. If no objection is received

<PAGE>

by  Stockholder  on or  before  the  last  day of such 30 day  period,  then the
Proposed Stock Purchase Consideration  Adjustment delivered by Stockholder shall
be final. If an objection has been made and Stockholder and Purchaser are unable
to resolve all of their  disagreements with respect to the proposed  adjustments
within 15 days following the delivery of the Purchaser's objection,  the dispute
shall be  submitted to  arbitration  as provided in Section 17.1 except that the
arbitrator  shall be  instructed to deliver his  determination  of the number of
Adjustment  Shares to be  delivered  to the  Stockholder  to the parties and the
Escrow  Agent  no later  than 30 days  after  the  arbitration  hearing.  If the
Stockholder and the Purchaser are able to resolve any such  disagreements,  they
shall jointly  notify the Escrow Agent in writing as to the number of Adjustment
Shares to be  delivered to the  Stockholder.  Stockholder  shall  provide to the
Purchaser and its  accountants  full access to all relevant  books,  records and
work papers  utilized in preparing  the Proposed  Stock  Purchase  Consideration
Adjustment and the Financial Statements.

     3.  REPRESENTATIONS  AND  WARRANTIES  OF THE  ACQUIRED  COMPANIES  AND  THE
STOCKHOLDER3.  REPRESENTATIONS  AND WARRANTIES OF THE ACQUIRED COMPANIES AND THE
STOCKHOLDER. The Acquired Companies and the Stockholder,  jointly and severally,
represent  and warrant to Purchaser  that the  following are true and correct on
the date hereof, and shall be true and correct as of the Closing Date as if made
on that date;  when used in this Section 3, the term "best  knowledge" (or words
of similar import) shall mean such knowledge as shall have been obtained through
due and diligent investigation by those individuals listed on Schedule 3:

         3.1.  Organization  and  Good  Standing;  Qualification.  Each  of  the
Acquired Companies and the Subsidiaries is a corporation duly organized, validly
existing  and  in  good  standing  under  the  laws  of  its   jurisdiction   of
incorporation,  with all requisite corporate power and authority to carry on the
business in which it is engaged,  to own the  properties it owns, to execute and
deliver this Agreement and to consummate the transactions  contemplated  hereby.
Each of the  Acquired  Companies  and the  subsidiaries  is duly  qualified  and
licensed to do business in each  jurisdiction in which the character or location
of the properties owned or leased by the Acquired  Companies or the subsidiaries
or the practice of the  businesses  conducted  by the Acquired  Companies or the
subsidiaries makes such qualification  necessary or desirable,  except where the
failure to be so qualified would not have a Material Adverse Effect.

         3.2.  Subsidiaries.  Except as set forth on Schedule  3.2, the Acquired
Companies do not own,  directly or  indirectly,  any of the capital stock of any
other corporation or any equity, profit sharing, participation or other interest
in any  corporation,  partnership,  joint  venture  or  other  entity  (each,  a
"Subsidiary").

         3.3.  Capitalization.  The  authorized  capital  stock  of MEC  and LSI
consist,  respectively,  of 5,000 and 1,000 shares of Company  Common Stock,  of

<PAGE>

which 500 and 1,000 shares, respectively,  are issued and outstanding. As of the
Closing Date, the  Stockholder  owns all of the issued and  outstanding  Company
Common  Stock in the amounts set forth on  Schedule  3.3,  free and clear of all
liens,  pledges,  restrictions,  voting  trusts  or  other  security  interests,
encumbrances of any nature whatsoever.  Each outstanding share of Company Common
Stock has been legally and validly  issued and is fully paid and  nonassessable.
No shares  of  Company  Common  Stock are  owned by the  Acquired  Companies  in
treasury.  No shares of Company  Common Stock have been issued or disposed of in
violation of the preemptive rights, rights of first refusal or similar rights of
the  Stockholder.  The Acquired  Companies have no bonds,  debentures,  notes or
other  obligations  the  holders  of  which  have  the  right  to  vote  (or are
convertible  into or exercisable  for securities  having the right to vote) with
the Stockholder on any matter.

         3.4.  Transactions  in Capital  Stock.  Except as set forth on Schedule
3.4,  there  exist  no  options,  warrants,  subscriptions  or other  rights  to
purchase,  or  securities  convertible  into  or  exchangeable  for,  any of the
authorized or outstanding  securities of the Acquired Companies,  and no option,
warrant, call, conversion right or commitment of any kind exists which obligates
the Acquired  Companies  to issue any of its  authorized  but  unissued  capital
stock.  Except as set forth on Schedule  3.4,  the  Acquired  Companies  have no
obligation  (contingent or otherwise) to purchase,  redeem or otherwise  acquire
any of its equity  securities or any interests therein or to pay any dividend or
make any distribution in respect thereof.

         3.5. Corporate Records.  Copies of the Certificate of Incorporation and
Bylaws,  and  all  amendments  thereto,  of the  Acquired  Companies  have  been
delivered  or made  available to  Purchaser  and are true,  correct and complete
copies  thereof,  as in  effect  on the date  hereof.  The  minute  books of the
Acquired Companies and the Subsidiaries,  copies of which have been delivered or
made  available to Purchaser,  contain all material  minutes and consents of the
directors and stockholders of the Acquired  Companies and the Subsidiaries since
owned by Stockholder.

         3.6.  Governmental  Consents.  Except as disclosed in Schedule  3.6, no
filing or  registration  with,  or  authorization,  consent or approval  of, any
Governmental  Entity,  to the  best  knowledge  of the  Acquired  Companies,  is
necessary  for  the  consummation  of  the  transactions  contemplated  by  this
Agreement.

         3.7.  Authorization  and  Validity.  The  Acquired  Companies  have the
corporate  power and  authority  to  execute  this  Agreement  and carry out its
obligations hereunder.  The execution,  delivery and performance by the Acquired
Companies of this Agreement and the other agreements  contemplated  hereby,  and
the  consummation  of the  transactions  contemplated  hereby and  thereby to be
performed by the Acquired  Companies,  have been duly authorized by the Acquired
Companies.  This  Agreement has been duly executed and delivered by the Acquired
Companies  and  constitutes  the  legal,  valid and  binding  obligation  of the

<PAGE>

Acquired  Companies,  enforceable  against the Acquired  Companies in accordance
with its terms, except as may be limited by applicable bankruptcy, insolvency or
similar  laws  affecting  creditors'  rights  generally or the  availability  of
equitable  remedies.  The Acquired  Companies have obtained,  in accordance with
applicable law and its Certificates of Incorporation and Bylaws, the approval of
its stockholders necessary for the consummation of the transactions contemplated
hereby.

         3.8. No Conflict.  Except as disclosed on Schedule  3.8, the  execution
and delivery of the documents contemplated hereunder and the consummation of the
transactions contemplated thereby by the Acquired Companies will not (i) violate
any provision of the Acquired Companies'  organizational documents, (ii) violate
any  provision of or result in the breach of or entitle any party to  accelerate
(whether  after the  giving  of notice or lapse of time or both) any  obligation
under, any mortgage, lien, lease, material contract, license, permit, instrument
or  any  other  material  agreement  to  which  the  Acquired  Companies  or the
Subsidiaries is a party, (iii) result in the creation or imposition of any lien,
charge, pledge,  security interest or other encumbrance upon any property of the
Acquired  Companies or the  Subsidiaries,  or (iv) violate or conflict  with any
order, award,  judgment or decree or other restriction or conflict with any law,
ordinance, rule or regulation to which the Acquired Companies or its property is
subject except for those which would not have a Material Adverse Effect.

         3.9.  Financial  Statements.  Purchaser has received the  Stockholder's
audited consolidated balance sheets and related audited consolidated  statements
of operations and  accumulated  deficits and of cash flows of the Stockholder at
December 31, 1996 and 1995 and the reports  thereon of KPMG Peat Marwick LLP and
the  unaudited  balance  sheets and income  statements  for each of the Acquired
Companies  at  December  31, 1996 and 1995 and for the ten month  period  ending
October  31, 1997  (collectively  the  "Company  Balance  Sheets").  The Company
Balance Sheets reflect all adjustments,  including  normal  recurring  accruals,
considered  necessary for a fair  presentation of the financial  position of the
Acquired Companies,  subject to normal year end adjustments. The Company Balance
Sheets  related  to the  period  ended  December  31,  1996  and  1995  were the
underlying  financial  statements  utilized in  connection  with  preparing  the
Stockholder's consolidated statements of operations.

         The  Stockholder  will also furnish to Purchaser the unaudited  interim
balance sheet at November 30, 1997 of each of the Acquired Companies and related
unaudited  statements of operations  for the fiscal period then ended by January
15,  1998  (the  unaudited  interim  balance  sheet  and  related  statement  of
operations  at  November  30,  1997  shall  be  referred  to as  the  "Financial
Statements").  All of the Financial  Statements  are complete and correct,  have
been prepared on a basis consistent with past practices,  and fairly present the
separate  financial  positions  of each of the  Acquired  Companies  at the date
thereof.  The Financial  Statements  reflect all property and assets used in the
business of the Acquired  Companies in a manner  consistent with past practices.
No statement of income on the Financial Statements contains any extraordinary or

<PAGE>

nonrecurring item or expense and none of the Financial  Statements  reflects any
revaluation  of assets  (except as specified  therein).  Since November 30, 1997
(the "Company  Balance Sheet Date") there has been no material adverse change in
the  assets  or  liabilities  or in the  business  or  condition,  financial  or
otherwise,  or the results of operations or prospects of the Acquired  Companies
or the  Subsidiaries,  whether  as a result  of any  legislative  or  regulatory
change,  revocation of any license,  litigation,  administrative  action,  fire,
explosion,  accident,  casualty,  labor trouble,  flood,  drought,  riot, storm,
condemnation  or act of God or  other  public  force  or  otherwise,  except  as
disclosed and consented to by Purchaser; and to the best knowledge,  information
and belief of the Acquired  Companies and the Stockholder,  no fact or condition
exists or is contemplated  or threatened  which might cause such a change in the
future.

         3.10. No Undisclosed Liabilities. Except as set forth on Schedule 3.10,
the Financial  Statements  reflect all liabilities of the Acquired Companies and
the Subsidiaries,  accrued, contingent or otherwise that would be required to be
reflected thereon,  or in the notes thereto, in accordance with GAAP, except for
liabilities  and  obligations  incurred in the ordinary course of business since
the Acquired  Companies Balance Sheet Date. Except as set forth in the Financial
Statements  or on  Schedule  3.10,  each  of  the  Acquired  Companies  and  the
Subsidiaries  is not liable upon or with  respect to, or  obligated in any other
way to provide funds in respect of or to guarantee or assume in any manner,  any
debt,   obligation  or  dividend  of  any  person,   corporation,   association,
partnership,  joint  venture,  trust or other  entity,  and neither the Acquired
Companies nor the  Stockholder  know of any valid basis for the assertion of any
other claims or liabilities of any nature or in any amount.

         3.11. Employee Matters.

              A. Cash  Compensation.  Schedule  3.11(a)  contains a complete and
accurate  list of the  names,  titles  and annual  cash  compensation  as of the
Closing  Date,   including   without   limitation   wages,   salaries,   bonuses
(discretionary   and   formula)   and  other   cash   compensation   (the  "Cash
Compensation") of all employees of the Acquired  Companies and the Subsidiaries.
In addition,  Schedule 3.11(a)  contains a complete and accurate  description of
(i) all increases in Cash  Compensation  of employees of the Acquired  Companies
and the  Subsidiaries  during  the  current  fiscal  year  and  the  immediately
preceding  fiscal year and (ii) any promised  increases in Cash  Compensation of
employees of the Acquired  Companies and the Subsidiaries that have not yet been
effected, other than in the reasonable and ordinary course of business.

              B.  Compensation  Plans.  Schedule 3.11(b) contains a complete and
accurate  list  of  all  compensation  plans,  arrangements  or  practices  (the
"Compensation  Plans")  sponsored  by the  Acquired  Companies  or to which  the
Acquired Companies contribute on behalf of its employees,  other than Employment
Agreements  listed on Schedule  3.11(c) and  Employee  Benefit  Plans  listed on

<PAGE>

Schedule  3.12(a).  The  Compensation  Plans include without  limitation  plans,
arrangements  or  practices  that  provide  for  performance  awards,  and stock
ownership  or stock  options.  The  Acquired  Companies  have  provided  or made
available to Purchaser a copy of each  written  Compensation  Plan and a written
description of each unwritten Compensation Plan. Except as set forth on Schedule
3.11(b),  each of the Compensation Plans can be terminated or amended at will by
the Acquired Companies.

              C. Employment Agreements. Except as set forth on Schedule 3.11(c),
neither  the  Acquired  Companies  nor  the  Subsidiaries  are a  party  to  any
employment  agreement  ("Employment  Agreements")  with  respect  to  any of its
employees.  Employment  Agreements include without  limitation  employee leasing
agreements, employee services agreements and non-competition agreements.

              D. Employee  Policies and Procedures.  Schedule 3.11(d) contains a
complete and accurate  list of all employee  manuals and all material  policies,
procedures and work-related  rules (the "Employee Policies and Procedures") that
currently apply to employees of the Acquired  Companies.  The Acquired Companies
have  provided or made  available  to  Purchaser a copy of all written  Employee
Policies and  Procedures  and a written  description  of all material  unwritten
Employee Policies and Procedures.

              E. Unwritten Amendments.  Except as described on Schedule 3.11(b),
3.11(c) or 3.11(d), no material unwritten  amendments have been made, whether by
oral  communication,  pattern  of  conduct  or  otherwise,  with  respect to any
Compensation Plans or, Employee Policies and Procedures.

              F.  Labor  Compliance.  Each  of the  Acquired  Companies  and the
Subsidiaries  have been and is in compliance  with all applicable  laws,  rules,
regulations and ordinances respecting employment and employment practices, terms
and conditions of employment  and wages and hours,  except for any such failures
to be in compliance that, individually or in the aggregate,  would not result in
a Material  Adverse  Effect,  and the Acquired  Companies are not liable for any
arrearages  of  wages  or  penalties  for  failure  to  comply  with  any of the
foregoing.  Each of the Acquired Companies and the Subsidiaries have not engaged
in any unfair labor  practices  or  discriminated  on the basis of race,  color,
religion,  sex, national origin,  age,  disability or handicap in its employment
conditions or practices that would, individually or in the aggregate,  result in
a Material Adverse Effect. Except as set forth on Schedule 3.11(f), there are no
(i) unfair labor  practice  charges or complaints or racial,  color,  religious,
sex,  national origin,  age,  disability or handicap  discrimination  charges or
complaints  pending or, to the best knowledge of the Acquired  Companies and the
Stockholder,  threatened  against the  Acquired  Companies  or the  Subsidiaries
before any  federal,  state or local court,  board,  department,  commission  or
agency  (nor,  to  the  best  knowledge  of  the  Acquired   Companies  and  the
Stockholder,  does any valid basis  therefor  exist) or (ii) existing or, to the

<PAGE>

best knowledge of the Acquired  Companies and the Stockholder,  threatened labor
strikes, disputes,  grievances,  controversies or other labor troubles affecting
the Acquired Companies (nor, to the best knowledge of the Acquired Companies and
the Stockholder, does any valid basis therefor exist).

              G. Unions.  Each of the Acquired  Companies  and the  Subsidiaries
have never been a party to any agreement with any union,  labor  organization or
collective  bargaining  unit.  No  employees  of the  Acquired  Companies or the
Subsidiaries  are  represented by any union,  labor  organization  or collective
bargaining  unit.  Except  as set  forth  on  Schedule  3.11(g),  to the  actual
knowledge  of the  Acquired  Companies,  none of the  employees  of the Acquired
Companies or the Subsidiaries have threatened to organize or join a union, labor
organization or collective bargaining unit.

              H.  Aliens.  All  employees  of the  Acquired  Companies  and  the
Subsidiaries are, to the best knowledge of the Acquired Companies,  citizens of,
or are authorized in accordance with federal immigration laws to be employed in,
the United States.

         3.12. Employee Benefit Plans.

              A.  Identification.  Schedule  3.12(a)  contains  a  complete  and
accurate list of all employee  benefit plans (within the meaning of Section 3(3)
of ERISA  sponsored by the Acquired  Companies and the  Subsidiaries or to which
the  Acquired  Companies  and the  Subsidiaries  contributes  on behalf of their
employees and all employee benefit plans previously  sponsored or contributed to
on behalf of their  employees  since the date the Acquired  Companies  have been
owned by the Stockholder (the "Employee Benefit Plans").  The Acquired Companies
have  provided or made  available  to  Purchaser  copies of all plan  documents,
determination   letters,   pending  determination  letter  applications,   trust
instruments,  insurance  contracts,  administrative  services contracts,  annual
reports, actuarial valuations, summary plan descriptions,  summaries of material
modifications,  administrative  forms and other documents that constitute a part
of or are incident to the  administration  of the  Employee  Benefit  Plans.  In
addition,  the Acquired Companies have provided or made available to Purchaser a
written  description  of all  existing  practices  engaged  in by  the  Acquired
Companies and the Subsidiaries that constitute Employee Benefit Plans. Except as
set forth on Schedule  3.12(a) and subject to the  requirements  of the Code and
ERISA,  each of the Employee  Benefit Plans can be terminated or amended at will
by the Acquired Companies. Except as set forth on Schedule 3.12(a), no unwritten
amendment exists with respect to any Employee Benefit Plan.  Except as set forth
on Schedule 3.12(b)-(l), each of the following paragraphs is true and correct.

              B.   Administration.   Each   Employee   Benefit   Plan  has  been
administered  and maintained in compliance with all applicable  laws,  rules and
regulations,   except  where  the  failure  to  be  in  compliance   would  not,
individually or in the aggregate,  result in a Material  Adverse Effect.  To the

<PAGE>

best of the knowledge of the Acquired Companies,  the Acquired Companies and the
Subsidiaries  have (i) made all necessary  filings with respect to such Employee
Benefit Plans, including the timely filing of Form 5500 if applicable,  and (ii)
made  all  necessary  filings,  reports  and  disclosures  pursuant  to and have
complied  with  all  requirements  of the IRS  Voluntary  Compliance  Resolution
Program, if applicable,  with respect to all profit sharing retirement plans and
pension plans in which employees of the Acquired  Companies and the Subsidiaries
participate.

              C.  Examinations.  Except as set forth on  Schedule  3.11(c),  the
Acquired  Companies have not received any notice that any Employee  Benefit Plan
is currently the subject of an audit, investigation, enforcement action or other
similar proceeding conducted by any state or federal agency.

              D.  Prohibited  Transactions.  To the best of the knowledge of the
Acquired Companies,  no prohibited  transactions  (within the meaning of Section
4975 of the Code or Sections 406 and 407 of ERISA) have occurred with respect to
any Employee Benefit Plans.

              E. Claims and Litigation.  No pending or, to the actual  knowledge
of the Acquired  Companies and the  Stockholder,  threatened  claims,  suits, or
other  proceedings  exist with respect to any  Employee  Benefit Plan other than
normal benefit claims filed by participants or beneficiaries.

              F. Qualification. As set forth in more detail on Schedule 3.12(f),
the Stockholder has applied for a favorable  determination letter or ruling from
the IRS for each of the Employee  Benefit Plans intended to be qualified  within
the meaning of Section 401(a) of the Code and/or  tax-exempt  within the meaning
of  Section  501(a) of the Code.  Except as set forth on  Schedule  3.12(f),  no
proceedings exist or, to the actual knowledge of the Acquired  Companies and the
Stockholder have been threatened that could result in the revocation of any such
favorable determination letter or ruling.

              G. Funding  Status.  Neither the  Stockholder  nor any member of a
controlled   group  with  the   Stockholder   (within  the  meaning  of  Section
412(n)(6)(B))  sponsors  any plans which (1) are subject to the minimum  funding
requirements  of Code  Section  412 or ERISA  Section  302 or (2) are subject to
Title IV of ERISA assumptions.

              H. Excise  Taxes.  To the best of the  knowledge  of the  Acquired
Companies,  neither the Acquired  Companies nor any member of a Controlled Group
has any liability to pay excise taxes with respect to any Employee  Benefit Plan
under applicable provisions of the Code or ERISA.
<PAGE>

              I.  Multiemployer  Plans.  Neither the Acquired  Companies nor any
member of a Controlled  Group is or ever has been  obligated to  contribute to a
multiemployer plan within the meaning of Section 3(37) of ERISA.

              J.  Pension  Benefit  Guaranty  Corporation.  None of the Employee
Benefit Plans are subject to the requirements of Title IV of ERISA.

              K.  Retirees.  Neither  the  Acquired  Companies  nor  any  of the
Subsidiaries has any obligation or commitment to provide medical, dental or life
insurance benefits to or on behalf of any of its employees who may retire or any
of its former  employees who have retired except as may be required  pursuant to
the  continuation  of  coverage  provisions  of  Section  4980B  of the Code and
Sections 501 through 508 of ERISA.

              L. Other  Compensation.  Except as set forth on Schedules 3.11(a),
3.11(b),  3.11(c),  3.11(d) and 3.12(a),  neither the Acquired Companies nor the
Subsidiaries is a party to any  compensation or debt arrangement with any person
relating to the provision of health care related services.

         3.13. Absence of Certain Changes.  Except as set forth on Schedule 3.13
or as contemplated in this Agreement, since the Acquired Companies Balance Sheet
Date, the Acquired Companies and the Subsidiaries have not:

              A. suffered a Material  Adverse  Effect,  whether or not caused by
any deliberate act or omission of the Acquired Companies or the Subsidiaries;

              B.  contracted  for the purpose of  acquiring  any  capital  asset
having a cost in excess of $20,000 or made any single  expenditure for a capital
asset in excess of $20,000;

              C.  incurred  any  indebtedness  for  borrowed  money in excess of
$20,000 (other than  short-term  borrowings in the ordinary course of business),
or issued or sold any debt securities;

              D. incurred or discharged any material  liabilities or obligations
except in the ordinary course of business;

              E.  paid any  amount  on any  indebtedness  prior to the due date,
forgiven or cancelled  any claims or any debt in excess of $20,000,  or released
or waived any rights or claims except in the ordinary course of business;

              F. mortgaged, pledged or subjected to any security interest, lien,
lease or other charge or encumbrance any of its properties or assets (other than

<PAGE>

statutory  liens arising in the ordinary  course of business or other liens that
do not  materially  detract  from the  value or  interfere  with the use of such
properties or assets);

              G.  suffered  any damage or  destruction  to or loss of any assets
(whether  or  not  covered  by  insurance)  that  has,  individually  or in  the
aggregate, resulted in a Material Adverse Effect;

              H. acquired or disposed of any assets having an aggregate value in
excess of $20,000, except in the ordinary course of business;

              I.  written up or written  down the  carrying  value of any of its
assets, other than accounts receivable in the ordinary course of business;

              J.  changed  the  costing  system  or   depreciation   methods  of
accounting for its assets in any material respect;

              K. lost or terminated any employee,  patient, customer or supplier
that has,  individually  or in the  aggregate,  resulted  in a Material  Adverse
Effect;

              L.  increased  the  compensation  of any  director,  officer,  key
employee or consultant, except as disclosed on Schedule 3.11(a);

              M.  increased  the   compensation  of  any  employee  (except  for
increases in the ordinary  course of business  consistent with past practice) or
hired any new employee who is expected to receive annualized  compensation of at
least $20,000;

              N.  formed  or  acquired  or  disposed  of  any  interest  in  any
corporation, partnership, joint venture or other entity;

              O. redeemed,  purchased or otherwise acquired, or sold, granted or
otherwise  disposed of, directly or indirectly,  any of its capital stock,  paid
any dividend or made any distribution or payment on any of its capital stock, or
agreed to change the terms and conditions of any such capital stock;

              P.  entered into any  agreement  providing  for total  payments in
excess of $20,000 in any twelve (12) month  period with any person or group,  or
modified  or  amended in any  material  respect  the terms of any such  existing
agreement,  except in the ordinary course of business whereupon the sum of total
payments shall not exceed $20,000 in any twelve (12) month period;

              Q. entered  into,  adopted or amended any Employee  Benefit  Plan,
except as contemplated hereby or the other agreements contemplated hereby; or
<PAGE>

              R. entered into any other commitment or transaction or experienced
any other event that would materially  interfere with its performance under this
Agreement or any other agreement or document executed or to be executed pursuant
to this Agreement, or otherwise has, individually or in the aggregate,  resulted
in a Material Adverse Effect.

         3.14. Title to Assets and Properties.

              A. Real Property.  The Acquired  Companies and the Subsidiaries do
not own any interest  (other than  leasehold  interests  referred to on Schedule
3.14(c))  in real  property.  The leased real  property  referred to on Schedule
3.14(c)  constitutes  the only real  property  necessary  for the conduct of the
Acquired Companies' business.

              B. Personal Property. Except as set forth on Schedule 3.14(b), the
Acquired  Companies and/or the  Subsidiaries  have valid and marketable title to
all the  personal  property  constituting  the  Assets.  The  personal  property
constituting the Assets is adequate for the conduct of the Acquired  Companies's
and the  Subsidiaries  businesses  in the  manner  in which  they are  currently
conducted and contemplated to be conducted by the Stockholder. Upon consummation
of the transactions  contemplated  hereby,  such interest in the Assets shall be
transferred to Purchaser free and clear of all security interests, liens, claims
and encumbrances, other than those set forth on Schedule 3.14(b) (the "Permitted
Encumbrances") and statutory liens arising in the ordinary course of business or
other liens that do not materially  detract from the value or interfere with the
use of such properties or assets.

              C.  Leases.  Schedule  3.14(c)  sets  forth  a true,  correct  and
complete list and brief description of (i) all leases of real property, and (ii)
leases of personal  property  involving  rental  payments within any twelve (12)
month  period in  excess  of  $12,000,  in  either  case to which  the  Acquired
Companies or the  Subsidiaries is a party,  either as lessor or lessee,  are set
forth on Schedule 3.14(c). To the best knowledge of the Acquired Companies,  all
such leases are valid and enforceable in accordance with their  respective terms
and no event has occurred which, with the giving of notice, the lapse of time or
both, would constitute an event of default  thereunder,  including the execution
of this Agreement or the consummation of the transactions contemplated hereby.

         3.15. Condition of Fixed Assets.  Except as set forth in Schedule 3.15,
all of the  fixtures,  structures,  machinery  and  equipment  reflected  in the
Financial  Statements and used by the Acquired Companies and the Subsidiaries in
its business are in good operating condition and repair,  subject to normal wear
and tear, and conform in all material  respects with all applicable  ordinances,
regulations and other laws, and the Acquired  Companies have no actual knowledge
of any latent defects therein.
<PAGE>

         3.16. Commitments.

              A. Commitments;  Defaults. Except as set forth on Schedule 3.16 or
as  otherwise  disclosed  pursuant  to  this  Agreement,  neither  the  Acquired
Companies nor any of the Subsidiaries is a party to nor bound by, nor are any of
the  shares of  Company  Common  Stock  subject  to,  nor are the  Assets or the
businesses of the Acquired  Companies or the  Subsidiaries  bound by, whether or
not in writing, any of the following (collectively, "Commitments"):

                   I) partnership or joint venture agreement;

                   II) guaranty or suretyship,  indemnification  or contribution
agreement or performance bond;

                   III) debt  instrument,  loan  agreement  or other  obligation
relating  to  indebtedness  for  borrowed  money or money  lent or to be lent to
another;

                   IV) contract to purchase real property;

                   V) agreements or arrangements with eye care professionals;

                   VI)  agreements  with  suppliers  of  eye  care  and  related
products;

                   VII)  agreement  with dealers or sales or commission  agents,
public relations or advertising  agencies,  accountants or attorneys (other than
in connection  with this  Agreement and the  transactions  contemplated  hereby)
involving  total  payments  within  any twelve  (12)  month  period in excess of
$20,000  and which is not  terminable  on thirty  (30)  days'  notice or without
penalty;

                   VIII)   agreement   relating  to  any   material   matter  or
transaction  in  which an  interest  is held by a person  or  entity  that is an
Affiliate of the Acquired Companies or the Stockholder;

                   IX)  agreement  for the  acquisition  of services,  supplies,
equipment,  inventory, fixtures or other property involving more than $20,000 in
the aggregate, except in the ordinary course of business.

                   X) powers of attorney;

                   XI) contracts containing non-competition covenants;
<PAGE>

                   XII) agreement  providing for the purchase from a supplier of
all or  substantially  all of the  requirements  of the Acquired  Companies of a
particular  product  or  services,  except as is  consistent  with the  Acquired
Companies  previous  purchasing  history and which does not involve  more than a
twelve month commitment on behalf of the Acquired Companies;

                   XIII)  agreements  with  health  maintenance   organizations,
preferred provider organization, managed care entities and similar entities; or

                   XIV) any other  agreement or  commitment in excess of $20,000
not made in the ordinary course of business or that is material to the business,
operations,  condition  (financial or otherwise) or results of operations of the
Acquired Companies.

True, correct and complete copies of the written Commitments,  and true, correct
and complete written descriptions of the oral Commitments,  have heretofore been
delivered or made available to Purchaser.  To the best knowledge of the Acquired
Companies  and the  Stockholder,  there are no  existing  events of  default  or
events, occurrences,  acts or omissions that, with the giving of notice or lapse
of time or both, would constitute  defaults by the Acquired  Companies or any of
the  Subsidiaries  or, to the best  knowledge of the Acquired  Companies and the
Stockholder,  any other party to a material  Commitment,  and no penalties  have
been  incurred  nor  are  amendments  pending,  with  respect  to  the  material
Commitments.  The  Commitments  are in full  force and  effect and are valid and
enforceable  obligations of the Acquired  Companies or the Subsidiaries,  and to
the best knowledge of the Acquired Companies and the Stockholder,  are valid and
enforceable  obligations of the other parties thereto,  in accordance with their
respective terms, and no defenses, off-sets or counterclaims have been asserted,
nor has the  Acquired  Companies  waived  any  material  rights  thereunder.  No
consents  or  approvals  are  required  under  the  terms of any  Commitment  in
connection with the transactions contemplated herein.

              B.  No  Cancellation  or  Termination  of  Commitment.  Except  as
disclosed  pursuant to this  Agreement  and except where such default  would not
have a Material  Adverse  Effect,  (i) neither the  Acquired  Companies  nor the
Subsidiaries  has received notice of any plan or intention of any other party to
any Commitment to exercise any right to cancel or terminate any Commitment,  and
the Acquired  Companies do not know of any fact that would  justify the exercise
of such a right;  and (ii) neither the Acquired  Companies nor the  Subsidiaries
currently  contemplates,  or has reason to believe  any other  person  currently
contemplates, any amendment or change to any Commitment.

         3.17.  Insurance.  The Acquired  Companies and the  Subsidiaries  carry
property, liability,  malpractice, workers' compensation and such other types of

<PAGE>

insurance  pursuant to the insurance  policies  listed and briefly  described on
Section 3.17 (the "Insurance  Policies").  The Insurance Policies are all of the
insurance  policies of the Acquired  Companies and the Subsidiaries  relating to
the  business of the Acquired  Companies  and the Assets.  All of the  Insurance
Policies are issued by insurers of  recognized  responsibility  and, to the best
knowledge of the Acquired Companies, are valid and enforceable policies,  except
as may be limited by applicable bankruptcy, insolvency or similar laws affecting
creditors'  rights  generally or the  availability  of equitable  remedies.  All
Insurance  Policies shall be maintained in force without  interruption up to and
including the Closing Date.  True,  complete and correct copies of all Insurance
Policies have been provided or made available to Purchaser.  Except as set forth
on Schedule  3.17,  neither the  Acquired  Companies  nor the  Subsidiaries  has
received  any notice or other  communication  from any  issuer of any  Insurance
Policy cancelling such policy, materially increasing any deductibles or retained
amounts thereunder,  and to the best knowledge of the Acquired Companies and the
Stockholder,  no such  cancellation  or increase of  deductibles,  retainages or
premiums  is  threatened.  Except as set forth on  Schedule  3.17,  neither  the
Acquired  Companies  nor any of the  Subsidiaries  has any  outstanding  claims,
settlements  or premiums  owed against any  Insurance  Policy,  and the Acquired
Companies have given all notices or has presented all potential or actual claims
under any Insurance  Policy in due and timely  fashion.  Schedule 3.17 also sets
forth a list of all claims under any  Insurance  Policy in excess of $10,000 per
occurrence  filed by the Acquired  Companies  since the Acquired  Companies have
been owned by the Stockholder.

         3.18. Proprietary Rights and Information. Set forth on Schedule 3.18 is
a true and correct description of the following ("Proprietary Rights"):

              A. all  trademarks,  trade  names,  service  marks and other trade
designations,  including  common  law  rights,  registrations  and  applications
therefor,  and all patents and copyrights and  applications  therefor  currently
owned, in whole or in part, by the Acquired  Companies or the Subsidiaries,  and
all licenses,  royalties,  assignments and other similar agreements  relating to
the  foregoing to which the Acquired  Companies or the  Subsidiaries  is a party
(including the expiration date thereof if applicable); and

              B. all agreements  relating to  technology,  know-how or processes
that the Acquired  Companies and the  Subsidiaries are licensed or authorized to
use by others (other than technology,  know-how or processes generally available
to other lens grinding businesses), or which it licenses or authorizes others to
use.

The Acquired  Companies and the  Subsidiaries own or have the legal right to use
the Proprietary  Rights, and to the best knowledge of the Acquired Companies and
the Stockholder such ownership or use does not conflict, infringe or violate the
rights of any other person.  Except as disclosed on Schedule 3.18, no consent of

<PAGE>

any person will be required for the use of any  Proprietary  Rights by Purchaser
upon  consummation of the transactions  contemplated  hereby and the Proprietary
Rights are freely transferable.  No claim has been asserted by any person to the
ownership of or for  infringement by the Acquired  Companies or the Subsidiaries
of the proprietary right of any other person,  and the Acquired Companies do not
know of any  valid  basis  for any  such  claim.  To the best  knowledge  of the
Acquired  Companies  and  the  Stockholder,   the  Acquired  Companies  and  the
Subsidiaries  have the  right to use,  free and clear of any  adverse  claims or
rights of others, all trade secrets,  customer lists and proprietary information
required for the marketing of all merchandise and services formerly or presently
sold or marketed by it.

         3.19.  Taxes.

              A. Filing of Tax Returns.  Each of the Acquired  Companies and the
Subsidiaries  have duly and timely filed and prior to the Closing Date will duly
and  timely  file  (in  accordance  with  any  extensions  duly  granted  by the
appropriate   governmental   agency,   if  applicable)   with  the   appropriate
governmental  agencies  all federal,  state,  local or foreign  income,  excise,
corporate,  franchise,  property,  sales, use, payroll,  withholding,  provider,
value added and other tax returns and reports  (collectively  the "Tax Returns")
required  to be  filed  by the  United  States  or any  state  or any  political
subdivision thereof or any foreign jurisdiction. All such Tax Returns or reports
are  complete and  accurate in all  material  respects and properly  reflect the
taxes of the Acquired  Companies and the  Subsidiaries  for the periods  covered
thereby.

              B.  Payment  of  Taxes.  Except  for such  items  as the  Acquired
Companies or the  Subsidiaries  may be disputing in good faith by proceedings in
compliance  with  applicable  law, which are described on Schedule 3.19, (i) the
Acquired  Companies  and  the  Subsidiaries  have  paid  all  taxes,  penalties,
assessments  and  interest  that have become due with respect to any Tax Returns
that they have filed and have  properly  accrued on their  books and records for
all of the same that have not yet become due,  and (ii) the  Acquired  Companies
and the Subsidiaries are not delinquent in the payment of any tax, assessment or
governmental charge.

              C. No Pending Deficiencies,  Delinquencies, Assessments or Audits.
Except as set forth on Schedule  3.19,  neither the Acquired  Companies  nor the
Subsidiaries have received any notice that any tax deficiency or delinquency has
been asserted against the Acquired  Companies or any of the Subsidiaries.  There
is  no  unpaid  assessment,   proposal  for  additional  taxes,   deficiency  or
delinquency in the payment of any of the taxes of the Acquired  Companies or any
of the Subsidiaries that could be asserted by any taxing authority.  There is no
taxing  authority  audit of the Acquired  Companies  or any of the  Subsidiaries
pending, or to the best knowledge of the Acquired Companies and the Stockholder,
threatened,  and the results of any completed  audits are properly  reflected in

<PAGE>

the Financial  Statements.  The Acquired Companies and the Subsidiaries have not
violated any federal, state, local or foreign tax law.

              D.  No  Extension  of  Limitation  Period.  Neither  the  Acquired
Companies nor the Subsidiaries have granted an extension to any taxing authority
of the  limitation  period  during  which any tax  liability  may be assessed or
collected.

              E. All Withholding  Requirements Satisfied. All monies required to
be  withheld  by the  Acquired  Companies  and  the  Subsidiaries  and  paid  to
governmental agencies for all income, social security,  unemployment  insurance,
sales,  excise,  use and other taxes have been collected or withheld and paid to
the respective governmental agencies.

              F.  Foreign  Person.  Neither the Acquired  Companies,  any of the
Subsidiaries  nor the Stockholder is a foreign person,  as such term is referred
to in Section 1445(f)(3) of the Code.

              G. Safe Harbor Lease. None of the Assets constitutes property that
the  Acquired  Companies,  the  Subsidiaries,  Purchaser,  or any  Affiliate  of
Purchaser,  will be required to treat as being owned by another person  pursuant
to the "Safe Harbor Lease"  provisions of Section 168(f)(8) of the Code prior to
repeal by the Tax Equity and Fiscal Responsibility Act of 1982.

              H. Tax Exempt Entity. None of the Assets are subject to a lease to
a "tax exempt entity" as such term is defined in Section 168(h)(2) of the Code.

              I.  Collapsible  Corporation.   The  Acquired  Companies  and  the
Subsidiaries have not at any time consented, and the Stockholder will not permit
the Acquired  Companies nor the Subsidiaries to elect, to have the provisions of
Section 341(f)(2) of the Code apply to any of them.

              J. Boycotts.  Neither the Acquired  Companies nor the Subsidiaries
have at any time participated in or cooperated with any international boycott as
defined in Section 999 of the Code.

              K. Parachute  Payments.  No payment required or contemplated to be
made by the Acquired  Companies or the Subsidiaries  will be characterized as an
"excess parachute payment" within the meaning of Section 280G(b)(1) of the Code.

              L.  S  Corporation.   Neither  the  Acquired   Companies  nor  the
Subsidiaries  have  made an  election  to be taxed as an "S"  corporation  under
Section 1362(a) of the Code.
<PAGE>

              M. Personal Service  Corporation.  Neither the Acquired  Companies
nor  the  Subsidiaries  are  a  personal  service  corporation  subject  to  the
provisions of Section 269A of the Code.

              N. Personal  Holding Company.  Neither the Acquired  Companies nor
the  Subsidiaries  are or has been a personal holding company within the meaning
of Section 542 of the Code.

              O. Tax Sharing Agreements.  Neither the Acquired Companies nor the
Subsidiaries  are party to any tax sharing  agreement  with any other  person or
entity.

              P. Section 338 Election.  Purchaser may elect under Section 338(g)
and Section  338(h)(10)  of the Internal  Revenue Code of 1986,  as amended (the
"Code"),  after the  Closing  Date to adjust  the tax basis in the assets of the
Acquired  Companies  pursuant  to Section  338(a) of the Code.  The  Stockholder
agrees that, after the Closing Date, at Purchaser's  request, it shall join with
Purchaser in a timely  election made pursuant to Sections  338(g) and 338(h)(10)
of the Code, and the Stockholder and Purchaser agree, at Purchaser's  option, to
make any  elections  comparable  to the  elections  under  Sections  338(g)  and
338(h)(10) under any applicable  state or local laws. The Stockholder  agrees to
take all steps necessary to perfect a joint election under Section 338(h)(10) of
the  Code  pursuant  to  the  procedures   specified  in  Treas.   Reg.  Section
1.338(h)(10)-1(d)(2),  including executing an Internal Revenue Service Form 8023
and agreeing to the amount of and allocation of the Deemed Sale Price determined
by the Purchaser  pursuant to the procedures  specified in Treas.  Reg.  Section
1.338(h)(10)-1(f).  Stockholder  agrees to pay all taxes  which  result from the
election contemplated by this Section 3.19(p).

         3.20.  Governmental  Authorizations.  The  Acquired  Companies  and the
Subsidiaries  possess  all  necessary  licenses,  franchises,  permits and other
governmental  authorizations,  including,  but  not  limited  to  all  licenses,
franchises,   permits  and  authorizations  for  the  conduct  of  the  Acquired
Companies' and the Subsidiaries'  businesses as now conducted,  all of which are
listed (with  expiration  dates, if applicable) on Schedule 3.20.  Except as set
forth on Section 3.20, the transactions  contemplated by this Agreement will not
result in a default under or a breach or violation  of, or adversely  affect the
rights  and  benefits  afforded  by any such  licenses,  franchises,  permits or
authorizations  which,  singly or in the  aggregate,  would not have a  Material
Adverse Effect. All such licenses,  franchises, permits and other authorizations
are  valid  and in  full  force  and  effect,  the  Acquired  Companies  and the
Subsidiaries  are in current  compliance  therewith  and  neither  the  Acquired
Companies  nor any  Subsidiary  have  received any notice that any  governmental
authority  is  considering  challenging,   revoking,  cancelling,   restricting,
conditioning  or not  renewing  any such  license,  franchise,  permit  or other
authorization.
<PAGE>

         3.21.  Compliance with Applicable Laws. The Acquired Companies and each
of the Subsidiaries hold all permits, licenses,  variances,  exemptions,  orders
and  approvals  of all  Governmental  Entities  material to the  business of the
Acquired  Companies or such Subsidiary,  as the case may be, including,  without
limitation,  applicable  state  corporation,  insurance  and  health  regulatory
authorities,  and other  Governmental  Entities  regulating  exclusive  provider
organizations,  preferred  provider  organizations,  medical  utilization review
organizations,  medical service  organizations,  lay  intermediaries,  secondary
contractors, or third party administrators (the "Company Permits"). The Acquired
Companies and the Subsidiaries  are in current  compliance with the terms of the
Acquired Companies Permits,  except for such failures to comply which, singly or
in the aggregate,  would not have a Material Adverse Effect. Except as disclosed
in Section  3.21,  the Acquired  Companies and each of the  Subsidiaries  are in
compliance  with all laws,  including  applicable  Medicare and  Medicaid  laws,
ordinances  and  regulations  of any  Governmental  Entity,  including,  without
limitation,  applicable  state  corporation,  insurance  and  health  regulatory
authorities  and  other  Governmental  Entities  regulating  exclusive  provider
organizations,  preferred  provider  organizations,  medical  utilization review
organizations,  medical service  organizations,  lay  intermediaries,  secondary
contractors or third-party administrators and all Medicare and Medicaid provider
agreements to which it is a party,  except where the failure to comply would not
have a Material Adverse Effect. Except as disclosed in Section 3.21, to the best
knowledge of the Acquired  Companies and the  Stockholder,  no  investigation or
review by any Governmental  Entity,  including,  without limitation,  applicable
state corporation,  insurance and health regulatory  authorities with respect to
the Acquired Companies or any of the Subsidiaries is pending, or threatened, nor
has any Governmental  Entity,  including,  without limitation,  applicable state
corporation, insurance and health regulatory authority indicated an intention to
conduct the same, other than those the outcome of which would not be material to
the business of the Acquired Companies or such Subsidiary, as the case may be.

         3.22.  Litigation.  Except as  described  on Section  3.22 or otherwise
disclosed  pursuant to this  Agreement,  the  Acquired  Companies  have not been
notified of any legal actions or  administrative  proceedings or  investigations
which affect or could affect the Acquired  Companies Common Stock, the Assets or
the  operation,  business,  condition  (financial or  otherwise),  or results of
operations of the Acquired Companies or the Subsidiaries which (i) if successful
could,  individually or in the aggregate, have a Material Adverse Effect or (ii)
could  adversely  affect the  ability of the  Acquired  Companies  to effect the
transactions  contemplated  hereby.  Neither  the  Acquired  Companies  nor  the
Subsidiaries  are (a) subject to any continuing court or  administrative  order,
judgment,  writ, injunction or decree applicable specifically to the Assets, the
Acquired Companies or to its business,  assets,  operations or employees, or (b)
in default with respect to any such order, judgment, writ, injunction or decree.
Neither the Acquired  Companies  nor the  Stockholder  have any knowledge of any
valid basis for any such  action,  proceeding  or  investigation.  Except as set
forth on Schedule 3.22, all claims  asserted,  general  liability  incidents and

<PAGE>

incident  reports  have  been  submitted  to  the  Acquired  Companies'  insurer
therefor.  All claims made or threatened  against the Acquired  Companies or the
Subsidiaries  in excess  of its  deductible  are  covered  under  its  Insurance
Policies.

         3.23. Banking  Relations.  Set forth on Schedule 3.23 is a complete and
accurate  list of all borrowing  and  investing  arrangements  that the Acquired
Companies  and  the   Subsidiaries   have  with  any  bank  or  other  financial
institution,   indicating  with  respect  to  each   relationship  the  type  of
arrangement maintained (such as checking account,  borrowing arrangements,  safe
deposit box, etc.), the location thereof and the person or persons authorized in
respect thereof.

         3.24. Ownership Interests of Interested Persons;  Affiliations.  Except
as set forth on Schedule 3.24, no officer,  supervisory  employee or director of
the  Acquired  Companies  or the  Subsidiaries,  or  their  respective  spouses,
children or Affiliates,  owns directly or indirectly,  on an individual or joint
basis, any interest in, has a compensation or other financial  arrangement with,
or serves as an officer or director of, any customer or supplier of the Acquired
Companies or the Subsidiaries or any organization  that has a material  contract
or arrangement with the Acquired Companies or the Subsidiaries.

         3.25. Investments in Competitors. Except as disclosed on Schedule 3.25,
the Acquired  Companies do not own directly or indirectly  any interests or have
any  investment in any person that is a Competitor of the Acquired  Companies or
the Subsidiaries.

         3.26. Environmental Matters.

              A. Except as set forth on  Schedule  3.26,  neither  the  Acquired
Companies  nor  the  Subsidiaries   have,  in  violation  of  any  Environmental
Requirement,  engaged in or permitted any operations or activities  upon, or any
use or occupancy of the Property,  or any portion thereof, for the purpose of or
in any  way  involving  the  handling,  manufacture,  treatment,  storage,  use,
generation,  release, discharge,  refining, dumping or disposal of any Hazardous
Materials (whether legal or illegal, accidental or intentional) on, under, in or
about the Property,  or transported  any Hazardous  Materials to, from or across
the  Property,  nor, to the best  knowledge  of the Acquired  Companies  and the
Stockholder,  are any  Hazardous  Materials  presently  constructed,  deposited,
stored or otherwise  located on, under,  in or about the  Property,  nor, to the
best knowledge of the Acquired Companies and the Stockholder, have any Hazardous
Materials  migrated from the Property upon or beneath other  properties have any
Hazardous  Materials  migrated or  threatened  to migrate from other  properties
upon, about or beneath the Property.

              B.  Except  as set  forth  on  Schedule  3.26,  for so long as the
Acquired Companies or the Subsidiaries have owned or used the Property, the use,
maintenance  and operation of the Property,  and all  activities  and conduct of

<PAGE>

business  related thereto,  have at all times complied in all material  respects
with all Environmental Requirements.

              C.  Neither  the  Acquired  Companies  nor the  Subsidiaries  have
received written notice or other communication  concerning any alleged violation
of Environmental  Requirements,  whether or not corrected to the satisfaction of
the appropriate authority,  nor notice or other communication concerning alleged
liability for Environmental  Damages both in connection with the Property and in
connection  with an  Off-Site  Location  and there  exists no writ,  injunction,
decree,  order or judgment  outstanding,  nor any  lawsuit,  claim,  proceeding,
citation, directive, summons or investigation, pending or, to the best knowledge
of the  Acquired  Companies  and the  Stockholder,  threatened,  relating to the
ownership, use, maintenance or operation of the Property or Off-Site Location by
any person, or from alleged violation of Environmental Requirements, or from the
suspected presence of Hazardous Material on the Property.

              D.  Except  as set  forth  on  Schedule  3.26,  for so long as the
Acquired  Companies  or the  Subsidiaries  have owned or used the  Property,  no
Hazardous  Material has been  generated at the  Property and  transported  to an
Off-Site Location.

              E.  To  the  best  knowledge  of  the  Acquired   Companies,   any
underground  tanks  located on the Property (i)  currently  are being and to the
best knowledge of the Acquired  Companies and the  Stockholder  always have been
operated  in   compliance  in  all  material   respects   with  all   applicable
Environmental  Requirements,  and (ii) are  covered by a current  and  effective
Certificate of Coverage.

         3.27.   Certain   Payments.   Neither  the  Acquired   Companies,   the
Subsidiaries nor any director,  officer or employee of the Acquired Companies or
the Subsidiaries acting for or on behalf of the Acquired Companies, have paid or
caused to be paid,  directly or indirectly,  in connection  with the business of
the Acquired Companies or the Subsidiaries:

              A.  to any  government  or  agency  thereof  or any  agent  of any
supplier or customer any bribe, kick-back or other similar payment; or

              B. any  contribution  to any political  party or candidate  (other
than from personal  funds of directors,  officers or employees not reimbursed by
their respective employers or as otherwise permitted by applicable law).

         3.28.  Medicare and Medicaid  Programs.  The Acquired Companies and the
Subsidiaries  are  qualified  for  participation  in the  Medicare  and Medicare
programs and are party to provider  agreements  for such  programs  which are in
full force and effect with no events of default having occurred thereunder.  The
Acquired  Companies and the  Subsidiaries  have timely filed all claims or other

<PAGE>

reports required to be filed on or before the date hereof,  and will timely file
all claims and reports  required  to be filed on or prior to the  Closing  Date,
with  respect to the  purchase  of services by  third-party  payors  ("Payors"),
including  but not limited to Medicare and Medicaid  programs,  except where the
failure  to file  would  not,  individually  or in the  aggregate,  result  in a
Material  Adverse  Effect.  All such filed  claims or reports  are, and all such
claims and reports to be filed on or before the Closing  Date will be,  complete
and  accurate  in  all  material  respects.   The  Acquired  Companies  and  the
Subsidiaries have paid or have properly recorded on the Financial Statements all
actually  known and  undisputed  refunds,  discounts or  adjustments  which have
become due pursuant to such claims,  and neither the Acquired  Companies nor the
Subsidiaries  have any material  liability  to any Payor with  respect  thereto,
except as has been reserved for in the Acquired  Companies Balance Sheet.  There
are no pending appeals,  overpayment  determinations,  adjustments,  challenges,
audits,  litigation,  or notices of intent to reopen  Medicare  and/or  Medicaid
claims  determinations  or other  reports  required to be filed by the  Acquired
Companies  or the  Subsidiaries  in  order  to be paid by a Payor  for  services
rendered.  Neither the  Acquired  Companies,  the  Subsidiaries,  nor any of its
directors,  officers,  employees,   consultants  or  the  Stockholder  has  been
convicted of, or pled guilty or nolo contendere to, patient abuse or neglect, or
any other Medicare or Medicaid program-related offense. Neither the Stockholder,
the  Acquired  Companies,  the  Subsidiaries,  nor their  respective  directors,
officers, employees or consultants, has committed any offense which may serve as
the basis for suspension or exclusion  from the Medicare and Medicaid  programs,
including but not limited to,  defrauding a federal,  state or local  government
program,  loss of a license to provide health  services,  and failure to provide
quality care.

         3.29.   Fraud  and  Abuse.   Neither  the   Acquired   Companies,   the
Subsidiaries,  nor their  respective  officers and directors have engaged in any
activities which are prohibited under 42 U.S.C.  ss.ss.  1320-7,  7a or 7b or 42
U.S.C.  ss.1395nn (subject to the exceptions set forth in such legislation),  or
the  regulations  promulgated  thereunder  or pursuant to similar state or local
statutes  or  regulations,  or which  are  prohibited  by rules of  professional
conduct, including but not limited to the following:

              A.  knowingly and  willfully  making or causing to be made a false
statement  or  representation  of a  material  fact in any  application  for any
benefit or payment;

              B.  knowingly and  willfully  making or causing to be made a false
statement or representation of a material fact for use in determining  rights to
any benefit or payment;

              C.  failing  to  disclose  knowledge  by a  Medicare  or  Medicaid
claimant of the occurrence of any event affecting the initial or continued right

<PAGE>

to any benefit or payment on its own behalf or on behalf of another, with intent
to fraudulently secure such benefit or payment;

              D.  knowingly  and  willfully  offering,   paying,  soliciting  or
receiving any remuneration (including any kickback,  bribe, or rebate), directly
or  indirectly,  overtly  or  covertly,  in cash or in kind  (i) in  return  for
referring an  individual  to a person for the  furnishing  or arranging  for the
furnishing  of any item or service for which  payment may be made in whole or in
part by Medicare or  Medicaid,  or (ii) in return for  purchasing,  leasing,  or
ordering, or arranging for or recommending purchasing,  leasing, or ordering any
good,  facility,  service,  or item for which payment may be made in whole or in
part by Medicare or Medicaid; and

              E. referring a patient for designated  health services (as defined
in 42 U.S.C.  ss.1395nn) to or providing designated health services to a patient
upon a  referral  from an entity  or person  with  which the  Stockholder  or an
immediate family member has a financial relationship,  and to which no exception
under 42 U.S.C. ss.1395nn applies.

         3.30. Customers and Suppliers. Schedule 3.30 sets forth a true, correct
and complete list of the names and addresses of each payor which has  contracted
with the Acquired Companies and the Subsidiaries,  which accounted for more than
3% of the revenues of the Acquired  Companies or any Subsidiary in the three (3)
previous  fiscal years and each material  supplier of the Acquired  Companies or
any Subsidiary. Except as set forth on Schedule 3.30, the Acquired Companies and
the  Subsidiaries  have good  relations  with their payors and  suppliers and no
material  customer  or supplier  has  notified  the  Acquired  Companies  or any
Subsidiary  that it intends to discontinue  its  relationship  with the Acquired
Companies or such Subsidiary.

         3.31. [RESERVED]

         3.32. Investment Company Status. Neither the Acquired Companies nor any
of the Subsidiaries is currently,  or has ever been, an "investment  company" as
that term is defined in Section 368(a)(2)(F)(iii) and (iv) of the Code.

         3.33. Insolvency Proceedings. Neither the Acquired Companies nor any of
the  Subsidiaries  are currently  under the  jurisdiction  of a Federal or state
court in a Title 11 or similar  case within the meaning of Section  368(a)(3)(A)
of the Code.

         3.34.  Positive  Net Worth.  On the Closing  Date the book value of the
assets of the Acquired  Companies and the Subsidiaries  will equal or exceed the
sum of the liabilities of the Acquired Companies and the Subsidiaries.

         3.35. Accounts Receivable/Payable.
<PAGE>

              A. The  accounts  receivable  of the  Acquired  Companies  and the
Subsidiaries  relating to the operation of the Acquired  Companies  reflected on
the Acquired  Companies  Balance  Sheet,  to the extent  uncollected on the date
hereof,  are, and the accounts  receivable  of the  Acquired  Companies  and the
Subsidiaries relating to the operation of the Acquired Companies to be reflected
on the books of the  Acquired  Companies  on the  Closing  Date  (the  "Accounts
Receivable") will be, valid, existing and collectible (taking into consideration
the allowance for doubtful accounts set forth in the Financial Statements) using
reasonably  diligent  collection methods taking into account the size and nature
of the  receivable,  and  represent  amounts due for goods sold and delivered or
services  performed.  The Acquired  Companies are in  compliance  with all third
party payor and eye care  professional  arrangements  relating  to the  Accounts
Receivable.  There are not,  and on the date of  Closing  there will not be, any
refunds,  discounts,  set-offs,  defenses,  counterclaims  or other  adjustments
payable or  assessable  with  respect to the Accounts  Receivable.  The Acquired
Companies and the Subsidiaries  have collected  Accounts  Receivable only in the
ordinary  course  and has not  changed  collection  procedures  or  methods  nor
accelerated  the  pace  of  such  collection  efforts  in  anticipation  of  the
transactions  contemplated  in this  Agreement.  The Acquired  Companies and the
Subsidiaries  have paid  accounts  payable  in the  ordinary  course and has not
changed payment procedures or methods nor delayed the timing of such payments in
anticipation of the transactions contemplated in this Agreement.

              B. Since the Acquired  Companies  Balance Sheet Date,  neither the
Acquired  Companies  nor  any of the  Subsidiaries  have  changed  any  material
principle or practice with respect to the recordation of accounts  receivable or
the calculation of reserves therefor,  or any material  collection,  discount or
write-off  policy  or  procedure.   The  Acquired  Companies  and  each  of  the
Subsidiaries  are in compliance  with the material  terms and  conditions of all
third-party  payor  arrangements  relating to its accounts  receivable.  Without
limiting the generality of the foregoing, each of the Acquired Companies and the
Subsidiaries,  are  in  compliance  with  all  Medicare  and  Medicaid  provider
agreements to which it is a party.

         3.36.  Insurance Reserves.  The Acquired Companies have established and
maintains all required insurance company reserves in all of those states that it
is required to do so and has established and maintains all required deposits and
bonds as are necessary in such state.

         3.37.  Finder's Fee. Except as set forth on Schedule 3.37,  neither the
Acquired  Companies nor the  Stockholder  have incurred any  obligation  for any
finder's,   brokers  or  agent's  fee  in  connection   with  the   transactions
contemplated hereby.

         3.38.  Projections.   There  is  no  fact,  development  or  threatened
development  with  respect  to  the  markets,  products,  services,   customers,
facilities,  personnel,  vendors, suppliers,  operations, assets or prospects of

<PAGE>

the  Acquired  Companies  or the  Subsidiaries  which are known to the  Acquired
Companies  or the  Stockholder  which  would  materially  adversely  affect  the
projected  fiscal  year  1997  earnings  of  the  Acquired   Companies  and  the
Subsidiaries  disclosed  to  Purchaser  by  the  Stockholder,  other  than  such
conditions as may affect as a whole the economy.

         3.39.  Disclosure.  To the  best of the  Acquired  Companies's  and the
Stockholder's  knowledge,  no representation,  warranty or statement made by the
Acquired  Companies or the  Stockholder in this Agreement or any of the exhibits
or schedules hereto, or any agreements,  certificates,  documents or instruments
delivered or to be delivered to Purchaser in accordance  with this  Agreement or
the other  documents  contemplated  herein,  contains or will contain any untrue
statement  of a  material  fact or omits or will omit to state a  material  fact
necessary to make the statements  contained  herein or therein,  in light of the
circumstances under which they were made, not misleading. The Acquired Companies
and the  Stockholder  do not know of any fact or  condition  (other than general
economic  conditions or  legislative  or  administrative  changes in health care
delivery) which materially  adversely  affects,  or in the future may materially
affect, the condition (financial or otherwise), properties, assets, liabilities,
business, operations or prospects of the Acquired Companies or the Subsidiaries,
which has not been set forth herein or in the Schedules provided herewith.

         3.40.  Managed  Care  Contracts.  On  December  1, 1997,  the number of
enrollees  covered  under the MEC's  managed  care  contracts as reported by the
clients of MEC is substantially as set forth in Schedule 3.40. As of October 31,
1997,  the per member per month fee  payable  to MEC was  increased  to $1.21 in
connection  with the  agreement  between MEC and Free State  which  relates to a
Medicare HMO product. MEC has not received any written or verbal notice from the
discounted  fee for service eye care  providers  who contract with MEC that such
eye care providers are terminating  their  relationship  with MEC as a result of
MEC's recently  announced  reduction in reimbursement for cataract surgeries and
YAG procedures which will be effective January 1, 1998.

     4.  REPRESENTATIONS  AND  WARRANTIES OF THE  STOCKHOLDER.  The  Stockholder
represents  and warrants to Purchaser that the following are true and correct on
the date hereof, and shall be true and correct as of the Closing Date as if made
on that date:

         4.1.  Organization;   Stockholder  Authority.   The  Stockholder  is  a
corporation duly organized, validly existing and in good standing under the laws
of Delaware  with all  requisite  corporate  power and authority to carry on the
business in which it is engaged,  to own the  properties it owns, to execute and
deliver this Agreement and to consummate the transactions  contemplated  hereby.
The execution, delivery and performance by the Stockholder of this Agreement and
the  other   agreements   contemplated   hereby  and  the  consummation  of  the

<PAGE>

transactions  contemplated hereby and thereby to be performed by the Stockholder
have been duly  authorized  by the  Stockholder.  This  Agreement and each other
agreement contemplated hereby have been, or will be as of the Closing Date, duly
executed and delivered by the  Stockholder  and  constitute  or will  constitute
legal, valid and binding obligations of the Stockholder, enforceable against the
Stockholder in accordance with their respective terms,  except as may be limited
by applicable bankruptcy, insolvency or similar laws affecting creditors' rights
generally or the availability of equitable remedies.

         4.2. No  Violation.  Except as set forth on Schedule  4.2,  neither the
execution,  delivery or performance of this Agreement or the other agreements to
be executed and delivered by the  Stockholder  in connection  herewith,  nor the
consummation  of the  transactions  contemplated  hereby  or  thereby,  will (a)
conflict  with,  or result in a violation or breach of the terms,  conditions or
provisions of, or constitute a default under, any agreement,  indenture or other
instrument  under  which  the  Stockholder  is bound  or to  which  any of their
property  or shares  of  Company  Common  Stock  are  subject,  or result in the
creation or imposition of any security  interest,  lien,  charge or  encumbrance
upon any of their  property or shares of Company Common Stock or (b) to the best
knowledge of the  Stockholder,  violate or conflict with any  judgment,  decree,
order, statute,  rule or regulation of any court or any public,  governmental or
regulatory agency or body.

         4.3.  Consents.  Except  as set  forth on  Schedule  4.3,  no  consent,
authorization,  approval, permit or license of, or filing with, any governmental
or public body or authority, or any other person is required to authorize, or is
required in connection  with,  the execution,  delivery and  performance of this
Agreement or the agreements contemplated hereby on the part of the Stockholder.

         4.4.  Certain  Payments.  The  Stockholder has not paid or caused to be
paid,  directly or indirectly,  in connection  with the business of the Acquired
Companies or the Subsidiaries:

              A.  to any  government  or  agency  thereof  or any  agent  of any
supplier or customer any bribe, kick-back or other similar payment; or

              B. any  contribution  to any political  party or candidate  (other
than  from  personal  funds  not  reimbursed  by the  Acquired  Companies  or as
otherwise permitted by applicable law).

         4.5. Ownership of Interested Persons; Affiliations. Except as set forth
on Schedule 4.5,  neither the Stockholder  nor its Affiliates,  owns directly or
indirectly,  any interest in, has a compensation or other financial  arrangement
with,  or serves as an officer or director  of, any  customer or supplier of the
Acquired  Companies  or  any  organization  that  has  a  material  contract  or
arrangement  with the Acquired  Companies.  Neither the  Stockholder  nor any of
their  Affiliates  is, or within  the last  three (3) years  was, a party to any

<PAGE>

contract,  lease, agreement or arrangement,  including,  but not limited to, any
joint venture or consulting  agreement with any physician,  hospital,  pharmacy,
home health  agency or other  person which is in a position to make or influence
referrals to, or otherwise generate business for, the Acquired Companies.

         4.6.  Investments in Competitors.  Except as disclosed on Schedule 4.6,
the  Stockholder  does not own directly or indirectly  any interests or have any
investment in any person that is a Competitor of the Acquired Companies.

     5.  REPRESENTATIONS AND WARRANTIES OF PURCHASER.  Purchaser  represents and
warrants to the Acquired  Companies and the  Stockholder  that the following are
true and  correct  on the date  hereof  and shall be true and  correct as of the
Closing  Date as if made on such  date;  when used in this  Section  5, the term
"best  knowledge"  (or words of similar  import) shall mean such  knowledge,  as
shall have been obtained  after  conducting due and diligent  inquiry,  of those
individuals listed on Schedule 5:

         5.1.  Organization  and  Good  Standing;  Qualification.  Each  of  the
Purchaser and its subsidiaries is a corporation duly organized, validly existing
and in good standing under the laws of its jurisdiction of  incorporation,  with
all requisite corporate power and authority to carry on the business in which it
is engaged, to own the properties it owns, to execute and deliver this Agreement
and to consummate the transactions  contemplated  hereby.  Each of the Purchaser
and its  subsidiaries  is duly  qualified  and  licensed  to do business in each
jurisdiction  in which the  character  or  location of the  properties  owned or
leased by  Purchaser  or its  subsidiaries  or the  practice  of the  businesses
conducted by Purchaser or its subsidiaries makes such qualification necessary or
desirable, except where the failure to be so qualified would not have a Material
Adverse Effect.

         5.2. Subsidiaries.  Except as set forth on Schedule 5.2, Purchaser does
not  own,  directly  or  indirectly,  any  of the  capital  stock  of any  other
corporation or any equity,  profit sharing,  participation  or other interest in
any  corporation,  partnership,  joint venture or other entity.  With respect to
each  corporation  that is owned,  directly or  indirectly,  beneficially  or of
record by Purchaser (each, a "Purchaser Subsidiary"),  Schedule 5.2 sets forth a
true,   correct  and  complete  list  of  (i)  the  name  and   jurisdiction  of
incorporation of each Purchaser Subsidiary,  (ii) the jurisdiction in which each
Purchaser  Subsidiary  is  qualified  or  licensed  to do  business as a foreign
corporation,  (iii) the authorized  capital stock of each Purchaser  Subsidiary,
(iv) the number of shares of each class thereof issued and outstanding,  and (v)
the  number of shares and  percentage  of  outstanding  capital  stock  owned by
Purchaser.  All outstanding shares of capital stock of each Purchaser Subsidiary
have been duly authorized and validly issued, are fully paid and non-assessable,
and are  owned by  Purchaser  free and  clear of all  liens,  pledges,  security
interests,  restrictions,  voting  trusts or other  encumbrances  of any  nature
whatsoever.
<PAGE>

         5.3. Capitalization. The authorized capital stock of Purchaser consists
of 50,000,000  shares of Common Stock and 10,000,000  shares of preferred stock,
of which  11,830,166  shares of Common  Stock  were  issued and  outstanding  on
December 29, 1997.  Schedule 5.3 sets forth an accurate and complete list of all
outstanding options and warrants to acquire shares of Common Stock. The issuance
and  delivery  of the  shares of  Common  Stock to be  issued  by  Purchaser  in
connection  with this  Agreement  have been duly and validly  authorized  by all
necessary  corporate  action on the part of  Purchaser.  The Common  Stock being
transferred  by  Purchaser  hereunder  shall  be free and  clear  of all  liens,
pledges,  restrictions,  voting trusts, security interests or other encumbrances
of  any  nature  whatsoever,  except  as  set  forth  herein,  or in  the  Stock
Distribution Agreement. Each outstanding share of Common Stock and the shares to
be issued  hereunder have been legally and validly issued and are fully paid and
nonassessable.  No shares of Common  Stock have  been,  and the shares of Common
Stock to be issued pursuant to this Agreement will not be, issued or disposed of
in violation of the preemptive rights, rights of first refusal or similar rights
of any of Purchaser's stockholders.

         5.4.  Governmental  Consents.  Except as disclosed on Schedule  5.4, no
filing or  registration  with,  or  authorization,  consent or approval  of, any
Governmental  Entity,  to the best knowledge of Purchaser,  is necessary for the
consummation of the transactions contemplated by this Agreement.

         5.5. Authorization and Validity.  Purchaser has the corporate power and
authority to execute this Agreement and carry out its obligations hereunder. The
execution, delivery and performance by Purchaser of this Agreement and the other
agreements  contemplated  hereby,  and  the  consummation  of  the  transactions
contemplated  hereby and thereby to be  performed by  Purchaser,  have been duly
authorized by Purchaser.  This Agreement and the other  agreements  contemplated
hereby to be executed by Purchaser have been, or will be as of the Closing, duly
executed and delivered by Purchaser and constitute the legal,  valid and binding
obligation of Purchaser,  enforceable  against  Purchaser in accordance with its
terms, except as may be limited by applicable bankruptcy,  insolvency or similar
laws affecting  creditors'  rights  generally or the  availability  of equitable
remedies.

         5.6. No Conflict.  The execution and delivery of this Agreement and the
documents  contemplated  hereunder  and  the  consummation  of the  transactions
contemplated  thereby  by  Purchaser  will  not (i)  violate  any  provision  of
Purchaser's organizational documents, (ii) violate any provision of or result in
the breach of or entitle any party to  accelerate  (whether  after the giving of
notice or lapse of time or both)  any  obligation  under,  any  mortgage,  lien,
lease,  material  contract,  license,  permit,  instrument or any other material
agreement to which  Purchaser or the Purchaser  Subsidiaries  is a party,  (iii)
result in the  creation or  imposition  of any lien,  charge,  pledge,  security
interest or other  encumbrance  upon any property of Purchaser or the  Purchaser

<PAGE>

Subsidiaries,  or (iv) violate or conflict  with any order,  award,  judgment or
decree or other restriction or any law,  ordinance,  rule or regulation to which
Purchaser  or its  property  is subject  except for those which would not have a
Material Adverse Effect.

         5.7.  Finder's Fee. Except as disclosed on Schedule 5.7,  Purchaser has
not  incurred  any  obligation  for any  finder's,  broker's  or agent's  fee in
connection with the transactions contemplated hereby.

         5.8.  Purchaser   Documents.   Purchaser  has  furnished  the  Acquired
Companies and the  Stockholder  with a true and complete copy of each report and
registration  statement  filed by it with the SEC  (the  "Purchaser  Documents")
since its  initial  public  offering,  which are all the  documents  that it was
required to file with the SEC since such date. As of their respective dates, the
Purchaser  Documents did not contain any untrue  statements of material facts or
omit to state  material facts required to be stated therein or necessary to make
the  statements  therein,  in light of the  circumstances  under which they were
made, not misleading.  As of their  respective  dates,  the Purchaser  Documents
complied  in all  material  respects  with the  applicable  requirements  of the
Securities  Act and the Exchange Act and the rules and  regulations  promulgated
under  such  statutes.  The  financial  statements  contained  in the  Purchaser
Documents,  together  with the notes  thereto,  have been prepared in accordance
with GAAP,  reflect all  liabilities of Purchaser  required to be stated therein
and present  fairly the  financial  condition  of Purchaser at such date and the
results of operations and cash flows of Purchaser for the period then ended. The
Purchaser  Documents do not contain any untrue  statements of material  facts or
omit to state any material  facts  required to be stated therein or necessary to
make the statements therein, in light of the circumstances under which they were
made,  not  misleading  as of the  date  hereof  except  for  such  facts as are
disclosed herein and except for the transactions contemplated hereby.

         5.9  Physician  Dispute.  The  Stockholder  has notified  Purchaser and
Purchaser has  acknowledged  the  existence of a dispute among the  Stockholder,
LSI, Bernard Spier,  M.D. and Charles Crane, M.D. in connection with the Service
Agreement  effective  July 1, 1996  between  LSI and  Northern  New  Jersey  Eye
Institute,  P.A. (the "Service Agreement").  Purchaser has had an opportunity to
discuss such dispute with all relevant parties.

         5.10  Governmental  Authorizations.  Purchaser  possesses all necessary
licenses, franchises, permits and other governmental authorizations,  including,
but not limited to all licenses,  franchises, permits and authorizations for the
conduct of the Purchaser's businesses as now conducted,  all of which are listed
(with expiration  dates, if applicable) on Schedule 5.10. Except as set forth on
Section 5.10, the transactions contemplated by this Agreement will not result in
a default under or a breach or violation of, or adversely  affect the rights and
benefits  afforded by any such licenses,  franchises,  permits or authorizations

<PAGE>

which, singly or in the aggregate, would not have a Material Adverse Effect. All
such licenses,  franchises,  permits and other  authorizations  are valid and in
full force and effect, the Purchaser is in current compliance  therewith and has
not  received  any  notice  that  any  governmental   authority  is  considering
challenging, revoking, cancelling, restricting, conditioning or not renewing any
such license, franchise, permit or other authorization.

         5.11  Compliance  with  Applicable  Laws.  Purchaser holds all permits,
licenses,  variances,  exemptions,  orders  and  approvals  of all  Governmental
Entities  material  to  the  business  of  the  Purchaser   including,   without
limitation,  applicable  state  corporation,  insurance  and  health  regulatory
authorities,  and other  Governmental  Entities  regulating  exclusive  provider
organizations,  preferred  provider  organizations,  medical  utilization review
organizations,  medical service  organizations,  lay  intermediaries,  secondary
contractors,  or third  party  administrators  (the  "Purchaser  Permits").  The
Purchaser  is in current  compliance  with the terms of the  Purchaser  Permits,
except for such failures to comply which, singly or in the aggregate,  would not
have a  Material  Adverse  Effect.  Except as  disclosed  in Section  5.11,  the
Purchaser is in  compliance  with all laws,  including  applicable  Medicare and
Medicaid laws, ordinances and regulations of any Governmental Entity, including,
without   limitation,   applicable  state  corporation,   insurance  and  health
regulatory  authorities and other  Governmental  Entities  regulating  exclusive
provider organizations,  preferred provider  organizations,  medical utilization
review  organizations,   medical  service  organizations,   lay  intermediaries,
secondary  contractors  or  third-party  administrators  and  all  Medicare  and
Medicaid provider agreements to which it is a party, except where the failure to
comply would not have a Material Adverse Effect.  Except as disclosed in Section
5.11, to the best knowledge of the Purchaser,  no investigation or review by any
Governmental   Entity,   including,   without   limitation,   applicable   state
corporation,  insurance and health  regulatory  authorities  with respect to the
Purchaser is pending, or threatened, nor has any Governmental Entity, including,
without   limitation,   applicable  state  corporation,   insurance  and  health
regulatory  authority  indicated an  intention  to conduct the same,  other than
those  the  outcome  of which  would  not be  material  to the  business  of the
Purchaser.

<PAGE>

     6.  SECURITIES LAW MATTERS

         6.1. Investment Representations and Covenants.  Subject to the terms of
the Stock  Distribution  Agreement,  the  Stockholder  represents,  warrants and
covenants as follows:

              A. The  Stockholder  understands  that the Securities  will not be
registered  under the Securities Act or any state securities laws on the grounds
that the  issuance of the  Securities  is exempt from  registration  pursuant to
Section 4(2) of the  Securities Act and applicable  state  securities  laws, and
that the reliance of Purchaser on such  exemptions  is predicated in part on the
Stockholder's  representations,  warranties,  covenants and acknowledgements set
forth in this Section.

              B. The Stockholder  represents and warrants that the Securities to
be  acquired  by it upon  consummation  of the  transactions  described  in this
Agreement  will be acquired by the  Stockholder  for its own  account,  not as a
nominee or agent, and without a view to resale or other distribution  within the
meaning of the Securities Act and the rules and regulations thereunder, and that
the  Stockholder  will not  distribute any of the Securities in violation of the
Securities Act.

              C. The Stockholder (i) acknowledges  that the Securities issued to
it at the Closing must be held indefinitely by it unless subsequently registered
under the Securities Act or an exemption from registration is available, (ii) is
aware that any routine sales of  Securities  made pursuant to Rule 144 under the
Securities  Act may be made only in limited  amounts and in accordance  with the
terms and  conditions  of that Rule and that in such cases where the Rule is not
applicable,  compliance with some other registration exemption will be required,
(iii) is aware that Rule 144 is not  currently  available  for use for resale of
any of the Securities to be acquired by  Stockholder  upon  consummation  of the
transactions described in this Agreement,  and (iv) acknowledges and agrees that
the  transfer  of the  Securities  shall be  further  restricted  by  provisions
contained in the Stock Distribution Agreement.

              D. The  Stockholder  represents  and warrants to Purchaser that it
has such knowledge and experience in financial and business matters such that it
is capable of evaluating the merits and risks of an investment in the Securities
and is able to sustain a complete loss of such investment.

              E. The Stockholder confirms that it has had the opportunity to ask
questions  of and  receive  answers  from  Purchaser  concerning  the  terms and
conditions of its investment in the Securities, and that it has received, to its
satisfaction, such information about Purchaser's operations as it has requested.

              F. In order to ensure  compliance with the provisions of paragraph
(c) hereof,  the  Stockholder  agrees that after the Closing it will not sell or

<PAGE>

otherwise  transfer or dispose of any of the Securities or any interest  therein
except in compliance with the terms of the Stock Distribution Agreement.

              G. The Stockholder  acknowledges  and agrees that the certificates
or instruments  representing  the Securities to be issued to it pursuant to this
Agreement shall contain a restrictive legend noting the restrictions on transfer
described  in  this  Section  and  required  by  federal  and  applicable  state
securities laws, and that appropriate "stop-transfer" instructions will be given
to  Purchaser's  transfer  agent in the event  such  provisions  and  applicable
federal and state securities laws are not complied with by any Stockholder.

              H. The Stockholder  represents and warrants that Stockholder is an
"accredited  investor" as defined under the  Securities Act and state "Blue Sky"
laws.

              I. The Stockholder acknowledges that it has received the Purchaser
Documents  described  in Section  5.8 and has had an  opportunity  to review the
Purchaser Documents.

     7. COVENANTS OF THE ACQUIRED  COMPANIES AND THE  STOCKHOLDER.  The Acquired
Companies and the  Stockholder,  jointly and  severally,  agree that between the
date hereof and the Closing (with respect to the Acquired Companies'  covenants,
the Stockholder  agrees to use its best efforts to cause the Acquired  Companies
to perform):

         7.1.  Consummation  of  Agreement.   The  Acquired  Companies  and  the
Stockholder shall use their reasonable best efforts to cause the consummation of
the  transactions  contemplated  hereby  in  accordance  with  their  terms  and
conditions.

         7.2. Business  Operations.  The Acquired Companies and the Subsidiaries
shall operate their  businesses in the ordinary course and  substantially in the
manner  conducted  as of  the  date  hereof.  The  Acquired  Companies  and  the
Stockholder  shall use their reasonable best efforts to preserve the business of
the  Acquired  Companies  and the  Subsidiaries  intact,  to keep  available  to
Purchaser the services of their officers, agents and independent contractors and
to preserve for Purchaser their  relationships with their suppliers,  licensees,
distributors,  eye care  professionals,  customers  and others  having  business
relationships  with it. Neither the Acquired Companies nor the Stockholder shall
take any  action  that  would,  individually  or in the  aggregate,  result in a
Material Adverse Effect.

         7.3.  Access.  The Acquired  Companies and the  Stockholder  shall,  at
reasonable times during normal business hours and on reasonable  notice,  permit
Purchaser and its authorized representatives,  access to, and make available for
inspection,  all of the assets and properties of the Acquired  Companies and the
Subsidiaries,  including their  employees,  customers and suppliers,  and permit

<PAGE>

Purchaser and its authorized representatives to inspect and, at Purchaser's sole
cost and expense,  make copies of all documents,  records and  information  with
respect  to the  affairs  of the  Acquired  Companies  and the  Subsidiaries  as
Purchaser and its representatives may request.

         7.4.  Notification of Certain Matters.  The Acquired  Companies and the
Stockholder  shall promptly inform Purchaser in writing of (a) any notice of, or
other  communication  relating to, a default or event that, with notice or lapse
of time or both,  would become a default,  received by any of them subsequent to
the date of this  Agreement  and prior to the Closing Date under any  Commitment
material  to  the  Acquired  Companies'   condition  (financial  or  otherwise),
operations,  assets,  liabilities or business and to which it is subject; or (b)
any material adverse change in the Acquired Companies'  condition  (financial or
otherwise), operations, assets, liabilities or business.

         7.5. Approvals of Third Parties.  As soon as practicable after the date
hereof,  the Acquired  Companies and the Stockholder  shall secure all necessary
approvals and consents of  Governmental  Authorities to the  consummation of the
transactions  contemplated hereby and shall use their best efforts to secure all
necessary  approvals and consents of other third parties to the  consummation of
the transactions contemplated hereby.

         7.6.  Employee  Matters.  Except  as set forth in  Schedule  3.11 or as
otherwise  contemplated  by this  Agreement,  the Acquired  Companies shall not,
without the prior written approval of Purchaser, except as required by law or in
the ordinary course of business:

              A. increase the cash  compensation  of any directors,  officers or
employees  of the  Acquired  Companies  or the  Subsidiaries  (other than in the
ordinary course of business and consistent with past practice);

              B. adopt,  amend or  terminate  any (i)  Compensation  Plan;  (ii)
Employment Agreement;  (iii) Employee Policies and Procedures;  or (iv) Employee
Benefit Plan;

              C. take any action that could  deplete the assets of any  Employee
Benefit  Plan,  other  than  payment  of  benefits  in the  ordinary  course  to
participants and beneficiaries;

              D. fail to pay any premium or contribution  due or with respect to
any Employee Benefit Plan;

              E. fail to file any return or report with  respect to any Employee
Benefit Plan;
<PAGE>

              F. institute,  settle or dismiss any employment  litigation except
as could not,  individually  or in the aggregate,  result in a Material  Adverse
Effect;

              G. enter into,  modify,  amend or terminate any agreement with any
union, labor organization or collective bargaining unit; or

              H. take or fail to take any  action  with  respect  to any past or
present  employee of the  Acquired  Companies  or the  Subsidiaries  that would,
individually or in the aggregate, result in a Material Adverse Effect.

         7.7.  Contracts.  The Acquired  Companies shall not,  without the prior
written  approval  of  Purchaser,  assume  or enter  into any  contract,  lease,
license,  obligation,  indebtedness,  commitment,  purchase or sale in excess of
$20,000,  except  in the  ordinary  course  of  business  nor shall it waive any
material  right or cancel any  material  contract,  debt or claim,  nor shall it
alter any Commitment in any material respect.

         7.8. Capital Assets;  Payments of Liabilities.  The Acquired  Companies
shall not,  without  the prior  written  approval  of  Purchaser  (a) acquire or
dispose of any capital  asset having a fair market value of $20,000 or more,  or
acquire or dispose  of any  capital  asset  outside  of the  ordinary  course of
business or (b) discharge or satisfy any lien or  encumbrance  or pay or perform
any obligation or liability other than (i) liabilities and obligations reflected
in the Financial Statements or (ii) current liabilities and obligations incurred
in the usual  and  ordinary  course of  business  since the  Acquired  Companies
Balance  Sheet Date and, in either  case (i) or (ii) above,  only as required by
the express  terms of the  agreement or other  instrument  pursuant to which the
liability or obligation was incurred.

         7.9. Mortgages, Liens and Guaranties. The Acquired Companies shall not,
without  the prior  written  approval  of  Purchaser,  enter  into or assume any
mortgage,  pledge,  conditional sale or other title retention agreement,  permit
any security interest,  lien,  encumbrance or claim of any kind to attach to any
of its assets  (other than  statutory  liens  arising in the ordinary  course of
business  and  other  liens  that do not  materially  detract  from the value or
interfere with the use of such assets), whether now owned or hereafter acquired,
or guarantee or  otherwise  become  contingently  liable for any  obligation  of
another,  except obligations arising by reason of endorsement for collection and
other  similar  transactions  in the ordinary  course of  business,  or make any
capital contribution or investment in any person.

         7.10. [RESERVED]

         7.11.  Distributions  and  Repurchases.  No  distribution,  payment  or
dividend  of any kind will be declared or paid by the  Acquired  Companies  with

<PAGE>

respect of its capital  stock,  nor will any  repurchase  of any of the Acquired
Companies' capital stock be approved or effected.

         7.12.  Stock Options.  All  outstanding  options to purchase or acquire
shares of Company  Common  Stock  shall be  cancelled  and any  agreements  with
respect to such options shall be terminated.

         7.13.  Retained  Equity.  The  Acquired  Companies  shall not,  and the
Stockholder  shall not permit the Acquired  Companies to, make payment of all or
any portion of any retained  equity of the Acquired  Companies at any time prior
to Closing.

         7.14.   Termination  of  Retirement  Plans.   Prior  to  Closing,   the
Stockholder  shall cause the Acquired  Companies to take all steps  necessary to
discontinue  benefit  accruals under any Employee  Benefit Plan and to terminate
their  participation  in all  such  plans  effective  as of  Closing  or as soon
thereafter as may be practical.

         7.15. Delivery of Schedules. The Acquired Companies and the Stockholder
shall deliver to Purchaser all Schedules  required to be delivered by them prior
to the Closing.

         7.16.  Approval of Lender and Release.  The Acquired  Companies and the
Stockholder shall secure the consent and approval of its senior lender, Foothill
Capital Corporation,  to the transactions contemplated hereby and the release of
all liens held by such  lender on the assets and capital  stock of the  Acquired
Companies.

     8. COVENANTS OF PURCHASER8.  Purchaser  agrees that between the date hereof
and the Closing:

         8.1. Consummation of Agreement. Purchaser shall use its best efforts to
cause the  consummation of the  transactions  contemplated  hereby in accordance
with their terms and conditions.

         8.2.  Approvals of Third Parties.  Purchaser shall use its best efforts
to secure, as soon as practicable after the date hereof, all necessary approvals
and  consents  of  third  parties  to  the   consummation  of  the  transactions
contemplated hereby.

         8.3.  Access.  Purchaser  shall,  at  reasonable  times  during  normal
business hours and on reasonable  notice,  permit Stockholder and its authorized
representatives, access to, and make available for inspection, all of the assets
and properties of Purchaser, including their employees, customers and suppliers,
and permit  Stockholder  and its authorized  representatives  to inspect and, at
Stockholder's sole cost and expense,  make copies of all documents,  records and
information  with respect to the affairs of the Purchaser as Stockholder and its
representatives may request.
<PAGE>

         8.4.  Notification of Certain Matters.  Purchaser shall promptly inform
Purchaser in writing of (a) any notice of, or other communication relating to, a
default or event  that,  with  notice or lapse of time or both,  would  become a
default,  received by any of them  subsequent to the date of this  Agreement and
prior to the  Closing  Date under any  obligation  material  to the  Purchaser's
condition (financial or otherwise),  operations, assets, liabilities or business
and  to  which  it is  subject;  or  (b)  any  material  adverse  change  in the
Purchaser's condition (financial or otherwise),  operations, assets, liabilities
or business.

         8.5.   401(k)   Contributions.   If   pursuant  to  the  terms  of  the
Stockholder's  401(k) plan the  Stockholder  matches  contributions  made by the
Stockholders'  employees  pursuant to such plan, then the Stockholder shall give
the Purchaser written notice of the amount of such matching contribution and the
Purchaser  shall  reimburse  the  Stockholder  for such  matching  contributions
related  to  1997  for  those  employees  of the  Acquired  Companies  who  were
participating in such plan prior to the Closing Date. The Stockholder represents
and the  Purchaser  acknowledges  that the amount of the matching  contributions
through November 30, 1997 is $22,876.92.  In the event any of such contributions
reimbursed  by the  Purchaser  are  forfeited  by an  employee  of the  Acquired
Companies, the Stockholder agrees to reimburse the Purchaser for the amount paid
by it promptly upon the forfeiture thereof.

     9.  COVENANTS OF PURCHASER,  THE ACQUIRED  COMPANIES  AND THE  STOCKHOLDER.
Purchaser, the Acquired Companies and the Stockholder agree as follows:
<PAGE>

         9.1.  Amendment  of  Schedules.  Each party hereto  agrees  that,  with
respect to the  representations  and warranties of such party  contained in this
Agreement,  such party shall have the continuing obligation until the Closing to
attach,  supplement or amend  promptly the Schedules  with respect to any matter
that would have been or would be  required to be set forth or  described  in the
Schedules  in order to not breach any  representation,  warranty  or covenant of
such party  contained  herein;  provided  that no amendment or  supplement  to a
Schedule that  constitutes or reflects a material adverse change to the Acquired
Companies or the Assets may be made unless Purchaser  consents to such amendment
or supplement,  and no amendment or supplement to a Schedule that constitutes or
reflects a material  adverse change to Purchaser may be made unless the Acquired
Companies and the Stockholder  consent to such amendment or supplement.  For all
purposes  of this  Agreement,  including  without  limitation  for  purposes  of
determining whether the conditions set forth in Sections 10.1 and 11.1 have been
fulfilled,  the Schedules  hereto shall be deemed to be the Schedules as amended
or  supplemented  pursuant to this  Section  9.1. In the event that the Acquired
Companies are required to amend or supplement a Schedule in accordance with this
Section 9.1 and Purchaser does not consent to such  amendment or supplement,  or
Purchaser is required to amend or supplement a Schedule in accordance  with this
Section 9.1 and the Acquired Companies and the Stockholder do not consent,  this
Agreement  shall be deemed  terminated by mutual consent as set forth in Section
15.1(d) or Section 15.1(e) as appropriate.

         9.2.  Fees and  Expenses.  Each of the parties  shall pay the costs and
expenses  of their own  advisors  with  respect to legal,  accounting  and other
professional  services rendered in connection with the preparation,  negotiation
and  consummation  of this  Agreement,  provided,  however,  all such  costs and
expenses  incurred  by  the  Acquired   Companies  shall  be  paid  for  by  the
Stockholder.

         9.3. Tax Matters.

              A. Returns. The Acquired Companies and the Subsidiaries shall duly
and timely  file all Tax  Returns  required to be filed on or before the Closing
Date and duly and timely pay all taxes shown on such Tax Returns to be due.

              B. Tax Sharing  Agreements.  Any tax sharing agreement between the
Acquired  Companies  or any of the  Subsidiaries  and any other  party  shall be
terminated  as of the  Closing  Date and shall  have no  further  effect for any
taxable year (whether the current year, a future year or a past year).

              C. Audits. The Stockholder will allow Purchaser and its counsel to
participate,  at their expense, in any audits of the consolidated federal income
tax returns of the Acquired Companies and the Subsidiaries. The Stockholder will
not settle any such audit without the prior written consent of Purchaser.
<PAGE>

     10.  CONDITIONS  PRECEDENT TO  OBLIGATIONS  OF PURCHASER.  Except as may be
waived in writing by  Purchaser,  the  obligations  of Purchaser  hereunder  are
subject  to the  fulfillment  at or  prior  to the  Closing  Date of each of the
following conditions precedent:

         10.1.   Representations   and  Warranties.   The   representations  and
warranties of the Acquired Companies and the Stockholder  contained herein shall
have been true and correct in all  material  respects  when  initially  made and
shall be true and correct in all material respects as of the Closing Date.

         10.2. Covenants.  The Acquired Companies and the Stockholder shall have
performed  and  complied  with all  covenants  required by this  Agreement to be
performed and complied with by the Acquired  Companies or the Stockholder  prior
to the Closing Date.

         10.3.  Proceedings.  No  action,  proceeding  or order by any  court or
governmental  body or agency  shall have been  threatened  orally or in writing,
asserted,  instituted or entered to restrain or prohibit the carrying out of the
transactions contemplated hereby.

         10.4. No Material  Adverse  Change.  No material  adverse change in the
condition (financial or otherwise),  operations, assets, liabilities or business
of the Acquired  Companies  shall have  occurred  since the  Acquired  Companies
Balance  Sheet Date,  whether or not such  change  shall have been caused by the
deliberate  act or omission of the Acquired  Companies or the  Stockholder.  For
purposes  hereof,  the  termination  of the employment  relationship  of Bernard
Spier, M.D. and Charles Crane, M.D. with Northern New Jersey Eye Institute, P.A.
will not be considered a material adverse change.

         10.5.   Government  Approvals  and  Required  Consents.   The  Acquired
Companies,  the  Stockholder  and  Purchaser  shall have  obtained all necessary
government  and other  third-party  approvals and consents  (other than consents
technically  required as a result of the transactions  contemplated hereby under
the terms of managed care  contracts  to which the Acquired  Companies or any of
its employees are a party).

         10.6. Closing  Deliveries.  Purchaser shall have received all documents
and agreements,  duly executed and delivered in form reasonably  satisfactory to
Purchaser, referred to in Section 12.1.

         10.7.  Exemption  Under  Securities  Laws.  The transfer of Purchaser's
Securities to the  Stockholder as  contemplated  in this Agreement shall qualify
for one or more exemptions from registration  under state and federal securities

<PAGE>

laws. Purchaser shall pay all filing fees in connection with any filing required
to qualify the transfer of the Securities for such exemption(s).

         10.8. Approval of Purchaser's Board of Directors.  Purchaser shall have
received the approval of its Board of Directors.

     11. CONDITIONS  PRECEDENT TO OBLIGATIONS OF THE ACQUIRED  COMPANIES AND THE
STOCKHOLDER Except as may be waived in writing by the Acquired Companies and the
Stockholder,  the  obligations  of the Acquired  Companies  and the  Stockholder
hereunder are subject to  fulfillment at or prior to the Closing Date of each of
the following conditions precedent:

         11.1.   Representations   and  Warranties.   The   representations  and
warranties  of  Purchaser  contained  herein  shall be true and  correct  in all
material  respects  when  initially  made and shall be true and  correct  in all
material respects as of the Closing Date.

         11.2.  Covenants.  Purchaser shall have performed and complied with all
covenants and conditions required by this Agreement to be performed and complied
with by it prior to the Closing Date.

         11.3.  Proceedings.  No  action,  proceeding  or order by any  court or
governmental  body or agency shall have been  threatened  in writing,  asserted,
instituted  or  entered  to  restrain  or  prohibit  the  carrying  out  of  the
transactions contemplated hereby.

         11.4.   Government  Approvals  and  Required  Consents.   The  Acquired
Companies  the  Stockholder  and  Purchaser  shall have  obtained all  necessary
government  and other  third-party  approvals and consents  (other than consents
technically  required as a result of the transactions  contemplated hereby under
the terms of managed care  contracts  to which the Acquired  Companies or any of
its employees are a party).

         11.5.  Closing  Deliveries.  The Acquired Companies and the Stockholder
shall have received all documents, instruments and agreements, duly executed and
delivered in form reasonably satisfactory to the Acquired Companies, referred to
in Section 12.2.

         11.6. No Material  Adverse  Change.  No material  adverse change in the
condition (financial or otherwise),  operations, assets, liabilities or business
of the Purchaser  shall have occurred since the Effective  Date,  whether or not
such  change  shall  have  been  caused by the  deliberate  act or  omission  of
Purchaser.
<PAGE>

         11.7.  Consent of Lender.  The Acquired Companies and Stockholder shall
have received the approval of its senior lender,  Foothill  Capital  Corporation
and a release of all of such lender's liens against the Acquired Companies.

         11.8.  Approval of  Stockholder's  Board of Directors.  The Stockholder
shall have received the approval of its Board of Directors.

     12. CLOSING DELIVERIES.

         12.1.  Deliveries  of the Acquired  Companies and the  Stockholder.  At
Closing,  the  Acquired  Companies or the  Stockholder,  as  appropriate,  shall
deliver to Purchaser the following,  all of which shall be in a form  reasonably
satisfactory to Purchaser:

              A.  certificates  representing  all of the issued and  outstanding
shares of Company  Common Stock,  duly endorsed in blank by the  Stockholder  or
accompanied by duly endorsed stock powers in blank, with all necessary  transfer
tax and other revenue stamps, acquired at the Stockholder's expense, affixed and
cancelled.  The Stockholder  agrees to cure any deficiencies with respect to the
endorsement of the certificates or other documents of conveyance with respect to
the  Acquired  Companies  Common  Stock  or with  respect  to the  stock  powers
accompanying any Company Common Stock;

              B.  a copy  of  resolutions  of the  Boards  of  Directors  of the
Acquired Companies  authorizing the execution,  delivery and performance of this
Agreement and all other  documents  and  agreements to be executed in connection
herewith, certified by the Secretary of the Acquired Companies as being true and
correct  copies  of  the  originals  thereof  subject  to  no  modifications  or
amendments;

              C. a certificate  of an officer of the Acquired  Companies and the
Stockholder,  dated the Closing Date, certifying the truth and accuracy of their
respective  representations  and warranties  contained  herein, on and as of the
Closing Date;

              D. a certificate  of an officer of the Acquired  Companies and the
Stockholder,  dated the  Closing  Date  certifying  (i) the  performance  of and
compliance by them with all covenants  contained herein on and as of the Closing
Date and (ii) that all  conditions  precedent of the Acquired  Companies and the
Stockholder to the Closing have been satisfied;

              E. a certificate of an officer of the Acquired Companies dated the
Closing Date,  certifying  the incumbency and signatures of each officer who has
executed documents delivered pursuant to the Agreement on behalf of the Acquired
Companies;
<PAGE>

              F. a  certificate,  dated  within  fifteen  (15) days prior to the
Closing Date, of the  Secretary of State of the state of  incorporation  for the
Acquired  Companies  and  each  of  the  Subsidiaries   establishing  that  such
corporations are in existence, have paid all franchise or similar taxes, and are
in  good  standing  to  transact   business  in  their   respective   states  of
organization;

              G.  certificates,  if  applicable,  dated within fifteen (15) days
prior to the Closing  Date, of the  Secretaries  of State of the states in which
the  Acquired  Companies  and  each  of the  Subsidiaries  are  qualified  to do
business,  to the effect that such corporations are qualified to do business and
in good standing as foreign corporations in each of such states;

              H.  an  opinion  of  counsel  to  the   Acquired   Companies   and
Stockholder,  dated as of the Closing Date, in  substantially  the form attached
hereto as Exhibit 12.1(h),  (which may be relied upon by Purchaser,  its counsel
and its  underwriters  in connection  with any  registration  statement filed by
Purchaser);

              I.  if  applicable,  all  authorizations,  consents,  permits  and
licenses referenced in Section 3.6;

              J. the  resignations of the directors and officers of the Acquired
Companies and each of the Subsidiaries effective immediately upon Closing;

              K. an executed Stock Distribution  Agreement between Purchaser and
the Stockholder in substantially the form attached hereto as Exhibit 12.1(k);

              L. an executed Escrow Agreement,  if applicable,  in substantially
the form attached hereto as Exhibit 12.1(l);

              M. an executed Employment  Agreement between Purchaser and each of
Mark Gordon,  Ellen Gordon and Howard Levin in  substantially  the form attached
hereto as Exhibit 12.1(m);

              N. a new lease or leases or assignments of existing leases between
the landlords under each lease for real property  described on Schedule  3.15(c)
and Purchaser in form and substance reasonably satisfactory to Purchaser;

              O. the consent of Foothill Capital  Corporation to the transaction
and its  release of all liens on the assets and  capital  stock of the  Acquired
Companies;

              P. a termination  agreement  executed  between the Stockholder and
each  of  Mark  Gordon,  O.D.,  Ellen  Gordon  and  Howard  Levin,  O.D.,  which

<PAGE>

termination  agreement shall terminate such individuals'  employment  agreements
with the Stockholder and permit such individuals to participate in the Business;
and

              Q. such other  instrument or instruments  of transfer  prepared by
Purchaser  as shall be  necessary  or  appropriate,  as Purchaser or its counsel
shall reasonably request, to carry out and effect the purpose and intent of this
Agreement.

         12.2. Deliveries of Purchaser.  At Closing,  Purchaser shall deliver to
the  Stockholder  the  following,  all of which  shall  be in a form  reasonably
satisfactory to the Stockholder:

              A. the Stock Purchase Consideration;

              B. a  copy  of  the  resolutions  of the  Board  of  Directors  of
Purchaser authorizing the execution,  delivery and performance of this Agreement
and all other  documents and  agreements to be executed in connection  herewith,
certified by the Secretary of Purchaser as being true and correct  copies of the
originals thereof subject to no modifications or amendments;

              C. a  certificate  of an officer of  Purchaser,  dated the Closing
Date, certifying the truth and accuracy of the representations and warranties of
Purchaser contained herein, on and as of the Closing Date;

              D. a  certificate  of an officer of  Purchaser,  dated the Closing
Date,  certifying  (i) the  performance  and  compliance  by Purchaser  with all
covenants  contained  herein  on and as of the  Closing  Date and (ii)  that all
conditions precedent of Purchaser to the Closing have been satisfied;

              E. a  certificate  of an officer of  Purchaser,  dated the Closing
Date,  certifying the incumbency and signatures of each officer who has executed
documents delivered pursuant to the Agreement on behalf of Purchaser;

              F. a  certificate,  dated  within  fifteen  (15) days prior to the
Closing  Date,  of the  Secretary of State of the State of Florida  establishing
that Purchaser is in existence, has paid all franchise or similar taxes, if any,
and is in good standing to transact business in such state;

              G.  certificates,  dated  within  fifteen  (15) days  prior to the
Closing  Date,  of the  Secretary  of State of each state in which  Purchaser is
qualified  to do  business,  to the effect that  Purchaser  is  qualified  to do
business  and is in  good  standing  as a  foreign  corporation  in each of such
states;
<PAGE>

              H. an  opinion  of  Shumaker,  Loop &  Kendrick,  LLP,  counsel to
Purchaser,  dated as of the Closing  Date,  in  substantially  the form attached
hereto as Exhibit 12.2(h);

              I. an executed Stock Distribution Agreement;

              J. an executed Escrow Agreement, if applicable;

              K. an executed Employment  Agreement between Purchaser and each of
Mark Gordon, Ellen Gordon and Howard Levin; and

              L. such other  instrument or instruments of transfer,  prepared by
the Acquired  Companies or the Stockholder as shall be necessary or appropriate,
as the Acquired  Companies,  the  Stockholder or their counsel shall  reasonable
request, to carry out and effect the purpose and intent of this Agreement.

     13. POST CLOSING MATTERS.

         13.1. Further Instruments of Transfer. From and after the Closing Date,
at the request of Purchaser and at the Stockholder's sole cost and expense,  the
Stockholder  shall  deliver any  further  instruments  of transfer  and take all
reasonable  action as may be necessary or  appropriate  to carry out the purpose
and intent of this Agreement.

         13.2.  Disclosure.  From and  after  the  Closing,  at the  request  of
Purchaser, the Stockholder agrees to provide all information which Purchaser may
from time to time request concerning themselves,  the Acquired Companies and the
transactions  contemplated hereby for inclusion in any registration statement or
other filing made by Purchaser  under the  Securities Act or the Exchange Act at
no additional cost to Purchaser.  The Stockholder  covenants and agrees that all
such  information  shall be true and correct when made and shall not contain any
untrue  statement of a material fact or omit to state a material fact  necessary
in order to make the statements therein contained not misleading.

         13.3.  Accountants' Consent. From and after the Closing, at the request
of Purchaser, the Stockholder agrees to request KPMG Peat Marwick LLP to consent
to the inclusion of the financial  statements of the Acquired  Companies and the
Subsidiaries  for the fiscal years ended December 31, 1995, 1996 and 1997 in any
registration  statement or other filing made by Purchaser  under the  Securities
Act or the  Exchange  Act;  provided,  however,  the  Stockholder  shall  not be
responsible  for any fees of KPMG  Peat  Marwick  LLP with  respect  to any work
performed on any such financial  statements,  which specifically  relates to the
inclusion of such  financial  statements in any such  registration  statement or
other filing made by Purchaser.
<PAGE>

         13.4.  Release of  Stockholder  Guaranty.  Within  the ninety  (90) day
period  immediately  following  the Closing  Date,  Purchaser  agrees to use its
reasonable  best  efforts  to assist  Stockholder  in  obtaining  a  release  of
Stockholder's  guarantee of that certain Master Lease Agreement between Hillside
Finance  International  LLC and LSI dated June 27, 1996,  including  Purchaser's
agreement to provide a guarantee of such obligation.

     14. REMEDIES.

         14.1.  Indemnification  by the  Stockholder.  Subject  to the terms and
conditions of this Agreement,  the Stockholder  agrees to indemnify,  defend and
hold  Purchaser  and its  directors,  officers,  members,  managers,  employees,
agents,  attorneys and affiliates harmless from and against all losses,  claims,
obligations,  demands,  assessments,  penalties,  liabilities,  costs,  damages,
reasonable  attorneys'  fees and  expenses  (collectively,  "Damages")  asserted
against or incurred by Purchaser or any of such individuals (including,  but not
limited to, any reduction in payments to or revenues of the Acquired Companies),
arising out of or resulting from:

              A. a breach of any  representation,  warranty  or  covenant of the
Acquired  Companies or the  Stockholder  contained  herein or in any schedule or
certificate   delivered   hereunder,   disregarding   for  purposes  hereof  any
materiality  qualifications  contained  therein to the extent  such  materiality
qualifications,  when  taken as a whole,  represent  a  material  breach of this
Agreement by the Acquired Companise or the Stockholder;

              B. any liability under the Securities Act, the Exchange Act or any
other federal or state "Blue Sky" or securities law or regulation, at common law
or otherwise,  (i) arising out of or based upon any untrue  statement or alleged
untrue  statement of a material fact relating to the  Stockholder,  the Acquired
Companies or the  Subsidiaries  and provided to Purchaser or its counsel by them
specifically for inclusion in a registration statement or any prospectus forming
a part thereof,  or any amendment  thereof or supplement  thereto,  or any other
filing made  pursuant to the Exchange  Act, or (ii) arising out of or based upon
any omission or alleged  omission to state  therein a material  fact relating to
the  Stockholder,  the  Acquired  Companies or the  Subsidiaries  required to be
stated therein or necessary to make the statements  therein not misleading,  and
not  provided to  Purchaser  or its  counsel by the  Acquired  Companies  or the
Stockholder;

              C. any liability  arising from any alleged  unlawful sale or offer
to sell or transfer any of the Common Stock by the Stockholder; or

              D. notwithstanding  anyting herein to the contrary,  any liability
arising  from any claim by  Northern  New  Jersey  Eye  Institute,  P.A.  or any
stockholder of or physician employed by Northern New Jersey Eye Institute,  P.A.

<PAGE>

that such  entity,  stockholder  or  physician  was  fraudulently  induced  into
entering into the Services Agreement, and any liability incurred or arising from
any breach by the Acquired  Companies of the Services Agreement and which breach
arose on or before the Closing Date, and any liability  incurred or arising from
the  unenforceability  of the Services  Agreement due to actions or inactions by
the  Stockholder  or the  Acquired  Companies  which  occurred  on or before the
Closing Date.

         14.2. Indemnification by Purchaser. Subject to the terms and conditions
of this  Agreement,  Purchaser  hereby agrees to indemnify,  defend and hold the
Stockholder  harmless from and against all Damages  asserted against or incurred
by them arising out of or resulting from:

              A. a  breach  by  Purchaser  of any  representation,  warranty  or
covenant  of  Purchaser  contained  therein or in any  schedule  or  certificate
delivered hereunder;

              B. except as specifically set forth herein, Purchaser's failure to
satisfy obligations and liabilities of the Acquired Companies; and

              C. any liability under the Securities Act, the Exchange Act or any
other federal or state "Blue Sky" or securities law or regulation, at common law
or  otherwise,  arising  out of or based  upon any untrue  statement  or alleged
untrue  statement of a material  fact  relating to  Purchaser,  contained in any
preliminary prospectus,  registration statement or any prospectus forming a part
thereof, or any amendment thereof or supplement thereto, arising out of or based
upon any omission or alleged  omission to state therein a material fact relating
to Purchaser  (including  the  subsidiaries),  required to be stated  therein or
necessary to make the statements therein not misleading.

         14.3.  Conditions of  Indemnification.  All claims for  indemnification
under this Agreement shall be asserted and resolved as follows:

              A. A party  claiming  indemnification  under  this  Agreement  (an
"Indemnified  Party") shall promptly (and, in any event,  at least ten (10) days
prior to the due date for any responsive pleadings,  filings or other documents)
(i) notify  the party from whom  indemnification  is sought  (the  "Indemnifying
Party") of any  third-party  claim or claims  asserted  against the  Indemnified
Party ("Third  Party Claim") that could give rise to a right of  indemnification
under this  Agreement  and (ii)  transmit  to the  Indemnifying  Party a written
notice ("Claim Notice")  describing in reasonable detail the nature of the Third
Party Claim, a copy of all papers served with respect to such claim (if any), an
estimate of the amount of damages  attributable to the Third Party Claim and the
basis  of  the  Indemnified  Party's  request  for  indemnification  under  this
Agreement.  Except as set forth in Section 14.6, the failure to promptly deliver
a Claim Notice shall not relieve the  Indemnifying  Party of its  obligations to
the  Indemnified  Party with respect to the related  Third Party Claim except to

<PAGE>

the extent that the resulting delay is materially  prejudicial to the defense of
such  claim.  Within  thirty  (30) days after  receipt of any Claim  Notice (the
"Election  Period"),  the Indemnifying  Party shall notify the Indemnified Party
(i) whether the  Indemnifying  Party  disputes  its  potential  liability to the
Indemnified  Party under this  Article 16 with respect to such Third Party Claim
and (ii) whether the Indemnifying Party desires, at the sole cost and expense of
the Indemnifying Party, to defend the Indemnified Party against such Third Party
Claim.

              If the  Indemnifying  Party notifies the Indemnified  Party within
the Election Period that the Indemnifying  Party elects to assume the defense of
the Third  Party  Claim,  then the  Indemnifying  Party  shall have the right to
defend, at its sole cost and expense,  such Third Party Claim by all appropriate
proceedings,   which   proceedings   shall  be  prosecuted   diligently  by  the
Indemnifying  Party to a final  conclusion  or settled at the  discretion of the
Indemnifying  Party in accordance with this Section 14.3. The Indemnifying Party
shall  have  full  control  of  such  defense  and  proceedings,  including  any
compromise or settlement thereof. The Indemnified Party is hereby authorized, at
the sole cost and expense of the Indemnifying Party (but only if the Indemnified
Party is entitled to  indemnification  hereunder),  to file, during the Election
Period,  any motion,  answer or other pleadings that the Indemnified Party shall
deem  necessary  or  appropriate  to  protect  its  interests  or  those  of the
Indemnifying  Party  and not  prejudicial  to the  Indemnifying  Party (it being
understood and agreed that if an Indemnified Party takes any such action that is
prejudicial and causes a final  adjudication that is adverse to the Indemnifying
Party,  the  Indemnifying  Party shall be relieved of its obligations  hereunder
with respect to such Third Party Claim). If requested by the Indemnifying Party,
the Indemnified  Party agrees,  at the sole cost and expense of the Indemnifying
Party,  to cooperate with the  Indemnifying  Party and its counsel in contesting
any Third Party Claim that the Indemnifying Party elects to contest,  including,
without limitation,  the making of any related  counterclaim  against the person
asserting the Third Party Claim or any  cross-complaint  against any person. The
Indemnified Party may participate in, but not control, any defense or settlement
of any Third  Party  Claim  controlled  by the  Indemnifying  Party  pursuant to
Section  14.3(b) and shall bear its own costs and expenses  with respect to such
participation;  provided,  however, that if the named parties to any such action
(including any impleaded  parties) include both the  Indemnifying  Party and the
Indemnified  Party,  and the Indemnified  Party has been advised by counsel that
there may be one or more legal defenses  available to it that are different from
or additional to those available to the Indemnifying Party, then the Indemnified
Party may employ separate counsel at the expense of the Indemnifying  Party, and
upon written  notification  thereof,  the Indemnifying  Party shall not have the
right to assume the defense of such action on behalf of the  Indemnified  Party;
provided further that the  Indemnifying  Party shall not, in connection with any
one such action or separate but substantially  similar or related actions in the
same jurisdiction  arising out of the same general allegations or circumstances,
be liable for the reasonable fees and expenses of more than one separate firm of

<PAGE>

attorneys at any time for the Indemnified  Party, which firm shall be designated
in writing by the Indemnified Party.

              B. If the Indemnifying Party fails to notify the Indemnified Party
within the  Election  Period that the  Indemnifying  Party  elects to defend the
Indemnified  Party pursuant to Section  14.3(b),  or if the  Indemnifying  Party
elects to defend the  Indemnified  Party  pursuant to Section  14.3(b) but fails
diligently  and promptly to prosecute or settle the Third Party Claim,  then the
Indemnified  Party shall have the right to defend,  at the sole cost and expense
of  the   Indemnifying   Party  (if  the   Indemnified   Party  is  entitled  to
indemnification   hereunder),   the  Third  Party   Claim  by  all   appropriate
proceedings,  which proceedings  shall be promptly and vigorously  prosecuted by
the Indemnified  Party to a final conclusion or settled.  The Indemnified  Party
shall have full control of such defense and proceedings, provided, however, that
the  Indemnified  Party may not enter  into,  without the  Indemnifying  Party's
consent,  which shall not be unreasonably withheld, any compromise or settlement
of such Third Party Claim.  Notwithstanding  the foregoing,  if the Indemnifying
Party has delivered a written notice to the Indemnified Party to the effect that
the Indemnifying Party disputes its potential liability to the Indemnified Party
under  this  Article  14 and  if  such  dispute  is  resolved  in  favor  of the
Indemnifying  Party,  the  Indemnifying  Party shall not be required to bear the
costs and expenses of the Indemnifying  Party's defense pursuant to this Section
or of the Indemnifying Party's  participation therein at the Indemnified Party's
request,  and the Indemnified  Party shall reimburse the  Indemnifying  Party in
full for all costs and expenses of such litigation.  The Indemnifying  Party may
participate  in, but not  control any defense or  settlement  controlled  by the
Indemnified Party pursuant to this Section 14.3(b),  and the Indemnifying  Party
shall  bear its own costs  and  expenses  with  respect  to such  participation;
provided,  however,  that if the named parties to any such action (including any
impleaded  parties)  include  both the  Indemnifying  Party and the  Indemnified
Party, and the Indemnifying  Party has been advised by counsel that there may be
one or  more  legal  defenses  available  to the  Indemnified  Party,  then  the
Indemnifying  Party may employ  separate  counsel and upon written  notification
thereof, the Indemnified Party shall not have the right to assume the defense of
such action on behalf of the Indemnifying Party.

              C. In the event any Indemnified  Party should have a claim against
any Indemnifying  Party hereunder that does not involve a Third Party Claim, the
Indemnified Party shall transmit to the Indemnifying Party a written notice (the
"Indemnity  Notice") describing in reasonable detail the nature of the claim, an
estimate  of the amount of damages  attributable  to such claim and the basis of
the Indemnified Party's request for indemnification under this Agreement. If the
Indemnifying  Party does not notify the Indemnified Party within sixty (60) days
from its receipt of the Indemnity  Notice that the  Indemnifying  Party disputes
such claim, the claim specified by the Indemnified Party in the Indemnity Notice
shall  be  deemed  a  liability  of the  Indemnifying  Party  hereunder.  If the
Indemnifying  Party has timely  disputed  such claim,  as provided  above,  such

<PAGE>

dispute  shall be resolved by  mediation or  arbitration  as provided in Section
18.1 if the parties do not reach a settlement of such dispute within thirty (30)
days after notice of a dispute is given.

              D. Payments of all amounts owing by an Indemnifying Party pursuant
to this  Article 14 relating to a Third Party Claim shall be made within  thirty
(30) days after the latest of (i) the settlement of such Third Party Claim, (ii)
the  expiration of the period for appeal of a final  adjudication  of such Third
Party  Claim or  (iii)  the  expiration  of the  period  for  appeal  of a final
adjudication of the  Indemnifying  Party's  liability to the  Indemnified  Party
under this  Agreement.  Payments of all amounts owing by an  Indemnifying  Party
pursuant  to Section  14.3(d)  shall be made  within  thirty (30) days after the
later of (i) the  expiration  of the sixty (60) day  Indemnity  Notice period or
(ii) the expiration of the period for appeal, if any, of a final adjudication or
arbitration of the Indemnifying Party's liability to the Indemnified Party under
this Agreement.

         14.4.  Exclusivity of Remedies. The remedies provided in this Agreement
shall be  exclusive  of any other  rights  or  remedies  available  to one party
against the other,  either at law or in equity;  provided  however such remedies
shall not be exclusive as to any claim based on fraud or any claim under Section
16 of this Agreement.  This Article 14 regarding  indemnification  shall survive
Closing.

         14.5.  Costs,  Expenses and Legal Fees. Each party hereto agrees to pay
the costs and expenses (including  attorneys' fees and expenses) incurred by the
other parties in successfully  (a) enforcing any of the terms of this Agreement,
or (b) proving that another party breached any of the terms of this Agreement.

         14.6.  Indemnification  Limitations.  Notwithstanding the provisions of
Sections 14.1 and 14.2, no party shall be required to indemnify  another  notice
of party with  respect to a breach of a  representation,  warranty  or  covenant
unless the notice of claim for indemnification is delivered within eighteen (18)
months after the Closing  Date,  except that a claim for  indemnification  for a
breach of the representations and warranties  contained in Sections 3.3 and 4.1,
may be made at any  time,  and a claim for  indemnification  for a breach of the
representations and warranties contained in Section 3.19 may be made at any time
within the applicable statute of limitations.

         14.7.  Tax  Benefits;  Insurance  Proceeds.  The  total  amount  of any
indemnity payments owed by one party to another party to this Agreement shall be
reduced by any correlative  tax benefit  received by the party to be indemnified
or the net  proceeds  received by the party to be  indemnified  with  respect to
recovery from third parties or insurance proceeds and such correlative insurance
benefit  shall be net of the  insurance  premium,  if any, that becomes due as a
result of such claim.

         14.8.  Indemnification  Basket. No duty of indemnification  shall arise
under Section 14 of this Agreement unless and until the amount of Damages of the
Indemnified  Party  exceeds one percent  (1%) of the  aggregate  Stock  Purchase

<PAGE>

Consideration  and then such liability  shall be limited to Damages in aggregate
in excess of one percent (1%) of the aggregate Stock Purchase Consideration.

     15. TERMINATION.

         15.1. Termination. This Agreement may be terminated:

              A.  at any  time  prior  to the  Closing  Date by  mutual  written
agreement of all parties;

              B. at any time prior to the Closing Date by Purchaser,  by written
notice to the  Stockholder,  if any  representation  or warranty of the Acquired
Companies or the  Stockholder  contained in this Agreement or in any certificate
or other  document  executed  and  delivered  by the  Acquired  Companies or the
Stockholder  pursuant to this  Agreement is or becomes untrue or breached in any
material respect or if the Acquired  Companies or the Stockholder fail to comply
in any material respect with any covenant or agreement contained herein, and any
such  misrepresentation,  noncompliance  or  breach  is  not  cured,  waived  or
eliminated within twenty (20) days after receipt of written notice thereof;

              C. at any time prior to the Closing  Date by the  Stockholder,  by
written  notice to  Purchaser,  if any  representation  or warranty of Purchaser
contained in this Agreement is or becomes  untrue in any material  respect or if
Purchaser fails to comply in any material respect with any covenant or agreement
contained herein, and any such misrepresentation, noncompliance or breach is not
cured,  waived or  eliminated  within  twenty (20) days after receipt or written
notice thereof;

              D. by  Purchaser,  by written  notice to the  Stockholder,  in the
event the  conditions  precedent set forth in Article 11 of this  Agreement have
not been satisfied or waived by December 31, 1997;

              E. by the Stockholder,  by written notice to the Purchaser, in the
event the  conditions  precedent set forth in Article 10 of this  Agreement have
not been satisfied or waived by December 31, 1997; or

              F. by either party, by written notice to the other, if the Closing
shall  not  have  occurred  on or  prior  to ten  business  days  following  the
satisfaction or waiver of all conditions precedent to Closing.
<PAGE>

         15.2. Effect of Termination.  In the event this Agreement is terminated
pursuant  to  Section  15.1,  this  Agreement  shall  be null and void and of no
further force and effect except that Purchaser,  the Acquired  Companies and the
Stockholder  shall each be entitled to pursue,  exercise and enforce any and all
remedies,  rights, powers and privileges available at law or in equity,  subject
to the limitations set forth in Section 14.1.

     16. NON-COMPETITION AND CONFIDENTIALITY COVENANTS.

         16.1. The Stockholder's Non-Competition Covenant.

              A. The Stockholder  recognizes  that their covenants  contained in
this Section 16.1 are an essential  part of this Agreement and that, but for the
agreement of the Stockholder to comply with such covenants,  Purchaser would not
have entered into this Agreement.  The Stockholder  acknowledges and agrees that
their  covenant not to compete is necessary  to ensure the  continuation  of the
Business  (as  defined  below) and is  necessary  to protect the  reputation  of
Purchaser,  and that irreparable and irrevocable harm and damage will be done to
Purchaser  if  the  Stockholder   competes  with   Purchaser.   The  Stockholder
accordingly agrees that for a period of five (5) years from the Closing Date, it
shall not:

                   I)  directly  or  indirectly,  either  as  principal,  agent,
independent  contractor,  consultant,  director,  officer,  employee,  employer,
advisor,  stockholder,  partner  or in any other  individual  or  representative
capacity  whatsoever,  either for their own  benefit  or for the  benefit of any
other person or entity knowingly (A) hire,  attempt to hire,  contact or solicit
with  respect to hiring any  employee of  Purchaser  (or of any of its direct or
indirect  subsidiaries) or (B) induce or otherwise counsel,  advise or encourage
any employee of Purchaser (or of any of its direct or indirect  subsidiaries) to
leave the employment of Purchaser;

                   II) act or serve,  directly or  indirectly,  as a  principal,
agent, independent contractor, consultant, director, officer, employee, employer
or advisor or in any other position or capacity with or for, or acquire a direct
or indirect  ownership interest in or otherwise conduct (whether as stockholder,
partner,  investor,  joint venturer, or as owner of any other type of interest),
any Competing Business as such term is defined herein;  provided,  however, that
this clause (ii) shall not prohibit Stockholder from being the owner of up to 1%
of any class of outstanding securities of any company or entity if such class of
securities is publicly traded; or

                   III)  directly or  indirectly,  either as  principal,  agent,
independent,  contractor,  consultant,  director,  officer, employee,  employer,
advisor,  stockholder,  partner  or in any other  individual  or  representative
capacity  whatsoever,  either for their own  benefit  or for the  benefit of any

<PAGE>

other  person or entity,  call upon or solicit any  customers  or clients of the
Business  for  the  purpose  of  providing   management  services  to  eye  care
professionals  or providing  managed care  services to third party payors or eye
care professionals.

              B. For the  purposes of this Section  16.1,  the  following  terms
shall have the meanings set forth below:

                   I) "Business" shall mean providing management services to eye
care  professionals and providing managed care services to third party payors or
eye care professionals.

                   II) "Competing Business" shall mean an individual,  business,
corporation,   association,  firm,  undertaking,   company,  partnership,  joint
venture,  organization  or other  entity  that  either  (A)  conducts a business
substantially  similar  to the  Business  within  any State  where the  Acquired
Companies or the  Subsidiaries  engage in  business,  or (B) provides or sells a
service which is the same or substantially  similar to, or otherwise competitive
with the services  provided by the Business  within any State where the Acquired
Companies or the Subsidiaries engage in business.

              C. Should any portion of this Section 16.1 be deemed unenforceable
because of the scope,  duration or territory  encompassed by the undertakings of
the  Stockholder  hereunder,  and only in such event,  then the  Stockholder and
Purchaser  consent and agree to such limitation on scope,  duration or territory
as  may  be  finally   adjudicated  as  enforceable  by  a  court  of  competent
jurisdiction after the exhaustion of all appeals.

              D. This covenant  shall be construed as an agreement  ancillary to
the other provisions of this Agreement,  and the existence of any claim or cause
of  action  of a  Stockholder  against  Purchaser,  whether  predicated  on this
Agreement or otherwise,  shall not  constitute a defense to the  enforcement  by
Purchaser  of  this  covenant.  Without  limiting  other  possible  remedies  to
Purchaser for breach of this covenant, the Stockholder agrees that injunctive or
other  equitable  relief  will be  available  to enforce the  covenants  of this
provision,  such relief to be without the  necessity of posting a bond,  cash or
otherwise.  The Stockholder and Purchaser further expressly acknowledge that the
damages  that would  result from a violation  of this  non-competition  covenant
would be  impossible  to predict  with any degree of  certainty,  and agree that
liquidated  damages in the amount of Stock Purchase  Consideration is reasonable
in light of the severe harm to the Business and Purchaser  which would result in
the event that a violation of this non-competition covenant were to occur.

         16.2. The Stockholder's Confidentiality Covenant. From the date hereof,
the  Stockholder  shall not,  directly or  indirectly,  use for any purpose,  or
disclose to any third  party,  any  information  of  Purchaser  or the  Acquired
Companies,  as  appropriate  (whether  written or oral),  including any business

<PAGE>

management or economic studies,  customer lists,  proprietary forms, proprietary
business or management methods,  marketing data, fee schedules, or trade secrets
of Purchaser or of the Acquired  Companies,  as  applicable,  and  including the
terms and provisions of this Agreement and any transaction or document  executed
by the parties pursuant to this Agreement.  Notwithstanding  the foregoing,  the
Stockholder may disclose  information  that they can establish (a) is or becomes
generally  available to and known by the public or optometric  community  (other
than as a result of an  unpermitted  disclosure  directly or  indirectly  by the
Stockholder or its Affiliates,  advisors or representatives);  (b) is or becomes
available to such  Stockholder  on a  nonconfidential  basis from a source other
than Purchaser, the Acquired Companies or their respective Affiliates,  advisors
or  representatives,  provided  that  such  source is not and was not bound by a
confidentiality  agreement with or other obligation of secrecy to Purchaser, the
Acquired Companies or their respective  Affiliates,  advisors or representatives
of which such Stockholder has knowledge; or (c) has already been or is hereafter
independently  acquired or developed by such Stockholder  without  violating any
confidentiality  agreement with or other obligation of secrecy to Purchaser, the
Acquired Companies or their respective Affiliates,  advisors or representatives.
Without limiting the other possible remedies to Purchaser for the breach of this
covenant, the Stockholder agrees that injunctive or other equitable relief shall
be available to enforce this  covenant,  such relief to be without the necessity
of posting a bond, cash or otherwise. The Stockholder further agrees that if any
restriction  contained  in  this  Section  16.2  is  held  by  any  court  to be
unenforceable or  unreasonable,  a lesser  restriction  shall be enforced in its
place  and  the  remaining  restrictions  contained  herein  shall  be  enforced
independently of each other.

         16.3. Survival.  The parties acknowledge and agree that this Article 16
shall survive the Closing of the transactions contemplated herein.

     17. DISPUTES.

         17.1.  Mediation and  Arbitration.  Any dispute,  controversy  or claim
(excluding  claims  arising  out of an  alleged  breach  of  Article  16 of this
Agreement) arising out of this Agreement,  or the breach thereof, that cannot be
settled through negotiation shall be settled (a) first, by the parties trying in
good faith to settle the dispute by  mediation  under the  Commercial  Mediation
Rules of the AAA (such mediation  session to be held in Tampa,  Florida,  and to
commence  within  15  days  of the  appointment  of the  mediator  by the  AAA),
administered by the AAA under its Commercial Arbitration Rules (such arbitration
to be held in Tampa, Florida,  before a single arbitrator and to commence within
15 days of the  appointment  of the  arbitrator by the AAA), and judgment on the
award rendered by the arbitrator may be entered in any court having jurisdiction
thereof.
<PAGE>

     18. MISCELLANEOUS.

         18.1.  Taxes. The Stockholder  shall pay all transfer taxes,  sales and
other taxes and charges, if any, which may become payable in connection with the
transactions  and  documents   contemplated   hereunder.   Notwithstanding   the
foregoing,  Purchaser  shall pay all transfer  taxes,  sales and other taxes and
charges  imposed by the State of Florida,  if any,  which may become  payable in
connection with the transactions and documents contemplated hereunder.

         18.2.  Remedies  Not  Exclusive.  No  remedy  conferred  by  any of the
specific  provisions  of this  Agreement  or any document  contemplated  by this
Agreement is intended to be exclusive  of any other  remedy,  and each and every
remedy shall be cumulative  and shall be in addition to every other remedy given
hereunder  or now or  hereafter  existing  at law or in equity or by  statute or
otherwise.  The  election of any one or more  remedies by any party hereto shall
not constitute a waiver of the right to pursue other available remedies.

         18.3. Parties Bound.  Except to the extent otherwise expressly provided
herein,  this  Agreement  shall be binding  upon and inure to the benefit of the
parties  hereto and their  respective  heirs,  representatives,  administrators,
guardians,  successors  and  assigns;  and no other person shall have any right,
benefit or obligation hereunder.

         18.4. Notices.  All notices,  reports,  records or other communications
that are required or permitted to be given to the parties  under this  Agreement
shall be sufficient in all respects if given in writing and delivered in person,
by telecopy,  by overnight  courier or by registered or certified mail,  postage
prepaid,  return  receipt  requested,  to the  receiving  party at the following
address:

                  If to Purchaser addressed to:

                           Vision Twenty-0ne, Inc.
                           7209 Bryan Dairy Road
                           Largo, Florida  33777
                           Facsimile No.: (813) 545-4419
                           Attn:  Richard T. Welch
<PAGE>

                  With copies to:

                           Shumaker, Loop & Kendrick
                           Post Office Box 172609
                           101 E. Kennedy Boulevard, Suite 2800
                           Tampa, Florida  33672-0609
                           Facsimile No. (813) 229-1660
                           Attn:  Darrell C. Smith, Esquire

                  If to the Acquired Companies or the Stockholder addressed to:

                           LaserSight Incorporated
                           12161 Lackland Road
                           St. Louis, MO  63146
                           Attn:  Michael R. Farris, Chief Executive Officer

                  With copies to:

                           Sonnenschein Nath & Rosenthal
                           One Metropolitan Square
                           Suite 3000
                           St. Louis, Missouri 63102
                           Facsimile No. (314) 259-5959
                           Attn:  Alan Bornstein, Esquire

or to such other  address  as such party may have given to the other  parties by
notice  pursuant to this Section 18.4.  Notice shall be deemed given on the date
of delivery, in the case of personal delivery or telecopy, or on the delivery or
refusal  date,  as  specified  on the return  receipt,  in the case of overnight
courier or registered or certified mail.

         18.5.  Choice of Law. This Agreement  shall be construed,  interpreted,
and the rights of the parties  determined  in accordance  with,  the laws of the
State of Florida  except with respect to matters of law  concerning the internal
affairs  of any  corporate  or  partnership  entity  which  is a party to or the
subject  of this  Agreement,  and as to those  matters  the law of the  state of
incorporation or organization of the respective entity shall govern.

         18.6.  Entire  Agreement;   Amendments  and  Waivers.  This  Agreement,
together with the documents  contemplated by this Agreement and all Exhibits and
Schedules  hereto and  thereto,  constitutes  the entire  agreement  between the
parties  pertaining to the subject  matter hereof and  supersedes  all prior and
contemporaneous  agreements,   understandings,   negotiations  and  discussions,
whether  oral  or  written,  of  the  parties,  and  there  are  no  warranties,
representations  or other agreements  between the parties in connection with the
subject  matter  hereof.  No  supplement,  modification  or waiver of any of the

<PAGE>

provisions of this Agreement  shall be binding  unless it shall be  specifically
designated  to be a  supplement,  modification  or waiver of this  Agreement and
shall be executed in writing by the party to be bound thereby.  No waiver of any
of the provisions of this Agreement shall be deemed or shall constitute a waiver
of any other provision  hereof  (whether or not similar),  nor shall such waiver
constitute a continuing waiver unless otherwise expressly provided.

         18.7.   Confidentiality   Agreements.   The  provisions  of  any  prior
confidentiality agreements and letters of intent between or among Purchaser, the
Acquired Companies and the Stockholder, as amended, shall terminate and cease to
be of any force or effect at and upon the Closing.

         18.8.  Assignment.  This  Agreement may not be assigned by operation of
law or  otherwise  except  that  Purchaser  shall have the right to assign  this
Agreement,  at any time,  to any  Affiliate  or direct or indirect  wholly-owned
subsidiary.

         18.9.  Attorneys'  Fees.  Except  as  otherwise  specifically  provided
herein, if any action or proceeding is brought by any party with respect to this
Agreement   or  the  other   documents   contemplated   with   respect   to  the
interpretation,  enforcement  or breach  hereof,  the  prevailing  party in such
action shall be entitled to an award of all  reasonable  costs of  litigation or
arbitration,  including, without limitation,  attorneys' fees, to be paid by the
losing  party,  in  such  amounts  as may be  determined  by  the  court  having
jurisdiction  of such action or proceeding or by the  arbitrators  deciding such
action or proceeding.

         18.10.  Further  Assurances.  From time to time  hereafter  and without
further consideration, each of the parties hereto shall execute and deliver such
additional or further  instruments  of  conveyance,  assignment and transfer and
take such  other  actions  as any of the other  parties  hereto  may  reasonably
request in order to more effectively  consummate the  transactions  contemplated
hereunder or as shall be reasonably  necessary or appropriate in connection with
the  carrying  out of the  parties'  respective  obligations  hereunder  for the
purposes of this Agreement.

         18.11.  Announcements  and Press  Releases.  Any press  releases or any
other  public  announcements  concerning  this  Agreement  or  the  transactions
contemplated  hereunder  shall be  approved  in  advance  by  Purchaser  and the
Stockholder;  provided,  however,  that such approval shall not be  unreasonably
withheld and if any party reasonably  believes that it has a legal obligation to
make a press release and the consent of the other party cannot be obtained, then
the release may be made without such approval.

         18.12.  No Tax  Representations.  Each  party  acknowledges  that it is
relying  solely  on its  advisors  to  determine  the  tax  consequences  of the
transactions  contemplated  hereunder and that no representation or warranty has

<PAGE>

been made by any party as to the tax consequences of such transactions except as
otherwise specifically set forth in this Agreement.

         18.13. No Rights as Stockholder.  The Stockholder  shall have no rights
as a  stockholder  with respect to any shares of Common Stock until the issuance
of a stock certificate  evidencing such shares.  Except as otherwise provided in
the Agreement,  no adjustment  shall be made for dividends or  distributions  or
other  rights  for  which  the  record  date is  prior to such  date  any  stock
certificate is issued.

         18.14. Multiple Counterparts.  This Agreement may be executed in one or
more counterparts,  each of which shall be deemed an original,  but all of which
together shall constitute one and the same instrument.

         18.15.  Headings.  The  headings of the several  articles  and sections
herein are inserted for convenience of reference only and are not intended to be
part of or to affect the meaning or interpretation of this Agreement.

         18.16.  Severability.  Each  article,  section and  subsection  of this
Agreement constitutes a separate and distinct undertaking, covenant or provision
of this  Agreement.  If any such  provision  shall  finally be  determined to be
unlawful, such provision shall be deemed severed from this Agreement,  but every
other provision of this Agreement shall remain in full force and effect.


<PAGE>


         IN  WITNESS  WHEREOF,  the  parties  hereto  have  duly  executed  this
Agreement as of the date first written above.

                                            MEC HEALTH CARE, INC.


                                            By: /s/ Gregory L. Wilson
                                               -------------------------
                                                  (Name)

                                                 Vice President
                                               -------------------------
                                                  (Title)


                                            LSI ACQUISITION, INC.


                                            By: /s/ Michael R. Farris     
                                               ------------------------- 
                                                  (Name)
     
                                                 President and CEO
                                               -------------------------
                                                  (Title)



                                            LASERSIGHT INCORPORATED

                                            By: /s/ Michael R. Farris
                                               -------------------------
                                                  (Name)
                                                  
                                                President and CEO
                                               -------------------------
                                                  (Title)


                                            VISION TWENTY-ONE, INC.

                                            By: /s/ Richard T. Welch
                                               -------------------------
                                                  (Name)

                                                Chief Financial Officer
                                               -------------------------
                                                  (Title)




                          STOCK DISTRIBUTION AGREEMENT
                          ----------------------------

     This Stock Distribution Agreement  ("Agreement"),  dated as of December 30,
1997,  is by and  between  Vision  Twenty-One,  Inc.  ("Vision  21"),  a Florida
corporation and any successor,  and LaserSight Incorporated (the "Stockholder"),
a Delaware corporation.

                                 R E C I T A L S
                                 ---------------

     A. The  Stockholder and Vision 21 have executed that certain Stock Purchase
Agreement  effective  as of December 1, 1997 (the "Stock  Purchase  Agreement"),
pursuant  to which  Vision  21 has  agreed  to  acquire  all of the  issued  and
outstanding  stock of MEC  Health  Care,  Inc.  and LSI  Acquisition,  Inc.,  in
exchange for delivery to the  Stockholder  of 812,500 shares of Vision 21 common
stock and the  Additional  Shares (as defined in the Stock  Purchase  Agreement,
collectively, the "Restricted Shares") and $6,500,000 in cash, as more fully set
forth in the Stock Purchase Agreement.

     B.  The  Stockholder  and  Vision  21  desire  to  enter  into  the plan of
distribution  (the "Plan of  Distribution")  described herein for liquidation of
the  Restricted   Shares  through,   at  Vision  21's  sole  option,  a  "shelf"
registration  statement,  private  placement,  redemption  by Vision 21 or other
method acceptable to Vision 21 and the Stockholder.

     NOW THEREFORE,  for and in consideration of the mutual  agreements,  terms,
covenants and conditions  herein and for other good and valuable  consideration,
the receipt and adequacy of which are hereby acknowledged,  the parties agree as
follows:

     1.  Plan of Distribution of Restricted  Shares.  

         (a)  Stockholder  agrees that on each date  specified  in Section  1(b)
below that number of the Restricted  Shares so indicated in connection with such
date shall,  at Vision  21's sole  option,  either (i) be sold  through a market
maker  designated  by Vision 21 through a "shelf"  registration  statement  (the
"Registration  Statement")  pursuant to Sections 2, 3 and 4 hereof, (ii) be sold
through a market  maker  designated  by Vision  21  through a private  placement
pursuant  to  Sections  5, 6 and 7 hereof  or other  method  of sale  reasonably
acceptable to Vision 21 and the Stockholder,  or (iii) be purchased by Vision 21
pursuant to Section 8 hereof.

         (b) The  Restricted  Shares shall be liquidated  on, or, at Vision 21's
option,  before  the  following  specified  dates  in  the  following  specified
increments in accordance with the terms of this Agreement:

                     RESTRICTED SHARES DISTRIBUTION SCHEDULE
                     ---------------------------------------


                                                     Number of Shares
                 Date                                to be Liquidated
 -------------------------------------------------------------------------------

    February 2 through                  166,666 and 25% of the Additional Shares
    February 27, 1998

    March 2 through March 31, 1998      166,667 and 25% of the Additional Shares


<PAGE>

    April 1 through April 30,           229,167 and 25% of the Additional Shares
    1998

    May 1 through May 29,               250,000 and 25% of the Additional Shares
    1998


         (c)  Vision 21 agrees  that no matter  how the  Restricted  Shares  are
liquidated  pursuant to this Agreement on each of the dates set forth in Section
1(b)  hereof  the  Stockholder  shall  receive  from  Vision 21 and/or the party
purchasing  Restricted  Shares a sum equal to the number of Restricted Shares to
be sold on such date times the closing price of Vision 21 common stock as quoted
by the NASDAQ  National  Market  System on such date.  Vision 21 also agrees the
Stockholder  shall receive a minimum of an aggregate of Six Million Five Hundred
Thousand  Dollars  ($6,500,000)  and a maximum of an aggregate of Seven  Million
Four Hundred  Seventy-Five  Thousand Dollars ($7,475,000) in connection with the
liquidation  of the Restricted  Shares.  In the event the  Stockholder  realizes
aggregate  gross proceeds from the sale of the Restricted  Shares equal to Seven
Million Four Hundred  Seventy-Five  Thousand Dollars  ($7,475,000)  prior to all
Restricted  Shares being liquidated  pursuant to the Plan of  Distribution,  the
Restricted Shares not yet liquidated, if any, shall be returned to Vision 21. If
by 4:00 p.m., New York time, on May 29, 1998, the  Stockholder  has not realized
the sum of at least Six Million Five Hundred Thousand Dollars  ($6,500,000) from
the sale of the Restricted  Shares,  Vision 21 shall pay the Stockholder by wire
transfer of  immediately  available  funds on May 29, 1998 the cash sum which is
equal  to Six  Million  Five  Hundred  Thousand  Dollars  ($6,500,000)  less the
proceeds  received  through  such  date  by the  Stockholder  from  the  sale of
Restricted Shares.  However, if on such date not all Restricted Shares have been
liquidated  and Vision 21 exercises its right under Section 8 of this  Agreement
to redeem such Restricted Shares, then, such Restricted Shares shall be returned
to Vision 21 in connection with the purchase thereof.

         (d) Stockholder agrees not to sell, pledge,  transfer or dispose of the
Restricted  Shares except in accordance with the terms of this Agreement and the
terms of that  certain  Stock  Pledge  Agreement  between  the  Stockholder  and
Foothill Capital Corporation dated as of December 30, 1997.

         (e) The  parties  acknowledge  and agree that the number of  Restricted
Shares (and therefore the Six Million Five Hundred Thousand Dollar  ($6,500,000)
minimum payment  contemplated by Section 1(c) and the Seven Million Four Hundred
Seventy-Five  Thousand  Dollar  ($7,475,000)  maximum  payment  contemplated  by
Section 1(c)) shall be subject to the adjustments contemplated by Section 2.5 of
the Stock Purchase Agreement.

     2.  Shelf Registration.

         (a)  Vision  21 may,  in its  sole  discretion,  file  and  cause to be
declared  effective as soon as practicable a Registration  Statement pursuant to
the  Securities  Act of 1933, as amended (the  "Securities  Act") for all of the
Restricted   Shares  not  yet   liquidated  in  accordance   with  the  Plan  of
Distribution,  which form will then be available for the sale of the  Restricted
Shares in accordance with the Plan of Distribution.  The Registration  Statement
shall be kept  effective  until such time as all of the  Restricted  Shares have
been liquidated, provided that Vision 21 may terminate an effective Registration
Statement prior to all of the Restricted  Shares being liquidated if on the date
of such termination Vision 21 is in compliance with the terms of this Agreement.
<PAGE>

         (b) Vision 21 shall have the right to  extend,  temporarily  suspend or
delay the  effectiveness  of any  Registration  Statement  for a period of up to
thirty (30) days if, upon the advice of counsel,  such extension,  suspension or
delay is  advisable  and in the best  interests  of  Vision  21  because  of the
existence of non-public material information,  or to allow Vision 21 to complete
any pending audit of its financial  statements,  any material  public  financing
plan,  any  pending  material  acquisition,  or  to  release  audited  financial
statements  for any pending  material  acquisition as required by the Securities
and Exchange Commission (the  "Commission"),  provided that Vision 21 shall only
be entitled to one such suspension during the Plan of Distribution.

         (c)  The  Stockholder  agrees  to  cooperate  with  Vision  21  in  all
reasonable  respects in connection with  registration of the Restricted  Shares,
including  timely  supplying  all  information  and  executing and returning all
documents requested by Vision 21 which are reasonable and customary.

         (d)  Vision  21  shall  be  entitled  to  include  in the  Registration
Statement any other  securities of Vision 21 (whether to be offered by Vision 21
or other Vision 21 security  holders and regardless of the proposed terms of the
transfer or sale of such other securities).

     3.  Registration  Covenants  of Vision 21. In the event Vision 21 elects to
file a  Registration  Statement to liquidate the  Restricted  Shares,  Vision 21
hereby covenants and agrees to:
                 
         (a) Take such  steps as may be  necessary  to comply  with the Blue Sky
laws of such states as may be required by law;  provided  that in no event shall
Vision 21 be obligated to qualify to do business in any state where it is not so
qualified or to take any action which would  subject it to unlimited  service of
process in any state where it is not at such time so subject;

         (b) Pay all fees and expenses of Vision 21's  counsel,  all  accounting
costs  (including  costs  associated  with the  preparation  of  interim  period
financial  statements),  registration  and  Blue Sky  filing  fees,  NASD  fees,
printing costs, experts' fees and expenses, costs of post-effective  amendments,
Eligible  Broker's Fees (as defined  herein),  and all other usual and customary
expenses in connection with the Registration Statement;

         (c) Notify  the  Stockholder  promptly  after it shall  receive  notice
thereof,  of the  date  and  time  when  such  Registration  Statement  and each
post-effective  amendment  thereto has become  effective or a supplement  to any
prospectus  forming a part of such  Registration  Statement  has been  filed and
provide the  Stockholder  with such number of  prospectuses,  and any amendments
thereof or supplements thereto, the Stockholder may reasonably request;

         (d) Promptly  notify the  Stockholder  of any request by the Commission
for the amending or supplementing of such  registration  statement or prospectus
or for additional  information and provide the  Stockholder  with copies of such
requests;
<PAGE>

         (e) Prepare and promptly file with the Commission  and promptly  notify
Stockholder of the filing of such amendments or supplements to such Registration
Statement  or  prospectus  as may be  necessary  to correct  any  statements  or
omissions if, at the time when a prospectus relating to the Restricted Shares is
required to be delivered under the Securities Act, any event has occurred as the
result of which any such  prospectus  or any other  prospectus as then in effect
may include an untrue statement of a material fact or omit to state any material
fact required to be stated therein or necessary to make the  statements  therein
not misleading;

         (f) Advise the  Stockholder  promptly  after it shall receive notice or
obtain  knowledge  thereof,  of the issuance of any stop order by the Commission
suspending the effectiveness of such Registration Statement or the initiation or
threatening of any proceeding for that purpose and promptly use its best efforts
to prevent the  issuance of any stop order or to obtain its  withdrawal  if such
stop order should be issued; and

         (g) Once the Registration Statement is effective Vision 21 shall, on or
before the relevant date set forth in Section 1(b) hereof, instruct its transfer
agent to immediately  remove any restrictive  legend from that number Restricted
Shares  then  eligible  to be sold  pursuant  to the Plan of  Distribution.  For
purposes of Sections 3(b) and 6(b) "Eligible Broker's Fees" shall mean brokers',
underwriters' and placement  agents' fees,  commissions and discounts related to
the liquidation of Restricted  Shares pursuant to a Registration  Statement or a
private  placement,  provided that if the Stockholder  receives in excess of Six
Million Five Hundred  Thousand  Dollars  ($6,500,000)  from the  liquidation  of
Restricted  Shares then the amount so received by the  Stockholder  in excess of
Six Million Five Hundred Thousand Dollars ($6,500,000), shall be utilized to pay
all customary  brokers',  underwriters' and placement agents' fees,  commissions
and discounts related to the liquidation of Restricted  Shares,  until such fees
are paid in full and thereafter such excess shall be retained by the Stockholder
subject to the limitations of Section 1(c).

     4.  Registration Covenants of Stockholder. In the event Vision 21 elects to
file a Registration  Statement to liquidate the Restricted  Shares,  Stockholder
hereby covenants and agrees:
                 
         (a) To cooperate with Vision 21 in its compliance  with all federal and
state securities laws,  including without limitation  providing such information
and signing such documents as are necessary to effect  registration  pursuant to
this Agreement; and

         (b) To the  entry  of  stop  transfer  instructions  with  Vision  21's
transfer  agent  against  the  transfer  of  any  Restricted  Shares  except  in
compliance with all applicable securities laws.

     5.  Private Placement.

         (a)  Vision 21 may,  in its sole  discretion,  sell  Restricted  Shares
pursuant to a private placement through a market maker designated by Vision 21.
<PAGE>

         (b)  The  Stockholder  agrees  to  cooperate  with  Vision  21  in  all
reasonable  respects in connection with the private  placement of the Restricted
Shares,  including  timely supplying all information and executing and returning
all documents requested by Vision 21 which are reasonable and customary.

         (c) Vision 21 shall be entitled to include in the private placement any
other  securities  of Vision 21  (whether  to be  offered  by Vision 21 or other
Vision 21 security  holders and regardless of the proposed terms of the transfer
or sale of such other securities).

         (d) In connection with any private  placement of Restricted  Shares the
Stockholder  shall be entitled to receive from Vision 21 and/or the purchaser of
the  Restricted  Shares so sold the closing  price of Vision 21 common  stock as
quoted by the NASDAQ  National Market System on the date of the sale pursuant to
the private placement.

     6. Private Placement  Covenants of Vision 21. In the event Vision 21 elects
to liquidate the Restricted  Shares pursuant to a private  placement,  Vision 21
hereby covenants and agrees to:

         (a) Take such  steps as may be  necessary  to comply  with the Blue Sky
laws of such states as may be required by law;  provided  that in no event shall
Vision 21 be obligated to qualify to do business in any state where it is not so
qualified or to take any action which would  subject it to unlimited  service of
process in any state where it is not at such time so subject; and

         (b) Pay all fees and expenses of Vision 21's  counsel,  all  accounting
costs  (including  costs  associated  with the  preparation  of  interim  period
financial  statements),  registration and Blue Sky filing fees,  printing costs,
experts'  fees and expenses,  Eligible  Brokers'  Fees,  and all other usual and
customary expenses in connection with the private placement.

     7.  Private  Placement  Covenants  of  Stockholder.  In the event Vision 21
elects to  liquidate  the  Restricted  Shares  pursuant to a private  placement,
Stockholder hereby covenants and agrees:

         (a) To cooperate with Vision 21 in its compliance  with all federal and
state securities laws,  including without limitation  providing such information
and signing  such  documents as are  necessary  to effect the private  placement
pursuant to this Agreement; and

         (b) That in no event will the  Stockholder  be eligible to receive more
than the maximum  amount  contemplated  by Section 1(c) from the  liquidation of
Restricted Shares.

     8. Redemption.  Vision 21 shall have the right to redeem all or any part of
the Restricted  Shares at any time by paying the Stockholder a cash sum equal to
the  number  resulting  from  multiplying  the  number of  Restricted  Shares so
redeemed  by the  greater of (i) the  Valuation  Price (as  defined in the Stock
Purchase  Agreement),  and (ii) the closing  price of Vision 21 common  stock as
quoted by the NASDAQ National Market System on the date of such  redemption.  In
no event will the  Stockholder  be  eligible  to receive  more than the  maximum
amount contemplated by Section 1(c) from the liquidation of Restricted Shares.
<PAGE>

     9.  Indemnification of Stockholder.  Whenever  registration with respect to
any shares of Stockholder's  Restricted  Shares is effected under the Securities
Act pursuant  hereto or when  Restricted  Shares are sold  pursuant to a private
placement,  Vision 21 will indemnify and hold harmless the  Stockholder  and its
directors and officers from and against any and all losses, claims, liabilities,
expenses  and  damages  (including  any and all  investigative,  legal and other
expenses  reasonably  incurred  in  connection  with,  and  any  amount  paid in
settlement of, any action,  suit or proceeding or any claim asserted),  to which
they may become subject under the Securities  Act, the Exchange Act of 1934 (the
"Exchange Act") or other federal or state statutory law or regulation, at common
law or  otherwise,  insofar as such  losses,  claims,  liabilities,  expenses or
damages arise out of or are based on any untrue statement or alleged omission to
state in the  Registration  Statement,  private  placement  memorandum  or other
document  filed with the  Commission,  a material  fact required to be stated or
necessary to make the  statements  in such a document not  misleading,  provided
that Vision 21 will not be liable to  Stockholder  to the extent that such loss,
claim, liability,  expense or damage is based on an untrue statement or omission
made in reliance on and in  conformity  with  written  information  furnished to
Vision 21 by  Stockholder  or  through  any  attorney-in-fact  for  Stockholder,
expressly for inclusion in the Registration Statement or any prospectus included
in the Registration Statement or a private placement memorandum.

     10. Indemnification of Vision 21. Whenever registration with respect to any
shares of Stockholder's  Restricted  Shares is effected under the Securities Act
pursuant  hereto  or when  Restricted  Shares  are sold  pursuant  to a  private
placement,  the Stockholder  will indemnify and hold harmless Vision 21 and each
of Vision  21's  directors  and  officers  from and  against any and all losses,
claims, liabilities,  expenses and damages (including any and all investigative,
legal and other expenses  reasonably incurred in connection with, and any amount
paid in settlement of, any addition,  suit or proceeding or any claim asserted),
to which they, or any of them, may become subject under the Securities  Act, the
Exchange Act or other federal or state  statutory law or  regulation,  at common
law or  otherwise,  insofar as such  losses,  claims,  liabilities,  expenses or
damages  arise out of or are based on any untrue  statement  or  alleged  untrue
statement of a material fact required to be stated in the Registration Statement
or private  placement  memorandum  or necessary to make the  statements  in such
documents not misleading; provided that Stockholder will not be liable except to
the extent that such loss, claim, liability, expense or damage arises from or is
based upon an untrue  statement  or  omission  or alleged  untrue  statement  or
omission  made  in  reliance  on  and in  conformity  with  written  information
furnished to Vision 21 by the  Stockholder,  or by the  Stockholder  through any
attorney-in-fact,  expressly for inclusion in the registration  statement or any
prospectus  included  in such  registration  statement  or a  private  placement
memorandum.

     11. Defense of Claim.  Promptly  after receipt by an  indemnified  party of
notice of the commencement of any action, the indemnified party shall notify the
indemnifying party in writing of the commencement  thereof if a claim in respect
thereof is to be made against any indemnifying  party under this Agreement,  but
the  omission of such  notice  shall not  relieve  the  indemnifying  party from
liability  which it may have to the  indemnified  party  under  this  Agreement,
except to the extent that the indemnifying party is actually  prejudiced by such
failure to give notice,  and shall not relieve the  indemnifying  party from any
liability which it may have to any  indemnified  party otherwise than under this
Agreement.  In case any action is brought against the  indemnified  party and it
shall  notify  the  indemnifying   party  of  the  commencement   thereof,   the
indemnifying  party shall be entitled to participate  in, and to the extent that

<PAGE>

it chooses,  to assume the defense thereof with counsel reasonably  satisfactory
to the indemnified  party, and after notice from the  indemnifying  party to the
indemnified party that it so chooses, the indemnifying party shall not be liable
for any legal or other expenses  subsequently  incurred by the indemnified party
in  connection  with  the  defense  thereof;  provided  however  that (i) if the
indemnifying party fails to take reasonable steps necessary to defend diligently
the claim within twenty (20) days after  receiving  notice from the  indemnified
party that the indemnified  party believes the indemnifying  party has failed to
diligently  defend  such  claim,  or  (ii)  if the  indemnified  party  who is a
defendant  in any  action  or  proceeding  which  is also  brought  against  the
indemnifying party reasonably shall have concluded that there are legal defenses
available to the indemnified  party which conflict with the defense  strategy of
the  indemnifying  party,  or  (iii)  if in  the  opinion  of  counsel  for  the
indemnified   party  a  conflict  of  interest  exists  that  requires  separate
representation  of the indemnified  party and the indemnifying  party,  then the
indemnified  party shall have the right to assume or continue its own defense as
set forth above and the indemnifying party shall reimburse the indemnified party
for the  costs of such  defense.  In no event  shall the  indemnifying  party be
reasonable for the fees of more than one firm for all indemnified parties.

     12. Survival of Indemnity. The indemnifications  provided by this Agreement
shall  be  a  continuing  right  to   indemnification   and  shall  survive  the
registration   and  sale  of  any   securities   by  any  person   entitled   to
indemnification hereunder and the expiration or termination of this Agreement.

     13.  Remedies.  If Vision 21 fails to take the actions or make the payments
described  in Sections  1(a) or 1(c) hereof on or before the date which is three
business days after the date  specified in such  Sections  (the "Default  Date")
then the following shall apply:

         (a) Vision 21 shall prepare, and, on or prior to 20 business days after
the Default Date (the "Filing  Date"),  file with the  Commission a registration
statement  on Form S-3 (or, if Form S-3 is not then  available,  on such form of
registration  statement as is then available to effect a registration  of all of
the Restricted Shares) covering the resale of all of the Restricted Shares. Such
registration  statement  (and each  amendment or  supplement  thereto)  shall be
provided  to (and  subject  to the  approval  of  (which  approval  shall not be
unreasonably  withheld or delayed)) the  Stockholder  and their counsel prior to
its  filing or other  submission,  except to the  extent  that a  post-effective
amendment  of  such  registration   statement,  or  supplement  to  the  related
prospectus,  is required by  applicable  securities  law to be filed before such
approval can  reasonably  be obtained,  in which case Vision 21 shall  provide a
copy of such amendment or  supplement,  as applicable,  to the  Stockholder  and
their counsel as soon as  practicable  after such filing.  Vision 21 shall cause
such  registration  statement to become  effective as soon as practicable  after
such filing and keep such  registration  statement  effective at all times until
such  date as is the  earlier  of (i) the  date on which  all of the  Restricted
Shares have been sold, and (ii) the date on which all of the  Restricted  Shares
may be  immediately  sold to the  public  without  registration  conditions,  or
limitations,  whether  pursuant to Rule 144(k) or otherwise  (the  "Registration
Period").

         Vision 21 shall cause such  registration  statement to become effective
as soon as  practicable,  but in no event  later than the  ninetieth  (90th) day
following  the  Default  Date  (the  "Registration   Deadline").   If  (i)  such
registration  statement  covering all of the  Restricted  Shares is not declared

<PAGE>

effective by the  Commission  on or before the  Registration  Deadline,  or (ii)
after such registration statement has been declared effective by the Commission,
sales of all the Restricted  Shares cannot be made pursuant to such registration
statement  (by  reason of a stop  order or Vision  21's  failure  to update  the
registration statement), then Vision 21 will make payments to the Stockholder in
such amounts and at such times as shall be  determined  pursuant to this Section
13(a) as partial relief for the damages to the Stockholder by reason of any such
delay in or  reduction of their  ability to sell the  Restricted  Shares  (which
remedy  shall not be  exclusive  of any other  remedies  available  at law or in
equity).  Vision 21 shall pay to the  Stockholder an amount equal to (i) (A) .01
per  month  (prorated  daily  during  the first 30 days  after the  Registration
Deadline) and .02 per month, prorated daily (thereafter) times (B) the aggregate
value  of the  Restricted  Shares  not yet  liquidated  pursuant  to the Plan of
Distribution  (such value shall be  calculated  utilizing  the closing  price of
Vision 21 common stock as quoted by the NASDAQ  National Market System as of the
date the  Restricted  Stock was issued) times (ii) the sum of: (A) the number of
months (prorated per day for partial months) following the Registration Deadline
but prior to the date such registration  statement is declared  effective by the
Commission  plus (B) the number of months  (prorated per day for partial months)
following  the  Registration  Deadline  but  prior  to  the  termination  of the
Registration  Period  that sales  cannot be made  pursuant  to the  Registration
Statement after the  Registration  Statement has been declared  effective.  Such
amounts  shall be paid in cash within five  business  days after the end of each
period that gives rise to such  obligation,  provided  that,  if any such period
extends  for more  than 30  days,  payments  shall be made for each  such 30 day
period within five business days after the end of such 30 day period.

         (b) The Stockholder  will be free to sell all of the Restricted  Shares
in a private  placement or other  transaction  subject only to  compliance  with
applicable  securities laws,  including,  without limitation,  to persons in the
United  States  whom  the  Stockholder   reasonably  believes  to  be  qualified
institutional  buyers as defined in Rule 144A under the Securities  Act, as such
rule may be amended from time to time ("Rule 144A"), in transactions  under Rule
144A and (ii) to a limited number of other institutional  "accredited investors"
(as defined in Rule 501(a)(1),  (2), (3) and (7) under  Regulation D of the Act)
in private sales exempt from registration  under the Act (such persons specified
in clauses (i) and (ii) being referred to herein as the "Eligible  Purchasers").
Sales  to  Eligible  Purchasers  shall  be made in  compliance  with  applicable
securities  laws and any  shares  so sold  shall  bear  appropriate  restrictive
legends.

         Vision  21  agrees  to take  all  necessary  steps  to  facilitate  the
Stockholder's sale of the Restricted Shares to Eligible  Purchasers.  During the
period of time the Stockholder is trying to sell the Restricted  Shares pursuant
to this Section 13(b),  Vision 21 shall advise the Stockholder  promptly and, if
requested by it, shall promptly confirm such advice in writing,  of any material
adverse  change,  or of any  event  or  condition  known to  Vision  21 which is
reasonably likely to result in a material change, in the condition (financial or
other), business, prospects, liabilities (contingent or otherwise),  properties,
net worth,  solvency  or  results of  operations  of Vision 21  (whether  or not
arising in the ordinary  course of business),  or of the happening of any event,
any  information  becoming  known or the existence of any  condition  that would
require any amendment or supplement to any Vision 21 filing with the  Commission
so that such filings  would not contain any untrue  statement of a material fact
or omit to state a material fact  required to be stated  therein or necessary to
make the statements  therein, in the light of the circumstances under which they
were made, not misleading.
<PAGE>

         Vision 21 will cooperate with the  Stockholder  and with its counsel in
connection with the qualification of the Restricted Shares for offering and sale
by the Stockholder and by dealers to Eligible Purchasers under the securities or
Blue Sky laws of such  jurisdictions  as the  Stockholder may designate and will
file such  consents  to  service  of process  or other  documents  necessary  or
appropriate in order to effect such qualification.

         For so long as any of the Restricted Shares are held by the Stockholder
and are "restricted  securities"  within the meaning of Rule 144(a)(3) under the
Act and  during any  period in which  Vision 21 is not  subject to Section 13 or
15(d) of the Securities Exchange Act of 1934, as amended, Vision 21 will furnish
to holders  and  beneficial  owners of the  Restricted  Shares  and  prospective
purchasers of Restricted Shares designated by such holders, upon request of such
holders or beneficial  owners or such  prospective  purchasers,  the information
required to be  delivered  pursuant to Rule  144A(d)(4)  under the Act to permit
compliance with Rule 144A in connection with resales of the Restricted Shares.

         (c) The  Stockholder  will be free to seek all other remedies which may
be  available  at law or in equity in  connection  with Vision  21's  failure to
comply with the terms of this Agreement.

     14. Listing on Securities Exchanges.  Vision 21 shall cause the listing and
the  continuation  of listing of Vision 21's common stock on the NASDAQ National
Market.  By February 1, 1998  Vision 21 shall file the  appropriate  application
(and pay the associated fee) for listing the Restricted Shares with NASDAQ.

     15.  SEC  Filings.  During  the  period  of time the  Stockholder  owns the
restricted  Shares  Vision 21 shall  supply the  Stockholder  with a copy of all
annual or quarterly  reports of Vision 21 and such other  reports and  documents
filed by the Company with the  Commission.  Such copies shall be supplied within
three business days after the filing thereof with the Commission.

     16.   Non-Transferability.   The  benefits  set  forth  herein,   including
indemnification  by Vision 21, are granted for the sole and personal  benefit of
the Stockholder and may not be transferred or assigned,  provided that Vision 21
consents to the terms and conditions of that certain Collateral Assignment among
Vision 21, the Stockholder and Foothill Capital  Corporation  dated December 30,
1997.

     17. Delay of Registration.  Stockholder  agrees that it shall have no right
to  obtain  or  seek  an  injunction   restraining  or  otherwise  delaying  any
registration statement filed by Vision 21.

     18. Notices.

         (a) All  communications  under this  Agreement  shall be in writing and
shall be sufficient in all respects if personally delivered or mailed by prepaid
certified or registered mail, return receipt requested, addressed as follows:
<PAGE>

                     (i)    If to Vision 21, at:
                            Vision Twenty-One, Inc.
                            7209 Bryan Dairy Road
                            Largo, Florida 34647
                            Attn:  Theodore N. Gillette, Chief Executive Officer

                            With a copy to:

                            Darrell C. Smith, Esquire
                            Shumaker, Loop & Kendrick, LLP
                            101 E. Kennedy Boulevard, Suite 2800
                            Tampa, Florida 33602

                     (ii)   If to the Stockholder at:      

                            LaserSight Incorporated
                            12161 Lackland Road                             
                            St. Louis, Missouri 63146 
                            Attn: Michael R. Farris, Chief Executive Officer


                            with a copy to:

                            Alan B. Bornstein, Esquire
                            Sonnenschein Nath & Rosenthal
                            One Metropolitan Square
                            Suite 3000
                            St. Louis, Missouri 63102

or at such other address as one party may have furnished in writing to the other
 party.

         (b) Any notice so  addressed,  when mailed by  registered  or certified
mail, shall be deemed to be given three days after so mailed, and when delivered
by hand shall be deemed to be given upon delivery.

     19. Counterparts.  One or more counterparts of this Agreement may be signed
by the  parties,  each of which shall be an original  but all of which  together
shall constitute one and the same instrument.

     20. Governing Law. This Agreement shall be construed in accordance with and
governed by the internal  laws of the State of Florida,  which shall  prevail in
all matters arising under or in connection with this Agreement.

     21.  Headings.  The  headings  in this  Agreement  are for  convenience  of
reference  only and  shall  not be deemed  to alter or  affect  the  meaning  or
interpretation of any provisions hereof.
<PAGE>

     22. Stock Lettering.  Vision 21 shall have the right to provide a legend on
the  shares  of Common  Stock  covered  hereunder  reflecting  the  restrictions
described herein.

     IN WITNESS WHEREOF,  the undersigned have executed this Agreement as of the
date and year first above written.


                                       VISION TWENTY-ONE, INC.


                                       By:  /s/ Richard T. Welch
                                          -------------------------------
                                             Richard T. Welch,      
                                             its Chief Financial Officer


                                       LASERSIGHT INCORPORATED


                                       By:  /s/ Michael R. Farris
                                          -------------------------------
                                             Michael R. Farris,
                                             its Chief Executive Officer




  

                      CONSENT AND AMENDMENT NUMBER FOUR TO
                           LOAN AND SECURITY AGREEMENT
                           ---------------------------


         THIS CONSENT AND AMENDMENT  NUMBER FOUR TO LOAN AND SECURITY  AGREEMENT
(this  "Consent  and  Amendment")  is entered  into as of December 30, 1997 (but
effective only in accordance  with the terms and conditions of Section 5 of this
Consent and Amendment), by and among FOOTHILL CAPITAL CORPORATION,  a California
corporation  ("Foothill"),   LASERSIGHT  INCORPORATED,  a  Delaware  corporation
("LaserSight"),   LASERSIGHT   TECHNOLOGIES,   INC.,   a  Delaware   corporation
("Technologies"),  MEC HEALTH CARE, INC., a Maryland  corporation  ("MEC"),  LSI
ACQUISITION,   INC.,  a  New  Jersey  corporation  ("LSI"),  LASERSIGHT  CENTERS
INCORPORATED,  a Delaware  corporation  ("Centers"),  and MRF,  INC., a Missouri
corporation  ("MRF,"  together  with  LaserSight,  Technologies,  MEC,  LSI, and
Centers, individually and collectively, jointly and severally, "Borrower"), with
reference to the following facts:

         A.   Foothill  and Borrower  heretofore  have entered into that certain
              Loan  and  Security  Agreement,  dated as of March  31,  1997,  as
              amended by that certain  Consent and Amendment  Number One to Loan
              and Security Agreement, dated as of July 28, 1997, by that certain
              Consent and Amendment  Number Two to Loan and Security  Agreement,
              dated as of August  29,  1997,  and by that  certain  Consent  and
              Amendment Number Three to Loan and Security Agreement, dated as of
              September 10, 1997 (as amended, the "Loan Agreement");

         B.   Borrower  has  requested  that  Foothill  consent  to the  sale by
              LaserSight of all of the issued and  outstanding  capital stock of
              MEC and LSI to Vision  Twenty-One,  Inc.,  a  Florida  corporation
              ("Vision")  for a total  purchase  price of  $13,000,000,  payable
              $6,500,000 in cash at closing to occur on the date hereof, and the
              balance  of  $6,500,000   (subject  to  certain   purchase   price
              adjustments)  to be paid  between the date hereof and May 29, 1998
              through LaserSight's  disposition,  on a periodic basis, of shares
              of Vision's  common stock received from Vision at the closing (the
              "Vision  Pledged  Shares"),  and, in the event that LaserSight has
              not  received  $6,500,000  through the  disposition  of the Vision
              Pledged  Shares on or before  May 29,  1998,  Vision  will pay the
              amount of any such  shortfall on such date to  LaserSight in cash;
              that Foothill  further agree to a waiver of compliance by Borrower
              with the  Financial  Covenants as set forth in the Loan  Agreement
              until June 15, 1998;  that the Loan Agreement be amended to delete
              MEC and LSI as  borrowers  thereunder  and  that  all  other  Loan
              Documents,  including,  but  not  limited  to,  the  Stock  Pledge

<PAGE>

              Agreement,  the Copyright Security Agreement,  the Patent Security
              Agreement,  the Trademark Security  Agreement,  and the Suretyship
              Agreement,  in each case  between the  Borrower  and  Foothill and
              dated as of March 31, 1997,  be  simultaneously  amended to delete
              MEC and LSI as parties thereto; and that Foothill further agree to
              release  its lien of the  capital  stock and assets of each of MEC
              and LSI and to amend all filed financing  statements to delete MEC
              and LSI as debtors (the foregoing  hereinafter  referred to as the
              "Transaction").

         C.   In response to the foregoing  request that Foothill consent to the
              Transaction,  Foothill  requires  that  the  Borrower,  out of the
              initial cash proceeds received by it from the Transaction,  reduce
              the amount  outstanding  under the Term Loan as of the date hereof
              by  $2,000,000,  with the balance of the Term Loan to be repaid on
              or  before  June  15,  1998,  out of the  proceeds  received  from
              LaserSight's  disposition  of  the  Vision  Pledged  Shares  after
              LaserSight  has received  $2,500,000  of such  proceeds;  that the
              Borrower,   also  out  of  the  initial  cash  proceeds  from  the
              Transaction,  repay all Revolving  Advances  outstanding as of the
              date hereof;  and that the Loan Agreement be amended to change the
              Maximum  Revolver Amount from  $4,000,000 to $2,000,000,  with all
              Revolving  Advances  being  fully  repaid  and the Loan  Agreement
              terminated as of June 15, 1998.

         D.   Foothill is willing to consent to the Transaction and to amend the
              Loan Agreement in accordance with the terms and conditions hereof;
              and

         E.   All  capitalized  terms used but not defined herein shall have the
              meanings  ascribed  to  them in the  Loan  Agreement,  as  amended
              hereby.

         NOW,  THEREFORE,  in consideration of the above recitals and the mutual
premises contained herein, Foothill and Borrower hereby agree as follows:

         1.   Amendments to the Loan Agreement.
              ---------------------------------

              A. Section 1.1 of the Loan Agreement  is hereby  amended to revise
the following defined terms:

         "Borrower"   means   LaserSight,   Technologies,   Centers   and   MRF,
individually and collectively, jointly and severally.

         "Maximum Revolver Amount" means $2,000,000.
<PAGE>

              B. Section 1.1 of the Loan Agreement  hereby is amended to include
the following defined terms:

         "Vision" means Vision Twenty-One, Inc., a Florida corporation.

         "Vision  Pledged  Shares"  means  812,500  shares  of  the  issued  and
outstanding  common  stock  of  Vision  received  by  LaserSight  as part of the
consideration  for the sale by  LaserSight  to Vision of all of the  issued  and
outstanding  capital  stock of MEC and LSI  pursuant  to the terms of the Vision
Stock Purchase Agreement.

         "Vision Stock  Purchase  Agreement"  means that certain Stock  Purchase
Agreement between Vision and LaserSight dated as of December 1, 1997 pursuant to
which  LaserSight has agreed to sell to Vision all of the issued and outstanding
capital stock of MEC and LSI for a total  consideration of $13,000,000,  payable
$6,500,000  in cash and the balance  through the issuance of the Vision  Pledged
Shares.

         "Vision  Stock   Distribution   Agreement"  means  that  certain  Stock
Distribution  Agreement  between Vision and LaserSight  dated as of December 30,
1997 pursuant to which Vision and  LaserSight  have agreed to the procedures for
the  disposition  of the Vision  Pledged Shares through the period from the date
hereof through May 29, 1998, at which time, in the event that LaserSight has not
received a minimum of  $6,500,000  from the  disposition  of the Vision  Pledges
Shares,   Vision  will  pay  any  such   shortfall  in  cash  to  LaserSight  in
consideration for any remaining Vision Pledged Shares held by LaserSight on such
date.


              C. Section  2.3 of the  Loan  Agreement  hereby is  amended in its
entirety to read as follows:

              2.3  Term  Loan.  Foothill  has  agreed  to make a "Term  Loan" to
         Borrower in the original principal amount of $4,000,000.  The Term Loan
         shall be repaid with an initial  repayment of  $2,000,000  on or before
         December 30, 1997,  and the balance of  $2,000,000  repaid  through the
         proceeds  received by  LaserSight  from the  disposition  of the Vision
         Pledged Shares  pursuant to the terms of the Vision Stock  Distribution
         Agreement, it being agreed between Borrower and Foothill that the first
         $2,500,000  of such  proceeds  shall be made  available  by Foothill to
         Borrower for  Revolving  Advances in  accordance  with the terms hereof
         through  the  application  of such  proceeds  to the  Foothill  Account
         pursuant to Section 2.7 hereof;  and all  proceeds  received  after the

<PAGE>

         receipt of initial  $2,500,000 in proceeds shall be applied by Foothill
         as  and  when  received  from  Vision,  pursuant  to the  Vision  Stock
         Distribution  Agreement or that certain Escrow Agreement between Vision
         and LaserSight dated as of December 30, 1997 (the "Escrow  Agreement"),
         in repayment  of the  remaining  outstanding  balance from time to time
         under the Term Loan until the Term Loan is fully  repaid;  and,  on May
         29,  1998,  in the event that the Term Loan has not been  fully  repaid
         from  proceeds  received  from the  disposition  of the Vision  Pledged
         Shares  and  Vision  is   obligated,   pursuant  to  the  Vision  Stock
         Distribution  Purchase  Agreement,  to pay a shortfall to LaserSight in
         the amount of the  difference  between  $6,500,000  (subject to certain
         purchase  price   adjustments)   and  the  amount   received  from  the
         disposition of the Vision Pledged Shares, any such cash payment made by
         Vision shall be applied by Foothill first to the payment of any balance
         remaining  outstanding  under  the Term  Loan,  and any  amount of such
         shortfall  payment  remaining  after  such  application,  shall be made
         available to Borrower for  Revolving  Advances in  accordance  with the
         terms hereof by application to the Foothill  Account.  The  outstanding
         principal  balance and all accrued and unpaid  interest  under the Term
         Loan shall be due and payable upon the  termination of this  Agreement,
         whether by its terms, by prepayment, by acceleration, or otherwise. The
         unpaid principal balance of the Term Loan may be prepaid in whole or in
         part  without  penalty of  premium at any time  during the term of this
         Agreement  upon 30 days prior  written  notice by Borrower to Foothill.
         All  amounts   outstanding   under  the  Term  Loan  shall   constitute
         Obligations.

              D.  Section  3.4 of the Loan  Agreement  hereby is  amended  in is
entirety to read as follows:

              3.4 Term. This Agreement shall become effective upon the execution
         and delivery hereof by each Borrower and Foothill and shall continue in
         full  force and  effect  for a term  ending on the date (the  "Maturity
         Date")  that is the earlier of (a) June 15,  1998,  and (b) the date on
         which  the sale of  Technologies  by  LaserSight  is  consummated.  The
         foregoing  notwithstanding,  Foothill shall have the right to terminate
         its obligations  under this Agreement  immediately  without notice upon
         the occurrence and during the continuance in the Event of Default.

         2. Consent.  Foothill  hereby consents to the  Transaction,  and agrees
that the  Transaction  shall  not be deemed  to cause  any  Default  or Event of
Default  under the Loan  Agreement,  as amended by this  Consent  and  Amendment
including,  but not  limited  to, any  Default  or Event of  Default  that would
otherwise have occurred as a result of the  Transaction  absent this Consent and
Amendment  under  Sections 7.3, 7.4 or 7.7 of the Loan  Agreement.  Foothill and
each  Borrower  hereby  agrees and  consents  to the  deletion of MEC and LSI as
Borrowers   under  the  Loan  Agreement  and  each  remaining   Borrower  hereby
acknowledges  and confirms  that the deletion of MEC and LSI as Borrowers  under

<PAGE>

the Loan  Agreement  shall not impair the  obligations  and  liabilities  of the
remaining Borrowers to Foothill. Foothill and Borrower further agree and consent
to conforming amendments to the Loan Documents to effect the deletion of MEC and
LSI as  parties  thereto,  including,  but not  limited  to,  the  Stock  Pledge
Agreement,  the Copyright Security Agreement,  the Trademark Security Agreement,
the Patent Security Agreement and the Suretyship  Agreement,  in each case dated
as of March 31, 1997, between the Borrower and Foothill.

         3. Waiver of Financial Covenant and Compliance.  Foothill hereby waives
Borrower's  compliance with the financial covenants set forth in Section 7.20 of
the Loan Agreement until June 16, 1998.

         4.  Representations  and  Warranties.  Borrower  hereby  represents and
warrants to Foothill that (a) the execution,  delivery,  and performance of this
Consent and Amendment and of the Loan Agreement,  as amended by this Consent and
Amendment,  are within its corporate  powers,  have been duly  authorized by all
necessary  corporate  action,  and are not in contravention of any law, rule, or
regulation,  or any order, judgment,  decree, writ, injunction,  or award of any
arbitrator,  court, or governmental authority, or of the terms of its charter or
bylaws, or of any contract or undertaking to which it is a party or by which any
of its properties  may be bound or affected,  and (b) this Consent and Amendment
and the Loan  Agreement,  as amended by this Consent and  Amendment,  constitute
Borrower's legal, valid, and binding obligation, enforceable against Borrower in
accordance with its terms.

         5.  Conditions  Precedent  to the  Effectiveness  of this  Consent  and
Amendment.  The  effectiveness  of this Consent and  Amendment is subject to the
fulfillment,  to the  satisfaction  of Foothill and its counsel,  of each of the
following conditions:

              A. Foothill  shall have received each of the following  documents,
duly executed, and each such document shall be in full force and effect:

              (1)  a  Collateral  Assignment  of  Rights  Under  Stock  Purchase
         Agreement,  Stock Distribution Agreement and Escrow Agreement,  in form
         and  substance  satisfactory  to Foothill,  executed  and  delivered by
         LaserSight  and  consented  to by  Vision,  in the  form of  Exhibit  A
         attached hereto; and

              (2) a Stock Pledge Agreement,  in form and substance  satisfactory
         to Foothill, executed by LaserSight in favor of Foothill in the form of
         Exhibit B attached hereto.
<PAGE>

              B.  Foothill   shall  have  received  the  original   certificates
representing or evidencing all of the Vision Pledged Shares, together with stock
powers or equivalent assignments with respect thereto duly endorsed in blank;

              C.  Foothill   shall  have  received   copies,   certified  by  an
appropriate officer of LaserSight,  as being true, complete, and correct, of the
Vision Stock Purchase Agreement,  the Vision Stock Distribution  Agreement,  the
Escrow Agreement and any other documents or agreement  executed and/or delivered
in  connection  therewith,  each  of  which  shall  be  in  form  and  substance
satisfactory to Foothill;

              D. No  Material  Adverse  Change  in the  financial  condition  of
Borrower or in the value of the Collateral shall have occurred;

              E.  The   representations  and  warranties  in  this  Consent  and
Amendment,  the Loan Agreement as amended by this Consent and Amendment, and the
other Loan Documents  shall be true and correct in all respects on and as of the
date  hereof,  as  though  made on such date  (except  to the  extent  that such
representations and warranties relate solely to an earlier date);

              F. No Event of Default or event which with the giving of notice or
passage of time would  constitute an Event of Default shall have occurred and be
continuing  on the date hereof,  nor shall result from the  consummation  of the
transactions contemplated herein;

              G. No injunction,  writ,  restraining order, or other order of any
nature prohibiting, directly or indirectly, the consummation of the transactions
contemplated  herein  shall  have  been  issued  and  remain  in  force  by  any
governmental authority against Borrower, Foothill, or any of their Affiliates;

              H. Foothill shall have received from Borrower a  modification  fee
in the amount of $75,000,  such fee fully earned by Foothill  upon its execution
of this Consent and Amendment,  such  modification  fee payable $50,000 upon the
execution of this  Consent and  Amendment by Foothill and the balance of $25,000
to be paid on the  earlier  to occur  of (i)  June 15,  1998 or (ii) the date on
which all of the  Obligations  of Borrower to Foothill  under the Loan Agreement
have been paid in full; and

              I.  Foothill  shall have  received  from Vision into the  Foothill
Account $6,500,000, the cash portion of the purchase price for the shares of MEC
and LSI under the Vision Stock Purchase Agreement,  and shall also have received
a  direction  letter  from  Borrower,  in form  and  substance  satisfactory  to
Foothill, directing the application of such funds to repay outstanding Revolving
Advances, to pay down the Term Loan by $2,000,000, and the use of the balance of
such funds.
<PAGE>

         6. Effect on Loan  Agreement.  The Loan  Agreement,  as amended hereby,
shall be and remain in full force and effect in accordance  with its  respective
terms and hereby is ratified  and  confirmed  in all  respects.  The  execution,
delivery,  and  performance of this Consent and Amendment shall not operate as a
waiver of or,  except as expressly set forth  herein,  as an  amendment,  of any
right, power, or remedy of Foothill under the Loan Agreement, as in effect prior
to the date hereof.

         7.  Further   Assurances.   Borrower  shall  execute  and  deliver  all
agreements,  documents,  and  instruments,  in  form  and  substance  reasonably
satisfactory  to  Foothill,  and take all  actions as  Foothill  may  reasonably
request from time to time, to perfect and maintain the  perfection  and priority
of Foothill's  security  interests in the Collateral and to fully consummate the
transactions  contemplated  under  this  Consent  and  Amendment  and  the  Loan
Agreement, as amended by this Consent and Amendment.  Foothill shall execute and
deliver  all  agreements,  documents  and  instruments,  in form  and  substance
reasonably satisfactory to Vision, and take all actions as Vision may reasonably
request  from time to time,  to release  Foothill's  security  interests  in the
capital stock of MEC and LSI, and in the personal property assets of MEC and LSI
as required by the terms and conditions of the Vision Stock Purchase Agreement.

         8. Miscellaneous.

              A. Upon the  effectiveness  of this  Consent and  Amendment,  each
reference in the Loan  Agreement  to "this  Agreement,"  "hereunder,"  "herein,"
"hereof," or words of like import referring to the Loan Agreement shall mean and
refer to the Loan Agreement as amended by this Consent and Amendment.

              B. Upon the  effectiveness  of this  Consent and  Amendment,  each
reference  in  the  Loan  Documents  to  the  "Loan  Agreement,"   "thereunder,"
"therein,"  "thereof," or words of like import  referring to the Loan  Agreement
shall  mean and refer to the Loan  Agreement  as  amended  by this  Consent  and
Amendment.

              C. This Consent and  Amendment  shall be governed by and construed
in accordance with the laws of the State of California.

              D. This  Consent  and  Amendment  may be executed in any number of
counterparts,  all of which taken  together  shall  constitute  one and the same
instrument  and any of the parties hereto may execute this Consent and Amendment
by signing any such counterpart.
<PAGE>

              E. Upon the effectiveness of this Consent and Amendment,  Foothill
hereby terminates its security  interests in, security titles to and other liens
on all real and  personal  property  assets of MEC and LSI  without  any further
action.


                  [Remainder of page intentionally left blank]

<PAGE>



                  IN WITNESS  WHEREOF,  the  parties  hereto  have  caused  this
Consent and Amendment to be duly executed as of the date first written above.

                                             FOOTHILL CAPITAL CORPORATION, 
                                             a California corporation


                                             By: /s/ Kent Dahl
                                                -------------------------

                                             Title:  E.V.P.
                                                    ---------------------


                                             LASERSIGHT INCORPORATED,
                                             a Delaware corporation


                                             By: /s/ Michael R. Farris
                                                -------------------------

                                             Title: President
                                                   ----------------------


                                             LASERSIGHT TECHNOLOGIES, INC.,
                                             a Delaware corporation


                                             By: /s/ Gregory L. Wilson
                                                -------------------------

                                             Title: Vice President
                                                   ----------------------


                                             MEC HEALTH CARE, INC.,
                                             a Maryland corporation


                                             By: /s/ Gregory L. Wilson
                                                -------------------------

                                             Title: Vice President
                                                   ----------------------




                       [Signatures Continued on Next Page]


<PAGE>

                                             LSI ACQUISITION, INC.,
                                             a New Jersey corporation


                                             By: /s/ Gregory L. Wilson
                                                -------------------------

                                             Title: Secretary/Treasurer
                                                   ----------------------


                                             LASERSIGHT CENTERS INCORPORATED,
                                             a Delaware corporation


                                             By: /s/ Gregory L. Wilson
                                                -------------------------

                                             Title: Vice President
                                                   ----------------------


                                             MRF, INC.,
                                             a Missouri corporation


                                             By: /s/ Gregory L. Wilson
                                                -------------------------

                                             Title: Secretary/Treasurer
                                                   ----------------------



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission